id	sid	tid	token	lemma	pos
dpc-2102	1	1	dermatology	dermatology	NOUN
dpc-2102	1	2	:	:	PUNCT
dpc-2102	1	3	practical	practical	ADJ
dpc-2102	1	4	and	and	CCONJ
dpc-2102	1	5	conceptual	conceptual	ADJ
dpc-2102	1	6	original	original	ADJ
dpc-2102	1	7	article	article	NOUN
dpc-2102	1	8	|	|	ADV
dpc-2102	1	9	dermatol	dermatol	ADJ
dpc-2102	1	10	pract	pract	NOUN
dpc-2102	1	11	concept	concept	NOUN
dpc-2102	1	12	.	.	PUNCT
dpc-2102	2	1	2022;12(3):e2022144	2022;12(3):e2022144	NUM
dpc-2102	2	2	1	1	NUM
dpc-2102	2	3	dermatology	dermatology	NOUN
dpc-2102	2	4	practical	practical	ADJ
dpc-2102	2	5	&	&	CCONJ
dpc-2102	2	6	conceptual	conceptual	ADJ
dpc-2102	2	7	comparison	comparison	NOUN
dpc-2102	2	8	of	of	ADP
dpc-2102	2	9	early	early	ADJ
dpc-2102	2	10	and	and	CCONJ
dpc-2102	2	11	late	late	ADJ
dpc-2102	2	12	onset	onset	VERB
dpc-2102	2	13	psoriasis	psoriasis	NOUN
dpc-2102	2	14	(	(	PUNCT
dpc-2102	2	15	eop	eop	PROPN
dpc-2102	2	16	and	and	CCONJ
dpc-2102	2	17	lop	lop	PROPN
dpc-2102	2	18	)	)	PUNCT
dpc-2102	2	19	regarding	regard	VERB
dpc-2102	2	20	systemic	systemic	ADJ
dpc-2102	2	21	inflammatory	inflammatory	ADJ
dpc-2102	2	22	comorbidities	comorbiditie	NOUN
dpc-2102	2	23	:	:	PUNCT
dpc-2102	2	24	lop	lop	NOUN
dpc-2102	2	25	is	be	AUX
dpc-2102	2	26	a	a	DET
dpc-2102	2	27	more	more	ADV
dpc-2102	2	28	rapid	rapid	ADJ
dpc-2102	2	29	subtype	subtype	NOUN
dpc-2102	2	30	of	of	ADP
dpc-2102	2	31	psoriasis	psoriasis	NOUN
dpc-2102	2	32	leyla	leyla	PRON
dpc-2102	2	33	huseynova	huseynova	PROPN
dpc-2102	2	34	terzi1	terzi1	PROPN
dpc-2102	2	35	,	,	PUNCT
dpc-2102	2	36	sibel	sibel	PROPN
dpc-2102	2	37	dogan	dogan	PROPN
dpc-2102	2	38	gunaydin1,2	gunaydin1,2	PROPN
dpc-2102	2	39	1	1	NUM
dpc-2102	2	40	 	 	SPACE
dpc-2102	2	41	hacettepe	hacettepe	NOUN
dpc-2102	2	42	university	university	NOUN
dpc-2102	2	43	,	,	PUNCT
dpc-2102	2	44	faculty	faculty	NOUN
dpc-2102	2	45	of	of	ADP
dpc-2102	2	46	medicine	medicine	NOUN
dpc-2102	2	47	,	,	PUNCT
dpc-2102	2	48	department	department	NOUN
dpc-2102	2	49	of	of	ADP
dpc-2102	2	50	dermatology	dermatology	NOUN
dpc-2102	2	51	and	and	CCONJ
dpc-2102	2	52	venereology	venereology	NOUN
dpc-2102	2	53	,	,	PUNCT
dpc-2102	2	54	ankara	ankara	PROPN
dpc-2102	2	55	,	,	PUNCT
dpc-2102	2	56	turkey	turkey	PROPN
dpc-2102	2	57	2	2	NUM
dpc-2102	2	58	 	 	SPACE
dpc-2102	2	59	hacettepe	hacettepe	NOUN
dpc-2102	2	60	university	university	NOUN
dpc-2102	2	61	,	,	PUNCT
dpc-2102	2	62	graduate	graduate	NOUN
dpc-2102	2	63	school	school	NOUN
dpc-2102	2	64	of	of	ADP
dpc-2102	2	65	medical	medical	ADJ
dpc-2102	2	66	sciences	sciences	PROPN
dpc-2102	2	67	,	,	PUNCT
dpc-2102	2	68	department	department	NOUN
dpc-2102	2	69	of	of	ADP
dpc-2102	2	70	pediatric	pediatric	ADJ
dpc-2102	2	71	basic	basic	ADJ
dpc-2102	2	72	sciences	science	NOUN
dpc-2102	2	73	,	,	PUNCT
dpc-2102	2	74	immunology	immunology	NOUN
dpc-2102	2	75	,	,	PUNCT
dpc-2102	2	76	ankara	ankara	PROPN
dpc-2102	2	77	,	,	PUNCT
dpc-2102	2	78	turkey	turkey	PROPN
dpc-2102	2	79	key	key	ADJ
dpc-2102	2	80	words	word	NOUN
dpc-2102	2	81	:	:	PUNCT
dpc-2102	2	82	psoriasis	psoriasis	NOUN
dpc-2102	2	83	,	,	PUNCT
dpc-2102	2	84	comorbidity	comorbidity	NOUN
dpc-2102	2	85	,	,	PUNCT
dpc-2102	2	86	early	early	ADJ
dpc-2102	2	87	onset	onset	VERB
dpc-2102	2	88	psoriasis	psoriasis	NOUN
dpc-2102	2	89	,	,	PUNCT
dpc-2102	2	90	late	late	ADJ
dpc-2102	2	91	onset	onset	NOUN
dpc-2102	2	92	psoriasis	psoriasis	NOUN
dpc-2102	2	93	,	,	PUNCT
dpc-2102	2	94	inflammation	inflammation	ADJ
dpc-2102	2	95	citation	citation	NOUN
dpc-2102	2	96	:	:	PUNCT
dpc-2102	2	97	huseynova	huseynova	PROPN
dpc-2102	2	98	terzi	terzi	PROPN
dpc-2102	2	99	l	l	PROPN
dpc-2102	2	100	,	,	PUNCT
dpc-2102	2	101	dogan	dogan	PROPN
dpc-2102	2	102	gunaydin	gunaydin	NOUN
dpc-2102	2	103	.	.	PUNCT
dpc-2102	3	1	comparison	comparison	NOUN
dpc-2102	3	2	of	of	ADP
dpc-2102	3	3	early	early	ADJ
dpc-2102	3	4	(	(	PUNCT
dpc-2102	3	5	eop	eop	PROPN
dpc-2102	3	6	)	)	PUNCT
dpc-2102	3	7	and	and	CCONJ
dpc-2102	3	8	late	late	ADJ
dpc-2102	3	9	onset	onset	VERB
dpc-2102	3	10	psoriasis	psoriasis	NOUN
dpc-2102	3	11	(	(	PUNCT
dpc-2102	3	12	lop	lop	NOUN
dpc-2102	3	13	)	)	PUNCT
dpc-2102	3	14	regarding	regard	VERB
dpc-2102	3	15	systemic	systemic	ADJ
dpc-2102	3	16	inflammatory	inflammatory	ADJ
dpc-2102	3	17	comorbidities	comorbiditie	NOUN
dpc-2102	3	18	:	:	PUNCT
dpc-2102	3	19	lop	lop	NOUN
dpc-2102	3	20	is	be	AUX
dpc-2102	3	21	a	a	DET
dpc-2102	3	22	more	more	ADV
dpc-2102	3	23	rapid	rapid	ADJ
dpc-2102	3	24	subtype	subtype	NOUN
dpc-2102	3	25	of	of	ADP
dpc-2102	3	26	psoriasis	psoriasis	NOUN
dpc-2102	3	27	.	.	PUNCT
dpc-2102	4	1	dermatol	dermatol	NOUN
dpc-2102	4	2	pract	pract	PROPN
dpc-2102	4	3	concept	concept	NOUN
dpc-2102	4	4	.	.	PUNCT
dpc-2102	5	1	2022;12(3):e2022144	2022;12(3):e2022144	X
dpc-2102	5	2	.	.	PUNCT
dpc-2102	6	1	doi	doi	NOUN
dpc-2102	6	2	:	:	PUNCT
dpc-2102	6	3	https://doi.org/10.5826/	https://doi.org/10.5826/	PROPN
dpc-2102	6	4	dpc.1203a144	dpc.1203a144	PRON
dpc-2102	6	5	accepted	accept	VERB
dpc-2102	6	6	:	:	PUNCT
dpc-2102	6	7	november	november	PROPN
dpc-2102	6	8	28	28	NUM
dpc-2102	6	9	,	,	PUNCT
dpc-2102	6	10	2021	2021	NUM
dpc-2102	6	11	;	;	PUNCT
dpc-2102	6	12	published	publish	VERB
dpc-2102	6	13	:	:	PUNCT
dpc-2102	7	1	july	july	PROPN
dpc-2102	7	2	2022	2022	NUM
dpc-2102	7	3	copyright	copyright	NOUN
dpc-2102	7	4	:	:	PUNCT
dpc-2102	7	5	©	©	PROPN
dpc-2102	7	6	2022	2022	NUM
dpc-2102	7	7	tognetti	tognetti	NOUN
dpc-2102	7	8	et	et	PROPN
dpc-2102	7	9	al	al	PROPN
dpc-2102	7	10	.	.	PUNCT
dpc-2102	8	1	this	this	PRON
dpc-2102	8	2	is	be	AUX
dpc-2102	8	3	an	an	DET
dpc-2102	8	4	open	open	ADJ
dpc-2102	8	5	-	-	PUNCT
dpc-2102	8	6	access	access	NOUN
dpc-2102	8	7	article	article	NOUN
dpc-2102	8	8	distributed	distribute	VERB
dpc-2102	8	9	under	under	ADP
dpc-2102	8	10	the	the	DET
dpc-2102	8	11	terms	term	NOUN
dpc-2102	8	12	of	of	ADP
dpc-2102	8	13	the	the	DET
dpc-2102	8	14	creative	creative	ADJ
dpc-2102	8	15	commons	common	NOUN
dpc-2102	8	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-2102	8	17	license	license	NOUN
dpc-2102	8	18	(	(	PUNCT
dpc-2102	8	19	by	by	ADP
dpc-2102	8	20	-	-	PUNCT
dpc-2102	8	21	nc-4.0	nc-4.0	NOUN
dpc-2102	8	22	)	)	PUNCT
dpc-2102	8	23	,	,	PUNCT
dpc-2102	8	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2102	8	25	,	,	PUNCT
dpc-2102	8	26	which	which	PRON
dpc-2102	8	27	permits	permit	VERB
dpc-2102	8	28	unrestricted	unrestricted	ADJ
dpc-2102	8	29	noncommercial	noncommercial	ADJ
dpc-2102	8	30	use	use	NOUN
dpc-2102	8	31	,	,	PUNCT
dpc-2102	8	32	distribution	distribution	NOUN
dpc-2102	8	33	,	,	PUNCT
dpc-2102	8	34	and	and	CCONJ
dpc-2102	8	35	reproduction	reproduction	NOUN
dpc-2102	8	36	in	in	ADP
dpc-2102	8	37	any	any	DET
dpc-2102	8	38	medium	medium	NOUN
dpc-2102	8	39	,	,	PUNCT
dpc-2102	8	40	provided	provide	VERB
dpc-2102	8	41	the	the	DET
dpc-2102	8	42	original	original	ADJ
dpc-2102	8	43	authors	author	NOUN
dpc-2102	8	44	and	and	CCONJ
dpc-2102	8	45	source	source	NOUN
dpc-2102	8	46	are	be	AUX
dpc-2102	8	47	credited	credit	VERB
dpc-2102	8	48	.	.	PUNCT
dpc-2102	9	1	funding	funding	NOUN
dpc-2102	9	2	:	:	PUNCT
dpc-2102	9	3	none	none	NOUN
dpc-2102	9	4	.	.	PUNCT
dpc-2102	10	1	competing	compete	VERB
dpc-2102	10	2	interests	interest	NOUN
dpc-2102	10	3	:	:	PUNCT
dpc-2102	10	4	none	none	NOUN
dpc-2102	10	5	.	.	PUNCT
dpc-2102	11	1	authorship	authorship	NOUN
dpc-2102	11	2	:	:	PUNCT
dpc-2102	11	3	all	all	DET
dpc-2102	11	4	authors	author	NOUN
dpc-2102	11	5	have	have	AUX
dpc-2102	11	6	contributed	contribute	VERB
dpc-2102	11	7	significantly	significantly	ADV
dpc-2102	11	8	to	to	ADP
dpc-2102	11	9	this	this	DET
dpc-2102	11	10	publication	publication	NOUN
dpc-2102	11	11	.	.	PUNCT
dpc-2102	12	1	corresponding	correspond	VERB
dpc-2102	12	2	author	author	NOUN
dpc-2102	12	3	:	:	PUNCT
dpc-2102	12	4	leyla	leyla	PROPN
dpc-2102	12	5	huseynova	huseynova	PROPN
dpc-2102	12	6	terzi	terzi	PROPN
dpc-2102	12	7	,	,	PUNCT
dpc-2102	12	8	md	md	PROPN
dpc-2102	12	9	,	,	PUNCT
dpc-2102	12	10	hacettepe	hacettepe	PROPN
dpc-2102	12	11	university	university	NOUN
dpc-2102	12	12	,	,	PUNCT
dpc-2102	12	13	faculty	faculty	NOUN
dpc-2102	12	14	of	of	ADP
dpc-2102	12	15	medicine	medicine	NOUN
dpc-2102	12	16	,	,	PUNCT
dpc-2102	12	17	department	department	NOUN
dpc-2102	12	18	of	of	ADP
dpc-2102	12	19	dermatology	dermatology	NOUN
dpc-2102	12	20	and	and	CCONJ
dpc-2102	12	21	venereology	venereology	NOUN
dpc-2102	12	22	9	9	NUM
dpc-2102	12	23	.	.	PUNCT
dpc-2102	13	1	entrance	entrance	NOUN
dpc-2102	13	2	,	,	PUNCT
dpc-2102	13	3	06100	06100	NUM
dpc-2102	13	4	sıhhiye	sıhhiye	PROPN
dpc-2102	13	5	,	,	PUNCT
dpc-2102	13	6	ankara	ankara	PROPN
dpc-2102	13	7	,	,	PUNCT
dpc-2102	13	8	turkey	turkey	PROPN
dpc-2102	13	9	,	,	PUNCT
dpc-2102	13	10	+90	+90	NOUN
dpc-2102	14	1	312	312	NUM
dpc-2102	14	2	305	305	NUM
dpc-2102	14	3	17	17	NUM
dpc-2102	14	4	0417	0417	NUM
dpc-2102	14	5	06	06	NUM
dpc-2102	14	6	,	,	PUNCT
dpc-2102	14	7	fax	fax	NOUN
dpc-2102	14	8	:	:	PUNCT
dpc-2102	14	9	+90	+90	NOUN
dpc-2102	14	10	312	312	NUM
dpc-2102	14	11	880	880	NUM
dpc-2102	14	12	58	58	NUM
dpc-2102	14	13	08	08	NUM
dpc-2102	14	14	,	,	PUNCT
dpc-2102	14	15	e	e	NOUN
dpc-2102	14	16	-	-	NOUN
dpc-2102	14	17	mail	mail	NOUN
dpc-2102	14	18	:	:	PUNCT
dpc-2102	14	19	leyla.huseynova@ymail.com	leyla.huseynova@ymail.com	PROPN
dpc-2102	15	1	introduction	introduction	NOUN
dpc-2102	15	2	:	:	PUNCT
dpc-2102	15	3	early	early	ADJ
dpc-2102	15	4	onset	onset	VERB
dpc-2102	15	5	psoriasis	psoriasis	NOUN
dpc-2102	15	6	(	(	PUNCT
dpc-2102	15	7	eop	eop	PROPN
dpc-2102	15	8	)	)	PUNCT
dpc-2102	15	9	and	and	CCONJ
dpc-2102	15	10	late	late	ADJ
dpc-2102	15	11	onset	onset	VERB
dpc-2102	15	12	psoriasis	psoriasis	NOUN
dpc-2102	15	13	(	(	PUNCT
dpc-2102	15	14	lop	lop	NOUN
dpc-2102	15	15	)	)	PUNCT
dpc-2102	15	16	differ	differ	VERB
dpc-2102	15	17	regarding	regard	VERB
dpc-2102	15	18	genetic	genetic	ADJ
dpc-2102	15	19	background	background	NOUN
dpc-2102	15	20	,	,	PUNCT
dpc-2102	15	21	clinical	clinical	ADJ
dpc-2102	15	22	presentation	presentation	NOUN
dpc-2102	15	23	and	and	CCONJ
dpc-2102	15	24	course	course	NOUN
dpc-2102	15	25	of	of	ADP
dpc-2102	15	26	disease	disease	NOUN
dpc-2102	15	27	.	.	PUNCT
dpc-2102	16	1	objectives	objective	NOUN
dpc-2102	16	2	:	:	PUNCT
dpc-2102	16	3	in	in	ADP
dpc-2102	16	4	this	this	DET
dpc-2102	16	5	study	study	NOUN
dpc-2102	16	6	,	,	PUNCT
dpc-2102	16	7	comparison	comparison	NOUN
dpc-2102	16	8	of	of	ADP
dpc-2102	16	9	eop	eop	PROPN
dpc-2102	16	10	and	and	CCONJ
dpc-2102	16	11	lop	lop	NOUN
dpc-2102	16	12	regarding	regard	VERB
dpc-2102	16	13	systemic	systemic	ADJ
dpc-2102	16	14	inflammatory	inflammatory	ADJ
dpc-2102	16	15	comorbidities	comorbiditie	NOUN
dpc-2102	16	16	which	which	PRON
dpc-2102	16	17	are	be	AUX
dpc-2102	16	18	frequently	frequently	ADV
dpc-2102	16	19	seen	see	VERB
dpc-2102	16	20	in	in	ADP
dpc-2102	16	21	psoriasis	psoriasis	NOUN
dpc-2102	16	22	and	and	CCONJ
dpc-2102	16	23	determination	determination	NOUN
dpc-2102	16	24	of	of	ADP
dpc-2102	16	25	possible	possible	ADJ
dpc-2102	16	26	differences	difference	NOUN
dpc-2102	16	27	is	be	AUX
dpc-2102	16	28	aimed	aim	VERB
dpc-2102	16	29	.	.	PUNCT
dpc-2102	17	1	methods	method	NOUN
dpc-2102	17	2	:	:	PUNCT
dpc-2102	17	3	a	a	DET
dpc-2102	17	4	total	total	NOUN
dpc-2102	17	5	of	of	ADP
dpc-2102	17	6	160	160	NUM
dpc-2102	17	7	plaque	plaque	NOUN
dpc-2102	17	8	psoriasis	psoriasis	NOUN
dpc-2102	17	9	patients	patient	NOUN
dpc-2102	17	10	(	(	PUNCT
dpc-2102	17	11	121	121	NUM
dpc-2102	17	12	with	with	ADP
dpc-2102	17	13	eop	eop	PROPN
dpc-2102	17	14	and	and	CCONJ
dpc-2102	17	15	39	39	NUM
dpc-2102	17	16	with	with	ADP
dpc-2102	17	17	lop	lop	NOUN
dpc-2102	17	18	)	)	PUNCT
dpc-2102	17	19	were	be	AUX
dpc-2102	17	20	enrolled	enrol	VERB
dpc-2102	17	21	for	for	ADP
dpc-2102	17	22	the	the	DET
dpc-2102	17	23	study	study	NOUN
dpc-2102	17	24	.	.	PUNCT
dpc-2102	18	1	data	datum	NOUN
dpc-2102	18	2	was	be	AUX
dpc-2102	18	3	collected	collect	VERB
dpc-2102	18	4	with	with	ADP
dpc-2102	18	5	face	face	NOUN
dpc-2102	18	6	-	-	PUNCT
dpc-2102	18	7	to	to	ADP
dpc-2102	18	8	-	-	PUNCT
dpc-2102	18	9	face	face	NOUN
dpc-2102	18	10	questionnaire	questionnaire	NOUN
dpc-2102	18	11	and	and	CCONJ
dpc-2102	18	12	patients	patient	NOUN
dpc-2102	18	13	medical	medical	ADJ
dpc-2102	18	14	chart	chart	NOUN
dpc-2102	18	15	evaluation	evaluation	NOUN
dpc-2102	18	16	.	.	PUNCT
dpc-2102	19	1	collected	collect	VERB
dpc-2102	19	2	data	datum	NOUN
dpc-2102	19	3	included	include	VERB
dpc-2102	19	4	medical	medical	ADJ
dpc-2102	19	5	and	and	CCONJ
dpc-2102	19	6	family	family	NOUN
dpc-2102	19	7	history	history	NOUN
dpc-2102	19	8	,	,	PUNCT
dpc-2102	19	9	clinical	clinical	ADJ
dpc-2102	19	10	features	feature	NOUN
dpc-2102	19	11	and	and	CCONJ
dpc-2102	19	12	parameters	parameter	NOUN
dpc-2102	19	13	indicating	indicate	VERB
dpc-2102	19	14	severity	severity	NOUN
dpc-2102	19	15	of	of	ADP
dpc-2102	19	16	psoriasis	psoriasis	NOUN
dpc-2102	19	17	,	,	PUNCT
dpc-2102	19	18	results	result	NOUN
dpc-2102	19	19	of	of	ADP
dpc-2102	19	20	laboratory	laboratory	NOUN
dpc-2102	19	21	work	work	NOUN
dpc-2102	19	22	-	-	PUNCT
dpc-2102	19	23	up	up	NOUN
dpc-2102	19	24	,	,	PUNCT
dpc-2102	19	25	physical	physical	ADJ
dpc-2102	19	26	and	and	CCONJ
dpc-2102	19	27	dermatological	dermatological	ADJ
dpc-2102	19	28	examination	examination	NOUN
dpc-2102	19	29	findings	finding	NOUN
dpc-2102	19	30	,	,	PUNCT
dpc-2102	19	31	presence	presence	NOUN
dpc-2102	19	32	of	of	ADP
dpc-2102	19	33	joint	joint	ADJ
dpc-2102	19	34	and	and	CCONJ
dpc-2102	19	35	nail	nail	NOUN
dpc-2102	19	36	involvement	involvement	NOUN
dpc-2102	19	37	and	and	CCONJ
dpc-2102	19	38	associated	associate	VERB
dpc-2102	19	39	inflammatory	inflammatory	ADJ
dpc-2102	19	40	systemic	systemic	ADJ
dpc-2102	19	41	comorbidities	comorbiditie	NOUN
dpc-2102	19	42	such	such	ADJ
dpc-2102	19	43	as	as	ADP
dpc-2102	19	44	cardiovascular	cardiovascular	ADJ
dpc-2102	19	45	diseases	disease	NOUN
dpc-2102	19	46	(	(	PUNCT
dpc-2102	19	47	cvd	cvd	PROPN
dpc-2102	19	48	)	)	PUNCT
dpc-2102	19	49	,	,	PUNCT
dpc-2102	19	50	diabetes	diabetes	NOUN
dpc-2102	19	51	mellitus	mellitus	NOUN
dpc-2102	19	52	(	(	PUNCT
dpc-2102	19	53	dm	dm	PROPN
dpc-2102	19	54	)	)	PUNCT
dpc-2102	19	55	,	,	PUNCT
dpc-2102	19	56	hypertension	hypertension	NOUN
dpc-2102	19	57	(	(	PUNCT
dpc-2102	19	58	ht	ht	PROPN
dpc-2102	19	59	)	)	PUNCT
dpc-2102	19	60	,	,	PUNCT
dpc-2102	19	61	metabolic	metabolic	NOUN
dpc-2102	19	62	syndrome	syndrome	NOUN
dpc-2102	19	63	(	(	PUNCT
dpc-2102	19	64	ms	ms	NOUN
dpc-2102	19	65	)	)	PUNCT
dpc-2102	19	66	,	,	PUNCT
dpc-2102	19	67	obesity	obesity	NOUN
dpc-2102	19	68	.	.	PUNCT
dpc-2102	20	1	results	result	NOUN
dpc-2102	20	2	:	:	PUNCT
dpc-2102	20	3	nail	nail	NOUN
dpc-2102	20	4	involvement	involvement	NOUN
dpc-2102	20	5	and	and	CCONJ
dpc-2102	20	6	psa	psa	NOUN
dpc-2102	20	7	occurred	occur	VERB
dpc-2102	20	8	more	more	ADV
dpc-2102	20	9	rapidly	rapidly	ADV
dpc-2102	20	10	in	in	ADP
dpc-2102	20	11	lop	lop	NOUN
dpc-2102	20	12	compared	compare	VERB
dpc-2102	20	13	to	to	ADP
dpc-2102	20	14	eop	eop	PROPN
dpc-2102	20	15	(	(	PUNCT
dpc-2102	20	16	p	p	X
dpc-2102	20	17	<	<	X
dpc-2102	20	18	0.01	0.01	NUM
dpc-2102	20	19	,	,	PUNCT
dpc-2102	20	20	p	p	X
dpc-2102	20	21	<	<	X
dpc-2102	20	22	0.01	0.01	NUM
dpc-2102	20	23	)	)	PUNCT
dpc-2102	20	24	.	.	PUNCT
dpc-2102	21	1	compared	compare	VERB
dpc-2102	21	2	frequencies	frequency	NOUN
dpc-2102	21	3	in	in	ADP
dpc-2102	21	4	lop	lop	PROPN
dpc-2102	21	5	and	and	CCONJ
dpc-2102	21	6	eop	eop	PROPN
dpc-2102	21	7	were	be	AUX
dpc-2102	21	8	7.7	7.7	NUM
dpc-2102	21	9	%	%	NOUN
dpc-2102	21	10	versus	versus	ADP
dpc-2102	21	11	0.8	0.8	NUM
dpc-2102	21	12	%	%	NOUN
dpc-2102	21	13	for	for	ADP
dpc-2102	21	14	cvd	cvd	PROPN
dpc-2102	21	15	,	,	PUNCT
dpc-2102	21	16	38.5	38.5	NUM
dpc-2102	21	17	%	%	NOUN
dpc-2102	21	18	versus	versus	ADP
dpc-2102	21	19	14	14	NUM
dpc-2102	21	20	%	%	NOUN
dpc-2102	21	21	for	for	ADP
dpc-2102	21	22	ht	ht	PROPN
dpc-2102	21	23	,	,	PUNCT
dpc-2102	21	24	33.3	33.3	NUM
dpc-2102	21	25	%	%	NOUN
dpc-2102	21	26	versus	versus	ADP
dpc-2102	21	27	9.9	9.9	NUM
dpc-2102	21	28	%	%	NOUN
dpc-2102	21	29	for	for	ADP
dpc-2102	21	30	dm	dm	PROPN
dpc-2102	21	31	and	and	CCONJ
dpc-2102	21	32	44.7	44.7	NUM
dpc-2102	21	33	%	%	NOUN
dpc-2102	21	34	versus	versus	ADP
dpc-2102	21	35	24.8	24.8	NUM
dpc-2102	21	36	%	%	NOUN
dpc-2102	21	37	for	for	ADP
dpc-2102	21	38	ms	ms	PROPN
dpc-2102	21	39	,	,	PUNCT
dpc-2102	21	40	respectively	respectively	ADV
dpc-2102	21	41	.	.	PUNCT
dpc-2102	22	1	cvd	cvd	PROPN
dpc-2102	22	2	,	,	PUNCT
dpc-2102	22	3	ht	ht	PROPN
dpc-2102	22	4	,	,	PUNCT
dpc-2102	22	5	dm	dm	PROPN
dpc-2102	22	6	and	and	CCONJ
dpc-2102	22	7	ms	ms	PROPN
dpc-2102	22	8	were	be	AUX
dpc-2102	22	9	significantly	significantly	ADV
dpc-2102	22	10	more	more	ADV
dpc-2102	22	11	frequent	frequent	ADJ
dpc-2102	22	12	in	in	ADP
dpc-2102	22	13	lop	lop	NOUN
dpc-2102	22	14	compared	compare	VERB
dpc-2102	22	15	to	to	ADP
dpc-2102	22	16	eop	eop	PROPN
dpc-2102	22	17	(	(	PUNCT
dpc-2102	22	18	p	p	X
dpc-2102	22	19	=	=	PROPN
dpc-2102	22	20	0.045	0.045	NUM
dpc-2102	22	21	,	,	PUNCT
dpc-2102	22	22	p	p	NOUN
dpc-2102	22	23	=	=	NOUN
dpc-2102	22	24	0.001	0.001	NUM
dpc-2102	22	25	,	,	PUNCT
dpc-2102	22	26	p	p	X
dpc-2102	22	27	<	<	X
dpc-2102	22	28	0.01	0.01	NUM
dpc-2102	22	29	,	,	PUNCT
dpc-2102	22	30	p	p	X
dpc-2102	22	31	=	=	NOUN
dpc-2102	22	32	0.022	0.022	NUM
dpc-2102	22	33	)	)	PUNCT
dpc-2102	22	34	.	.	PUNCT
dpc-2102	23	1	results	result	NOUN
dpc-2102	23	2	of	of	ADP
dpc-2102	23	3	multivariate	multivariate	NOUN
dpc-2102	23	4	analysis	analysis	NOUN
dpc-2102	23	5	performed	perform	VERB
dpc-2102	23	6	taking	take	VERB
dpc-2102	23	7	into	into	ADP
dpc-2102	23	8	account	account	NOUN
dpc-2102	23	9	the	the	DET
dpc-2102	23	10	age	age	NOUN
dpc-2102	23	11	,	,	PUNCT
dpc-2102	23	12	gender	gender	NOUN
dpc-2102	23	13	,	,	PUNCT
dpc-2102	23	14	severity	severity	NOUN
dpc-2102	23	15	parameters	parameter	NOUN
dpc-2102	23	16	of	of	ADP
dpc-2102	23	17	disease	disease	NOUN
dpc-2102	23	18	,	,	PUNCT
dpc-2102	23	19	alcohol	alcohol	NOUN
dpc-2102	23	20	consumption	consumption	NOUN
dpc-2102	23	21	,	,	PUNCT
dpc-2102	23	22	smoking	smoking	NOUN
dpc-2102	23	23	habits	habit	NOUN
dpc-2102	23	24	and	and	CCONJ
dpc-2102	23	25	other	other	ADJ
dpc-2102	23	26	concurrent	concurrent	ADJ
dpc-2102	23	27	systemic	systemic	ADJ
dpc-2102	23	28	comorbidities	comorbiditie	NOUN
dpc-2102	23	29	revealed	reveal	VERB
dpc-2102	23	30	lop	lop	NOUN
dpc-2102	23	31	to	to	PART
dpc-2102	23	32	be	be	AUX
dpc-2102	23	33	an	an	DET
dpc-2102	23	34	independent	independent	ADJ
dpc-2102	23	35	risk	risk	NOUN
dpc-2102	23	36	factor	factor	NOUN
dpc-2102	23	37	for	for	ADP
dpc-2102	23	38	cvd	cvd	PROPN
dpc-2102	23	39	and	and	CCONJ
dpc-2102	23	40	dm	dm	PROPN
dpc-2102	23	41	(	(	PUNCT
dpc-2102	23	42	p	p	X
dpc-2102	23	43	<	<	X
dpc-2102	23	44	0.01	0.01	NUM
dpc-2102	23	45	,	,	PUNCT
dpc-2102	23	46	r2	r2	NOUN
dpc-2102	23	47	:	:	PUNCT
dpc-2102	23	48	0.036	0.036	NUM
dpc-2102	23	49	,	,	PUNCT
dpc-2102	23	50	p	p	X
dpc-2102	23	51	<	<	X
dpc-2102	23	52	0.01	0.01	NUM
dpc-2102	23	53	,	,	PUNCT
dpc-2102	23	54	r2	r2	NOUN
dpc-2102	23	55	:	:	PUNCT
dpc-2102	23	56	0.077	0.077	NUM
dpc-2102	23	57	)	)	PUNCT
dpc-2102	23	58	.	.	PUNCT
dpc-2102	24	1	conclusions	conclusion	NOUN
dpc-2102	24	2	:	:	PUNCT
dpc-2102	25	1	lop	lop	NOUN
dpc-2102	25	2	seems	seem	VERB
dpc-2102	25	3	to	to	PART
dpc-2102	25	4	interact	interact	VERB
dpc-2102	25	5	with	with	ADP
dpc-2102	25	6	systemic	systemic	ADJ
dpc-2102	25	7	comorbidities	comorbiditie	NOUN
dpc-2102	25	8	hence	hence	ADV
dpc-2102	25	9	generates	generate	VERB
dpc-2102	25	10	more	more	ADV
dpc-2102	25	11	severe	severe	ADJ
dpc-2102	25	12	inflammatory	inflammatory	ADJ
dpc-2102	25	13	burden	burden	NOUN
dpc-2102	25	14	and	and	CCONJ
dpc-2102	25	15	shows	show	VERB
dpc-2102	25	16	a	a	DET
dpc-2102	25	17	more	more	ADV
dpc-2102	25	18	rapid	rapid	ADJ
dpc-2102	25	19	course	course	NOUN
dpc-2102	25	20	.	.	PUNCT
dpc-2102	26	1	abstract	abstract	ADJ
dpc-2102	26	2	2	2	NUM
dpc-2102	26	3	original	original	ADJ
dpc-2102	26	4	article	article	NOUN
dpc-2102	26	5	|	|	ADV
dpc-2102	26	6	dermatol	dermatol	ADJ
dpc-2102	26	7	pract	pract	NOUN
dpc-2102	26	8	concept	concept	NOUN
dpc-2102	26	9	.	.	PUNCT
dpc-2102	27	1	2022;12(3):e2022144	2022;12(3):e2022144	NUM
dpc-2102	27	2	introduction	introduction	NOUN
dpc-2102	27	3	psoriasis	psoriasis	NOUN
dpc-2102	27	4	is	be	AUX
dpc-2102	27	5	a	a	DET
dpc-2102	27	6	chronic	chronic	NOUN
dpc-2102	27	7	,	,	PUNCT
dpc-2102	27	8	multifactorial	multifactorial	ADJ
dpc-2102	27	9	inflammatory	inflammatory	ADJ
dpc-2102	27	10	skin	skin	NOUN
dpc-2102	27	11	disease	disease	NOUN
dpc-2102	27	12	with	with	ADP
dpc-2102	27	13	a	a	DET
dpc-2102	27	14	polygenic	polygenic	ADJ
dpc-2102	27	15	background	background	NOUN
dpc-2102	27	16	and	and	CCONJ
dpc-2102	27	17	variable	variable	ADJ
dpc-2102	27	18	clinical	clinical	ADJ
dpc-2102	27	19	presentations	presentation	NOUN
dpc-2102	27	20	.	.	PUNCT
dpc-2102	28	1	nowadays	nowadays	ADV
dpc-2102	28	2	,	,	PUNCT
dpc-2102	28	3	it	it	PRON
dpc-2102	28	4	is	be	AUX
dpc-2102	28	5	more	more	ADV
dpc-2102	28	6	frequently	frequently	ADV
dpc-2102	28	7	referred	refer	VERB
dpc-2102	28	8	as	as	ADP
dpc-2102	28	9	“	"	PUNCT
dpc-2102	28	10	psoriatic	psoriatic	ADJ
dpc-2102	28	11	disease	disease	NOUN
dpc-2102	28	12	”	"	PUNCT
dpc-2102	28	13	due	due	ADP
dpc-2102	28	14	to	to	ADP
dpc-2102	28	15	its	its	PRON
dpc-2102	28	16	association	association	NOUN
dpc-2102	28	17	with	with	ADP
dpc-2102	28	18	systemic	systemic	ADJ
dpc-2102	28	19	comorbidities	comorbiditie	NOUN
dpc-2102	28	20	such	such	ADJ
dpc-2102	28	21	as	as	ADP
dpc-2102	28	22	psoriatic	psoriatic	ADJ
dpc-2102	28	23	arthritis	arthritis	NOUN
dpc-2102	28	24	(	(	PUNCT
dpc-2102	28	25	psa	psa	NOUN
dpc-2102	28	26	)	)	PUNCT
dpc-2102	28	27	,	,	PUNCT
dpc-2102	28	28	obesity	obesity	NOUN
dpc-2102	28	29	(	(	PUNCT
dpc-2102	28	30	ob	ob	NOUN
dpc-2102	28	31	)	)	PUNCT
dpc-2102	28	32	,	,	PUNCT
dpc-2102	28	33	cardiovascular	cardiovascular	ADJ
dpc-2102	28	34	diseases	disease	NOUN
dpc-2102	28	35	(	(	PUNCT
dpc-2102	28	36	cvd	cvd	PROPN
dpc-2102	28	37	)	)	PUNCT
dpc-2102	28	38	,	,	PUNCT
dpc-2102	28	39	diabetes	diabetes	NOUN
dpc-2102	28	40	mellitus	mellitus	NOUN
dpc-2102	28	41	(	(	PUNCT
dpc-2102	28	42	dm	dm	PROPN
dpc-2102	28	43	)	)	PUNCT
dpc-2102	28	44	,	,	PUNCT
dpc-2102	28	45	hypertension	hypertension	NOUN
dpc-2102	28	46	(	(	PUNCT
dpc-2102	28	47	ht	ht	PROPN
dpc-2102	28	48	)	)	PUNCT
dpc-2102	28	49	,	,	PUNCT
dpc-2102	28	50	metabolic	metabolic	NOUN
dpc-2102	28	51	syndrome	syndrome	NOUN
dpc-2102	28	52	(	(	PUNCT
dpc-2102	28	53	ms	ms	NOUN
dpc-2102	28	54	)	)	PUNCT
dpc-2102	28	55	and	and	CCONJ
dpc-2102	28	56	inflammatory	inflammatory	ADJ
dpc-2102	28	57	bowel	bowel	NOUN
dpc-2102	28	58	diseases	disease	NOUN
dpc-2102	28	59	(	(	PUNCT
dpc-2102	28	60	ibd	ibd	NOUN
dpc-2102	28	61	)	)	PUNCT
dpc-2102	28	62	.	.	PUNCT
dpc-2102	29	1	psoriasis	psoriasis	NOUN
dpc-2102	29	2	is	be	AUX
dpc-2102	29	3	classified	classify	VERB
dpc-2102	29	4	based	base	VERB
dpc-2102	29	5	upon	upon	SCONJ
dpc-2102	29	6	phenotypic	phenotypic	ADJ
dpc-2102	29	7	presentation	presentation	NOUN
dpc-2102	29	8	,	,	PUNCT
dpc-2102	29	9	association	association	NOUN
dpc-2102	29	10	with	with	ADP
dpc-2102	29	11	human	human	ADJ
dpc-2102	29	12	leukocyte	leukocyte	NOUN
dpc-2102	29	13	antigen	antigen	NOUN
dpc-2102	29	14	(	(	PUNCT
dpc-2102	29	15	hla	hla	NOUN
dpc-2102	29	16	)	)	PUNCT
dpc-2102	29	17	and	and	CCONJ
dpc-2102	29	18	age	age	NOUN
dpc-2102	29	19	at	at	ADP
dpc-2102	29	20	onset	onset	NOUN
dpc-2102	29	21	[	[	X
dpc-2102	29	22	1	1	NUM
dpc-2102	29	23	]	]	PUNCT
dpc-2102	29	24	.	.	PUNCT
dpc-2102	30	1	henseler	henseler	PROPN
dpc-2102	30	2	and	and	CCONJ
dpc-2102	30	3	christophers	christopher	NOUN
dpc-2102	30	4	have	have	AUX
dpc-2102	30	5	observed	observe	VERB
dpc-2102	30	6	that	that	SCONJ
dpc-2102	30	7	clinical	clinical	ADJ
dpc-2102	30	8	characteristics	characteristic	NOUN
dpc-2102	30	9	of	of	ADP
dpc-2102	30	10	psoriasis	psoriasis	NOUN
dpc-2102	30	11	differ	differ	VERB
dpc-2102	30	12	according	accord	VERB
dpc-2102	30	13	to	to	ADP
dpc-2102	30	14	the	the	DET
dpc-2102	30	15	age	age	NOUN
dpc-2102	30	16	of	of	ADP
dpc-2102	30	17	onset	onset	NOUN
dpc-2102	30	18	[	[	X
dpc-2102	30	19	2	2	NUM
dpc-2102	30	20	]	]	PUNCT
dpc-2102	30	21	.	.	PUNCT
dpc-2102	31	1	in	in	ADP
dpc-2102	31	2	patients	patient	NOUN
dpc-2102	31	3	who	who	PRON
dpc-2102	31	4	developed	develop	VERB
dpc-2102	31	5	psoriasis	psoriasis	NOUN
dpc-2102	31	6	before	before	ADP
dpc-2102	31	7	age	age	NOUN
dpc-2102	31	8	40	40	NUM
dpc-2102	31	9	,	,	PUNCT
dpc-2102	31	10	psoriasis	psoriasis	NOUN
dpc-2102	31	11	tends	tend	VERB
dpc-2102	31	12	to	to	PART
dpc-2102	31	13	be	be	AUX
dpc-2102	31	14	more	more	ADV
dpc-2102	31	15	severe	severe	ADJ
dpc-2102	31	16	,	,	PUNCT
dpc-2102	31	17	recurrent	recurrent	ADJ
dpc-2102	31	18	and	and	CCONJ
dpc-2102	31	19	resistant	resistant	ADJ
dpc-2102	31	20	to	to	ADP
dpc-2102	31	21	treatment	treatment	NOUN
dpc-2102	31	22	.	.	PUNCT
dpc-2102	32	1	thus	thus	ADV
dpc-2102	32	2	,	,	PUNCT
dpc-2102	32	3	they	they	PRON
dpc-2102	32	4	offered	offer	VERB
dpc-2102	32	5	new	new	ADJ
dpc-2102	32	6	classification	classification	NOUN
dpc-2102	32	7	of	of	ADP
dpc-2102	32	8	psoriasis	psoriasis	NOUN
dpc-2102	32	9	based	base	VERB
dpc-2102	32	10	upon	upon	SCONJ
dpc-2102	32	11	the	the	DET
dpc-2102	32	12	age	age	NOUN
dpc-2102	32	13	of	of	ADP
dpc-2102	32	14	onset	onset	NOUN
dpc-2102	32	15	;	;	PUNCT
dpc-2102	32	16	psoriasis	psoriasis	NOUN
dpc-2102	32	17	which	which	PRON
dpc-2102	32	18	developed	develop	VERB
dpc-2102	32	19	before	before	ADP
dpc-2102	32	20	40	40	NUM
dpc-2102	32	21	years	year	NOUN
dpc-2102	32	22	was	be	AUX
dpc-2102	32	23	accepted	accept	VERB
dpc-2102	32	24	as	as	ADP
dpc-2102	32	25	early	early	ADJ
dpc-2102	32	26	onset	onset	VERB
dpc-2102	32	27	psoriasis	psoriasis	NOUN
dpc-2102	32	28	(	(	PUNCT
dpc-2102	32	29	eop	eop	PROPN
dpc-2102	32	30	)	)	PUNCT
dpc-2102	32	31	and	and	CCONJ
dpc-2102	32	32	psoriasis	psoriasis	NOUN
dpc-2102	32	33	which	which	PRON
dpc-2102	32	34	developed	develop	VERB
dpc-2102	32	35	after	after	ADP
dpc-2102	32	36	40	40	NUM
dpc-2102	32	37	years	year	NOUN
dpc-2102	32	38	as	as	ADP
dpc-2102	32	39	late	late	ADJ
dpc-2102	32	40	onset	onset	VERB
dpc-2102	32	41	psoriasis	psoriasis	NOUN
dpc-2102	32	42	(	(	PUNCT
dpc-2102	32	43	lop	lop	NOUN
dpc-2102	32	44	)	)	PUNCT
dpc-2102	32	45	.	.	PUNCT
dpc-2102	33	1	although	although	SCONJ
dpc-2102	33	2	this	this	DET
dpc-2102	33	3	cut	cut	NOUN
dpc-2102	33	4	-	-	PUNCT
dpc-2102	33	5	off	off	ADP
dpc-2102	33	6	point	point	NOUN
dpc-2102	33	7	have	have	AUX
dpc-2102	33	8	been	be	AUX
dpc-2102	33	9	used	use	VERB
dpc-2102	33	10	by	by	ADP
dpc-2102	33	11	several	several	ADJ
dpc-2102	33	12	authors	author	NOUN
dpc-2102	33	13	,	,	PUNCT
dpc-2102	33	14	others	other	NOUN
dpc-2102	33	15	have	have	AUX
dpc-2102	33	16	used	use	VERB
dpc-2102	33	17	a	a	DET
dpc-2102	33	18	wide	wide	ADJ
dpc-2102	33	19	range	range	NOUN
dpc-2102	33	20	of	of	ADP
dpc-2102	33	21	cut	cut	NOUN
dpc-2102	33	22	-	-	PUNCT
dpc-2102	33	23	off	off	ADP
dpc-2102	33	24	point	point	NOUN
dpc-2102	33	25	(	(	PUNCT
dpc-2102	33	26	30	30	NUM
dpc-2102	33	27	-	-	SYM
dpc-2102	33	28	50	50	NUM
dpc-2102	33	29	years	year	NOUN
dpc-2102	33	30	)	)	PUNCT
dpc-2102	33	31	,	,	PUNCT
dpc-2102	33	32	thus	thus	ADV
dpc-2102	33	33	limiting	limit	VERB
dpc-2102	33	34	comparisons	comparison	NOUN
dpc-2102	33	35	between	between	ADP
dpc-2102	33	36	studies	study	NOUN
dpc-2102	33	37	[	[	X
dpc-2102	33	38	1,3–6	1,3–6	NUM
dpc-2102	33	39	]	]	PUNCT
dpc-2102	33	40	.	.	PUNCT
dpc-2102	34	1	differences	difference	NOUN
dpc-2102	34	2	in	in	ADP
dpc-2102	34	3	the	the	DET
dpc-2102	34	4	clinical	clinical	ADJ
dpc-2102	34	5	characteristics	characteristic	NOUN
dpc-2102	34	6	and	and	CCONJ
dpc-2102	34	7	course	course	NOUN
dpc-2102	34	8	of	of	ADP
dpc-2102	34	9	the	the	DET
dpc-2102	34	10	disease	disease	NOUN
dpc-2102	34	11	,	,	PUNCT
dpc-2102	34	12	response	response	NOUN
dpc-2102	34	13	to	to	ADP
dpc-2102	34	14	treatment	treatment	NOUN
dpc-2102	34	15	,	,	PUNCT
dpc-2102	34	16	genetic	genetic	ADJ
dpc-2102	34	17	predisposition	predisposition	NOUN
dpc-2102	34	18	and	and	CCONJ
dpc-2102	34	19	psychosocial	psychosocial	ADJ
dpc-2102	34	20	effects	effect	NOUN
dpc-2102	34	21	in	in	ADP
dpc-2102	34	22	eop	eop	PROPN
dpc-2102	34	23	and	and	CCONJ
dpc-2102	34	24	lop	lop	PROPN
dpc-2102	34	25	have	have	AUX
dpc-2102	34	26	been	be	AUX
dpc-2102	34	27	reported	report	VERB
dpc-2102	34	28	in	in	ADP
dpc-2102	34	29	previous	previous	ADJ
dpc-2102	34	30	studies	study	NOUN
dpc-2102	34	31	.	.	PUNCT
dpc-2102	35	1	eop	eop	PROPN
dpc-2102	35	2	have	have	AUX
dpc-2102	35	3	been	be	AUX
dpc-2102	35	4	shown	show	VERB
dpc-2102	35	5	to	to	PART
dpc-2102	35	6	be	be	AUX
dpc-2102	35	7	more	more	ADV
dpc-2102	35	8	severe	severe	ADJ
dpc-2102	35	9	and	and	CCONJ
dpc-2102	35	10	pose	pose	VERB
dpc-2102	35	11	recurrent	recurrent	ADJ
dpc-2102	35	12	flares	flare	NOUN
dpc-2102	35	13	,	,	PUNCT
dpc-2102	35	14	positive	positive	ADJ
dpc-2102	35	15	family	family	NOUN
dpc-2102	35	16	history	history	NOUN
dpc-2102	35	17	,	,	PUNCT
dpc-2102	35	18	koebner	koebner	NOUN
dpc-2102	35	19	phenomenon	phenomenon	NOUN
dpc-2102	35	20	and	and	CCONJ
dpc-2102	35	21	association	association	NOUN
dpc-2102	35	22	with	with	ADP
dpc-2102	35	23	hla	hla	PROPN
dpc-2102	35	24	-	-	PUNCT
dpc-2102	35	25	c	c	NOUN
dpc-2102	36	1	[	[	X
dpc-2102	36	2	3–5,7–9	3–5,7–9	NUM
dpc-2102	36	3	]	]	PUNCT
dpc-2102	36	4	.	.	PUNCT
dpc-2102	37	1	eop	eop	PROPN
dpc-2102	37	2	was	be	AUX
dpc-2102	37	3	also	also	ADV
dpc-2102	37	4	claimed	claim	VERB
dpc-2102	37	5	to	to	PART
dpc-2102	37	6	have	have	VERB
dpc-2102	37	7	more	more	ADV
dpc-2102	37	8	prominent	prominent	ADJ
dpc-2102	37	9	psychosocial	psychosocial	ADJ
dpc-2102	37	10	effect	effect	NOUN
dpc-2102	37	11	and	and	CCONJ
dpc-2102	37	12	requirement	requirement	NOUN
dpc-2102	37	13	for	for	ADP
dpc-2102	37	14	systemic	systemic	ADJ
dpc-2102	37	15	treatment	treatment	NOUN
dpc-2102	37	16	is	be	AUX
dpc-2102	37	17	usually	usually	ADV
dpc-2102	37	18	more	more	ADV
dpc-2102	37	19	frequent	frequent	ADJ
dpc-2102	38	1	[	[	X
dpc-2102	38	2	1,7,10	1,7,10	NUM
dpc-2102	38	3	]	]	PUNCT
dpc-2102	38	4	.	.	PUNCT
dpc-2102	39	1	epidemiologic	epidemiologic	ADJ
dpc-2102	39	2	studies	study	NOUN
dpc-2102	39	3	have	have	AUX
dpc-2102	39	4	demonstrated	demonstrate	VERB
dpc-2102	39	5	association	association	NOUN
dpc-2102	39	6	of	of	ADP
dpc-2102	39	7	psoriasis	psoriasis	NOUN
dpc-2102	39	8	with	with	ADP
dpc-2102	39	9	systemic	systemic	ADJ
dpc-2102	39	10	inflammatory	inflammatory	ADJ
dpc-2102	39	11	diseases	disease	NOUN
dpc-2102	39	12	,	,	PUNCT
dpc-2102	39	13	but	but	CCONJ
dpc-2102	39	14	to	to	ADP
dpc-2102	39	15	our	our	PRON
dpc-2102	39	16	knowledge	knowledge	NOUN
dpc-2102	39	17	there	there	PRON
dpc-2102	39	18	is	be	VERB
dpc-2102	39	19	only	only	ADV
dpc-2102	39	20	one	one	NUM
dpc-2102	39	21	report	report	NOUN
dpc-2102	39	22	comparing	compare	VERB
dpc-2102	39	23	eop	eop	PROPN
dpc-2102	39	24	and	and	CCONJ
dpc-2102	39	25	lop	lop	NOUN
dpc-2102	39	26	regarding	regard	VERB
dpc-2102	39	27	concomitant	concomitant	ADJ
dpc-2102	39	28	systemic	systemic	ADJ
dpc-2102	39	29	inflammatory	inflammatory	ADJ
dpc-2102	39	30	comorbidities	comorbiditie	NOUN
dpc-2102	39	31	,	,	PUNCT
dpc-2102	39	32	which	which	PRON
dpc-2102	39	33	found	find	VERB
dpc-2102	39	34	ob	ob	PART
dpc-2102	39	35	to	to	PART
dpc-2102	39	36	be	be	AUX
dpc-2102	39	37	more	more	ADV
dpc-2102	39	38	frequent	frequent	ADJ
dpc-2102	39	39	in	in	ADP
dpc-2102	39	40	lop	lop	NOUN
dpc-2102	39	41	than	than	ADP
dpc-2102	39	42	eop	eop	PROPN
dpc-2102	40	1	[	[	X
dpc-2102	40	2	1	1	NUM
dpc-2102	40	3	]	]	PUNCT
dpc-2102	40	4	.	.	PUNCT
dpc-2102	41	1	objectives	objective	NOUN
dpc-2102	41	2	based	base	VERB
dpc-2102	41	3	on	on	ADP
dpc-2102	41	4	previous	previous	ADJ
dpc-2102	41	5	literature	literature	NOUN
dpc-2102	41	6	and	and	CCONJ
dpc-2102	41	7	lack	lack	NOUN
dpc-2102	41	8	of	of	ADP
dpc-2102	41	9	data	datum	NOUN
dpc-2102	41	10	in	in	ADP
dpc-2102	41	11	this	this	DET
dpc-2102	41	12	aspect	aspect	NOUN
dpc-2102	41	13	,	,	PUNCT
dpc-2102	41	14	we	we	PRON
dpc-2102	41	15	aimed	aim	VERB
dpc-2102	41	16	to	to	PART
dpc-2102	41	17	compare	compare	VERB
dpc-2102	41	18	inflammatory	inflammatory	ADJ
dpc-2102	41	19	comorbidities	comorbiditie	NOUN
dpc-2102	41	20	along	along	ADP
dpc-2102	41	21	with	with	ADP
dpc-2102	41	22	clinical	clinical	ADJ
dpc-2102	41	23	characteristics	characteristic	NOUN
dpc-2102	41	24	and	and	CCONJ
dpc-2102	41	25	severity	severity	NOUN
dpc-2102	41	26	of	of	ADP
dpc-2102	41	27	psoriatic	psoriatic	ADJ
dpc-2102	41	28	disease	disease	NOUN
dpc-2102	41	29	and	and	CCONJ
dpc-2102	41	30	possibly	possibly	ADV
dpc-2102	41	31	determine	determine	VERB
dpc-2102	41	32	differences	difference	NOUN
dpc-2102	41	33	in	in	ADP
dpc-2102	41	34	eop	eop	PROPN
dpc-2102	41	35	and	and	CCONJ
dpc-2102	41	36	lop	lop	VERB
dpc-2102	41	37	in	in	ADP
dpc-2102	41	38	this	this	DET
dpc-2102	41	39	study	study	NOUN
dpc-2102	41	40	.	.	PUNCT
dpc-2102	42	1	methods	method	NOUN
dpc-2102	42	2	patients	patient	NOUN
dpc-2102	42	3	data	datum	NOUN
dpc-2102	42	4	was	be	AUX
dpc-2102	42	5	collected	collect	VERB
dpc-2102	42	6	by	by	ADP
dpc-2102	42	7	a	a	DET
dpc-2102	42	8	face	face	NOUN
dpc-2102	42	9	-	-	PUNCT
dpc-2102	42	10	to	to	ADP
dpc-2102	42	11	-	-	PUNCT
dpc-2102	42	12	face	face	NOUN
dpc-2102	42	13	questionnaire	questionnaire	NOUN
dpc-2102	42	14	and	and	CCONJ
dpc-2102	42	15	medical	medical	ADJ
dpc-2102	42	16	chart	chart	NOUN
dpc-2102	42	17	evaluation	evaluation	NOUN
dpc-2102	42	18	.	.	PUNCT
dpc-2102	43	1	patients	patient	NOUN
dpc-2102	43	2	older	old	ADJ
dpc-2102	43	3	than	than	ADP
dpc-2102	43	4	18	18	NUM
dpc-2102	43	5	years	year	NOUN
dpc-2102	43	6	of	of	ADP
dpc-2102	43	7	age	age	NOUN
dpc-2102	43	8	with	with	ADP
dpc-2102	43	9	plaque	plaque	NOUN
dpc-2102	43	10	psoriasis	psoriasis	NOUN
dpc-2102	43	11	who	who	PRON
dpc-2102	43	12	were	be	AUX
dpc-2102	43	13	on	on	ADP
dpc-2102	43	14	follow	follow	NOUN
dpc-2102	43	15	-	-	PUNCT
dpc-2102	43	16	up	up	NOUN
dpc-2102	43	17	at	at	ADP
dpc-2102	43	18	our	our	PRON
dpc-2102	43	19	department	department	NOUN
dpc-2102	43	20	of	of	ADP
dpc-2102	43	21	dermatology	dermatology	NOUN
dpc-2102	43	22	between	between	ADP
dpc-2102	43	23	1st	1st	ADJ
dpc-2102	43	24	october	october	PROPN
dpc-2102	43	25	2018	2018	NUM
dpc-2102	43	26	and	and	CCONJ
dpc-2102	43	27	1st	1st	ADJ
dpc-2102	43	28	march	march	PROPN
dpc-2102	43	29	2019	2019	NUM
dpc-2102	43	30	were	be	AUX
dpc-2102	43	31	enrolled	enrol	VERB
dpc-2102	43	32	for	for	ADP
dpc-2102	43	33	the	the	DET
dpc-2102	43	34	study	study	NOUN
dpc-2102	43	35	.	.	PUNCT
dpc-2102	44	1	patients	patient	NOUN
dpc-2102	44	2	with	with	ADP
dpc-2102	44	3	disease	disease	NOUN
dpc-2102	44	4	onset	onset	VERB
dpc-2102	44	5	before	before	ADP
dpc-2102	44	6	age	age	NOUN
dpc-2102	44	7	of	of	ADP
dpc-2102	44	8	40	40	NUM
dpc-2102	44	9	years	year	NOUN
dpc-2102	44	10	were	be	AUX
dpc-2102	44	11	accepted	accept	VERB
dpc-2102	44	12	as	as	ADP
dpc-2102	44	13	eop	eop	PROPN
dpc-2102	44	14	and	and	CCONJ
dpc-2102	44	15	patients	patient	NOUN
dpc-2102	44	16	with	with	ADP
dpc-2102	44	17	disease	disease	NOUN
dpc-2102	44	18	onset	onset	VERB
dpc-2102	44	19	equal	equal	ADJ
dpc-2102	44	20	or	or	CCONJ
dpc-2102	44	21	after	after	ADP
dpc-2102	44	22	40	40	NUM
dpc-2102	44	23	years	year	NOUN
dpc-2102	44	24	were	be	AUX
dpc-2102	44	25	considered	consider	VERB
dpc-2102	44	26	to	to	PART
dpc-2102	44	27	have	have	VERB
dpc-2102	44	28	lop	lop	NOUN
dpc-2102	44	29	.	.	PUNCT
dpc-2102	45	1	the	the	DET
dpc-2102	45	2	study	study	NOUN
dpc-2102	45	3	was	be	AUX
dpc-2102	45	4	approved	approve	VERB
dpc-2102	45	5	by	by	ADP
dpc-2102	45	6	the	the	DET
dpc-2102	45	7	ethic	ethic	ADJ
dpc-2102	45	8	committee	committee	NOUN
dpc-2102	45	9	of	of	ADP
dpc-2102	45	10	non	non	ADJ
dpc-2102	45	11	-	-	ADJ
dpc-2102	45	12	invasive	invasive	ADJ
dpc-2102	45	13	clinical	clinical	ADJ
dpc-2102	45	14	studies	study	NOUN
dpc-2102	45	15	of	of	ADP
dpc-2102	45	16	hacettepe	hacettepe	PROPN
dpc-2102	45	17	university	university	NOUN
dpc-2102	45	18	(	(	PUNCT
dpc-2102	45	19	i	i	PROPN
dpc-2102	45	20	d	d	PROPN
dpc-2102	45	21	go	go	VERB
dpc-2102	45	22	18/1057	18/1057	NUM
dpc-2102	45	23	-	-	SYM
dpc-2102	45	24	30	30	NUM
dpc-2102	45	25	)	)	PUNCT
dpc-2102	45	26	.	.	PUNCT
dpc-2102	46	1	methods	method	NOUN
dpc-2102	46	2	questionnaire	questionnaire	VERB
dpc-2102	46	3	the	the	DET
dpc-2102	46	4	face	face	NOUN
dpc-2102	46	5	-	-	PUNCT
dpc-2102	46	6	to	to	ADP
dpc-2102	46	7	-	-	PUNCT
dpc-2102	46	8	face	face	NOUN
dpc-2102	46	9	questionnaire	questionnaire	NOUN
dpc-2102	46	10	consisted	consist	VERB
dpc-2102	46	11	of	of	ADP
dpc-2102	46	12	5	5	NUM
dpc-2102	46	13	main	main	ADJ
dpc-2102	46	14	sections	section	NOUN
dpc-2102	46	15	:	:	PUNCT
dpc-2102	46	16	(	(	PUNCT
dpc-2102	46	17	1	1	X
dpc-2102	46	18	)	)	PUNCT
dpc-2102	46	19	patient	patient	ADJ
dpc-2102	46	20	demographics	demographic	NOUN
dpc-2102	46	21	;	;	PUNCT
dpc-2102	46	22	(	(	PUNCT
dpc-2102	46	23	2	2	X
dpc-2102	46	24	)	)	PUNCT
dpc-2102	46	25	psoriasis	psoriasis	NOUN
dpc-2102	46	26	characteristics	characteristic	NOUN
dpc-2102	46	27	;	;	PUNCT
dpc-2102	46	28	(	(	PUNCT
dpc-2102	46	29	3	3	X
dpc-2102	46	30	)	)	PUNCT
dpc-2102	46	31	concurrent	concurrent	ADJ
dpc-2102	46	32	comorbidities	comorbiditie	NOUN
dpc-2102	46	33	;	;	PUNCT
dpc-2102	46	34	(	(	PUNCT
dpc-2102	46	35	4	4	X
dpc-2102	46	36	)	)	PUNCT
dpc-2102	46	37	physical	physical	ADJ
dpc-2102	46	38	and	and	CCONJ
dpc-2102	46	39	dermatological	dermatological	ADJ
dpc-2102	46	40	examination	examination	NOUN
dpc-2102	46	41	;	;	PUNCT
dpc-2102	46	42	(	(	PUNCT
dpc-2102	46	43	5	5	X
dpc-2102	46	44	)	)	PUNCT
dpc-2102	46	45	laboratory	laboratory	NOUN
dpc-2102	46	46	studies	study	NOUN
dpc-2102	46	47	.	.	PUNCT
dpc-2102	47	1	patient	patient	ADJ
dpc-2102	47	2	demographics	demographic	NOUN
dpc-2102	47	3	age	age	NOUN
dpc-2102	47	4	,	,	PUNCT
dpc-2102	47	5	gender	gender	NOUN
dpc-2102	47	6	,	,	PUNCT
dpc-2102	47	7	place	place	NOUN
dpc-2102	47	8	of	of	ADP
dpc-2102	47	9	birth	birth	NOUN
dpc-2102	47	10	,	,	PUNCT
dpc-2102	47	11	place	place	NOUN
dpc-2102	47	12	of	of	ADP
dpc-2102	47	13	residence	residence	NOUN
dpc-2102	47	14	was	be	AUX
dpc-2102	47	15	recorded	record	VERB
dpc-2102	47	16	.	.	PUNCT
dpc-2102	48	1	psoriasis	psoriasis	NOUN
dpc-2102	48	2	characteristics	characteristic	NOUN
dpc-2102	48	3	age	age	NOUN
dpc-2102	48	4	of	of	ADP
dpc-2102	48	5	onset	onset	NOUN
dpc-2102	48	6	of	of	ADP
dpc-2102	48	7	the	the	DET
dpc-2102	48	8	disease	disease	NOUN
dpc-2102	48	9	,	,	PUNCT
dpc-2102	48	10	existence	existence	NOUN
dpc-2102	48	11	of	of	ADP
dpc-2102	48	12	nail	nail	NOUN
dpc-2102	48	13	involvement	involvement	NOUN
dpc-2102	48	14	,	,	PUNCT
dpc-2102	48	15	age	age	NOUN
dpc-2102	48	16	at	at	ADP
dpc-2102	48	17	the	the	DET
dpc-2102	48	18	onset	onset	NOUN
dpc-2102	48	19	of	of	ADP
dpc-2102	48	20	nail	nail	NOUN
dpc-2102	48	21	involvement	involvement	NOUN
dpc-2102	48	22	,	,	PUNCT
dpc-2102	48	23	type	type	NOUN
dpc-2102	48	24	of	of	ADP
dpc-2102	48	25	nail	nail	NOUN
dpc-2102	48	26	involvement	involvement	NOUN
dpc-2102	48	27	,	,	PUNCT
dpc-2102	48	28	existence	existence	NOUN
dpc-2102	48	29	of	of	ADP
dpc-2102	48	30	concomitant	concomitant	ADJ
dpc-2102	48	31	psa	psa	NOUN
dpc-2102	48	32	,	,	PUNCT
dpc-2102	48	33	age	age	NOUN
dpc-2102	48	34	at	at	ADP
dpc-2102	48	35	the	the	DET
dpc-2102	48	36	onset	onset	NOUN
dpc-2102	48	37	of	of	ADP
dpc-2102	48	38	psa	psa	NOUN
dpc-2102	48	39	,	,	PUNCT
dpc-2102	48	40	family	family	NOUN
dpc-2102	48	41	history	history	NOUN
dpc-2102	48	42	of	of	ADP
dpc-2102	48	43	psoriasis	psoriasis	NOUN
dpc-2102	48	44	and	and	CCONJ
dpc-2102	48	45	psa	psa	VERB
dpc-2102	48	46	and	and	CCONJ
dpc-2102	48	47	age	age	NOUN
dpc-2102	48	48	at	at	ADP
dpc-2102	48	49	the	the	DET
dpc-2102	48	50	onset	onset	NOUN
dpc-2102	48	51	of	of	ADP
dpc-2102	48	52	psoriasis	psoriasis	NOUN
dpc-2102	48	53	and	and	CCONJ
dpc-2102	48	54	psa	psa	NOUN
dpc-2102	48	55	of	of	ADP
dpc-2102	48	56	the	the	DET
dpc-2102	48	57	family	family	NOUN
dpc-2102	48	58	member	member	NOUN
dpc-2102	48	59	,	,	PUNCT
dpc-2102	48	60	received	receive	VERB
dpc-2102	48	61	treatment	treatment	NOUN
dpc-2102	48	62	regimens	regimen	NOUN
dpc-2102	48	63	and	and	CCONJ
dpc-2102	48	64	duration	duration	NOUN
dpc-2102	48	65	of	of	ADP
dpc-2102	48	66	the	the	DET
dpc-2102	48	67	treatment	treatment	NOUN
dpc-2102	48	68	were	be	AUX
dpc-2102	48	69	recorded	record	VERB
dpc-2102	48	70	.	.	PUNCT
dpc-2102	49	1	duration	duration	NOUN
dpc-2102	49	2	of	of	ADP
dpc-2102	49	3	active	active	ADJ
dpc-2102	49	4	psoriatic	psoriatic	ADJ
dpc-2102	49	5	disease	disease	NOUN
dpc-2102	49	6	was	be	AUX
dpc-2102	49	7	also	also	ADV
dpc-2102	49	8	required	require	VERB
dpc-2102	49	9	to	to	PART
dpc-2102	49	10	be	be	AUX
dpc-2102	49	11	evaluated	evaluate	VERB
dpc-2102	49	12	.	.	PUNCT
dpc-2102	50	1	to	to	PART
dpc-2102	50	2	make	make	VERB
dpc-2102	50	3	this	this	DET
dpc-2102	50	4	assessment	assessment	NOUN
dpc-2102	50	5	;	;	PUNCT
dpc-2102	50	6	active	active	ADJ
dpc-2102	50	7	psoriatic	psoriatic	ADJ
dpc-2102	50	8	disease	disease	NOUN
dpc-2102	50	9	was	be	AUX
dpc-2102	50	10	defined	define	VERB
dpc-2102	50	11	as	as	ADP
dpc-2102	50	12	existence	existence	NOUN
dpc-2102	50	13	of	of	ADP
dpc-2102	50	14	cutaneous	cutaneous	ADJ
dpc-2102	50	15	psoriatic	psoriatic	ADJ
dpc-2102	50	16	lesions	lesion	NOUN
dpc-2102	50	17	affecting	affect	VERB
dpc-2102	50	18	more	more	ADJ
dpc-2102	50	19	than	than	ADP
dpc-2102	50	20	3	3	NUM
dpc-2102	50	21	%	%	NOUN
dpc-2102	50	22	of	of	ADP
dpc-2102	50	23	body	body	NOUN
dpc-2102	50	24	surface	surface	NOUN
dpc-2102	50	25	area	area	NOUN
dpc-2102	50	26	with	with	ADP
dpc-2102	50	27	or	or	CCONJ
dpc-2102	50	28	without	without	ADP
dpc-2102	50	29	given	give	VERB
dpc-2102	50	30	treatments	treatment	NOUN
dpc-2102	50	31	and	and	CCONJ
dpc-2102	50	32	was	be	AUX
dpc-2102	50	33	calculated	calculate	VERB
dpc-2102	50	34	for	for	ADP
dpc-2102	50	35	each	each	DET
dpc-2102	50	36	patient	patient	NOUN
dpc-2102	50	37	.	.	PUNCT
dpc-2102	51	1	hospitalizations	hospitalization	NOUN
dpc-2102	51	2	due	due	ADP
dpc-2102	51	3	to	to	ADP
dpc-2102	51	4	psoriasis	psoriasis	NOUN
dpc-2102	51	5	and	and	CCONJ
dpc-2102	51	6	any	any	DET
dpc-2102	51	7	existed	exist	VERB
dpc-2102	51	8	erythroderma	erythroderma	NOUN
dpc-2102	51	9	attacks	attack	NOUN
dpc-2102	51	10	were	be	AUX
dpc-2102	51	11	also	also	ADV
dpc-2102	51	12	recorded	record	VERB
dpc-2102	51	13	.	.	PUNCT
dpc-2102	52	1	existent	existent	ADJ
dpc-2102	52	2	or	or	CCONJ
dpc-2102	52	3	previous	previous	ADJ
dpc-2102	52	4	psoriatic	psoriatic	ADJ
dpc-2102	52	5	nail	nail	NOUN
dpc-2102	52	6	involvement	involvement	NOUN
dpc-2102	52	7	including	include	VERB
dpc-2102	52	8	onycholysis	onycholysis	NOUN
dpc-2102	52	9	,	,	PUNCT
dpc-2102	52	10	pitting	pitting	NOUN
dpc-2102	52	11	,	,	PUNCT
dpc-2102	52	12	subungual	subungual	ADJ
dpc-2102	52	13	hyperkeratosis	hyperkeratosis	NOUN
dpc-2102	52	14	and	and	CCONJ
dpc-2102	52	15	oil	oil	NOUN
dpc-2102	52	16	-	-	PUNCT
dpc-2102	52	17	drop	drop	NOUN
dpc-2102	52	18	sign	sign	NOUN
dpc-2102	52	19	were	be	AUX
dpc-2102	52	20	questioned	question	VERB
dpc-2102	52	21	in	in	ADP
dpc-2102	52	22	detail	detail	NOUN
dpc-2102	52	23	and	and	CCONJ
dpc-2102	52	24	recorded	record	VERB
dpc-2102	52	25	.	.	PUNCT
dpc-2102	53	1	joint	joint	ADJ
dpc-2102	53	2	involvement	involvement	NOUN
dpc-2102	53	3	was	be	AUX
dpc-2102	53	4	questioned	question	VERB
dpc-2102	53	5	based	base	VERB
dpc-2102	53	6	on	on	ADP
dpc-2102	53	7	the	the	DET
dpc-2102	53	8	previous	previous	ADJ
dpc-2102	53	9	diagnosis	diagnosis	NOUN
dpc-2102	53	10	of	of	ADP
dpc-2102	53	11	psa	psa	NOUN
dpc-2102	53	12	established	establish	VERB
dpc-2102	53	13	by	by	ADP
dpc-2102	53	14	a	a	DET
dpc-2102	53	15	rheumatologist	rheumatologist	NOUN
dpc-2102	53	16	.	.	PUNCT
dpc-2102	54	1	all	all	DET
dpc-2102	54	2	patients	patient	NOUN
dpc-2102	54	3	were	be	AUX
dpc-2102	54	4	also	also	ADV
dpc-2102	54	5	filled	fill	VERB
dpc-2102	54	6	out	out	ADP
dpc-2102	54	7	rheumatologic	rheumatologic	NOUN
dpc-2102	54	8	screening	screen	VERB
dpc-2102	54	9	questionnaire	questionnaire	NOUN
dpc-2102	54	10	(	(	PUNCT
dpc-2102	54	11	rsq	rsq	PROPN
dpc-2102	54	12	)	)	PUNCT
dpc-2102	54	13	regarding	regard	VERB
dpc-2102	54	14	existence	existence	NOUN
dpc-2102	54	15	of	of	ADP
dpc-2102	54	16	psa	psa	PROPN
dpc-2102	54	17	.	.	PROPN
dpc-2102	55	1	rsq	rsq	PROPN
dpc-2102	55	2	included	include	VERB
dpc-2102	55	3	5	5	NUM
dpc-2102	55	4	items	item	NOUN
dpc-2102	55	5	:	:	PUNCT
dpc-2102	55	6	(	(	PUNCT
dpc-2102	55	7	i	i	NOUN
dpc-2102	55	8	)	)	PUNCT
dpc-2102	55	9	existence	existence	NOUN
dpc-2102	55	10	of	of	ADP
dpc-2102	55	11	joint	joint	ADJ
dpc-2102	55	12	and	and	CCONJ
dpc-2102	55	13	muscle	muscle	NOUN
dpc-2102	55	14	pain	pain	NOUN
dpc-2102	55	15	at	at	ADP
dpc-2102	55	16	rest	rest	NOUN
dpc-2102	55	17	,	,	PUNCT
dpc-2102	55	18	(	(	PUNCT
dpc-2102	55	19	ii	ii	NOUN
dpc-2102	55	20	)	)	PUNCT
dpc-2102	55	21	existence	existence	NOUN
dpc-2102	55	22	of	of	ADP
dpc-2102	55	23	neck	neck	NOUN
dpc-2102	55	24	,	,	PUNCT
dpc-2102	55	25	waist	waist	NOUN
dpc-2102	55	26	or	or	CCONJ
dpc-2102	55	27	back	back	ADJ
dpc-2102	55	28	pain	pain	NOUN
dpc-2102	55	29	awakening	awakening	NOUN
dpc-2102	55	30	at	at	ADP
dpc-2102	55	31	nights	night	NOUN
dpc-2102	55	32	,	,	PUNCT
dpc-2102	55	33	(	(	PUNCT
dpc-2102	55	34	iii	iii	X
dpc-2102	55	35	)	)	PUNCT
dpc-2102	55	36	existence	existence	NOUN
dpc-2102	55	37	of	of	ADP
dpc-2102	55	38	pain	pain	NOUN
dpc-2102	55	39	,	,	PUNCT
dpc-2102	55	40	edema	edema	NOUN
dpc-2102	55	41	and	and	CCONJ
dpc-2102	55	42	tenderness	tenderness	NOUN
dpc-2102	55	43	in	in	ADP
dpc-2102	55	44	hands	hand	NOUN
dpc-2102	55	45	or	or	CCONJ
dpc-2102	55	46	feet	foot	NOUN
dpc-2102	55	47	joint	joint	ADJ
dpc-2102	55	48	,	,	PUNCT
dpc-2102	55	49	(	(	PUNCT
dpc-2102	55	50	iv	iv	X
dpc-2102	55	51	)	)	PUNCT
dpc-2102	55	52	history	history	NOUN
dpc-2102	55	53	of	of	ADP
dpc-2102	55	54	morning	morning	NOUN
dpc-2102	55	55	stiffness	stiffness	NOUN
dpc-2102	55	56	lasting	last	VERB
dpc-2102	55	57	for	for	ADP
dpc-2102	55	58	more	more	ADJ
dpc-2102	55	59	than	than	ADP
dpc-2102	55	60	20	20	NUM
dpc-2102	55	61	minutes	minute	NOUN
dpc-2102	55	62	,	,	PUNCT
dpc-2102	55	63	and	and	CCONJ
dpc-2102	55	64	(	(	PUNCT
dpc-2102	55	65	v	v	NOUN
dpc-2102	55	66	)	)	PUNCT
dpc-2102	55	67	existence	existence	NOUN
dpc-2102	55	68	of	of	ADP
dpc-2102	55	69	tenderness	tenderness	NOUN
dpc-2102	55	70	while	while	SCONJ
dpc-2102	55	71	stepping	step	VERB
dpc-2102	55	72	on	on	ADP
dpc-2102	55	73	heels	heel	NOUN
dpc-2102	55	74	in	in	ADP
dpc-2102	55	75	the	the	DET
dpc-2102	55	76	mornings	morning	NOUN
dpc-2102	55	77	[	[	X
dpc-2102	55	78	11	11	NUM
dpc-2102	55	79	]	]	PUNCT
dpc-2102	55	80	.	.	PUNCT
dpc-2102	56	1	patients	patient	NOUN
dpc-2102	56	2	were	be	AUX
dpc-2102	56	3	also	also	ADV
dpc-2102	56	4	consulted	consult	VERB
dpc-2102	56	5	to	to	ADP
dpc-2102	56	6	rheumatology	rheumatology	NOUN
dpc-2102	56	7	department	department	NOUN
dpc-2102	56	8	based	base	VERB
dpc-2102	56	9	on	on	ADP
dpc-2102	56	10	the	the	DET
dpc-2102	56	11	suspicion	suspicion	NOUN
dpc-2102	56	12	of	of	ADP
dpc-2102	56	13	psa	psa	NOUN
dpc-2102	56	14	according	accord	VERB
dpc-2102	56	15	to	to	AUX
dpc-2102	56	16	rsq	rsq	PROPN
dpc-2102	56	17	(	(	PUNCT
dpc-2102	56	18	patients	patient	NOUN
dpc-2102	56	19	with	with	ADP
dpc-2102	56	20	one	one	NUM
dpc-2102	56	21	or	or	CCONJ
dpc-2102	56	22	more	more	ADV
dpc-2102	56	23	positive	positive	ADJ
dpc-2102	56	24	answers	answer	NOUN
dpc-2102	56	25	to	to	ADP
dpc-2102	56	26	5	5	NUM
dpc-2102	56	27	items	item	NOUN
dpc-2102	56	28	were	be	AUX
dpc-2102	56	29	consulted	consult	VERB
dpc-2102	56	30	)	)	PUNCT
dpc-2102	56	31	and	and	CCONJ
dpc-2102	56	32	consultation	consultation	NOUN
dpc-2102	56	33	results	result	NOUN
dpc-2102	56	34	were	be	AUX
dpc-2102	56	35	added	add	VERB
dpc-2102	56	36	to	to	ADP
dpc-2102	56	37	the	the	DET
dpc-2102	56	38	study	study	NOUN
dpc-2102	56	39	data	datum	NOUN
dpc-2102	56	40	.	.	PUNCT
dpc-2102	57	1	concurrent	concurrent	ADJ
dpc-2102	57	2	comorbidities	comorbiditie	NOUN
dpc-2102	57	3	any	any	DET
dpc-2102	57	4	previous	previous	ADJ
dpc-2102	57	5	diagnosis	diagnosis	NOUN
dpc-2102	57	6	of	of	ADP
dpc-2102	57	7	concurrent	concurrent	ADJ
dpc-2102	57	8	systemic	systemic	ADJ
dpc-2102	57	9	inflammatory	inflammatory	ADJ
dpc-2102	57	10	comorbidities	comorbiditie	NOUN
dpc-2102	57	11	comprising	comprise	VERB
dpc-2102	57	12	ht	ht	PROPN
dpc-2102	57	13	,	,	PUNCT
dpc-2102	57	14	dm	dm	PROPN
dpc-2102	57	15	,	,	PUNCT
dpc-2102	57	16	nash	nash	PROPN
dpc-2102	57	17	,	,	PUNCT
dpc-2102	57	18	cvd	cvd	PROPN
dpc-2102	57	19	,	,	PUNCT
dpc-2102	57	20	dlp	dlp	PROPN
dpc-2102	57	21	,	,	PUNCT
dpc-2102	57	22	ms	ms	NOUN
dpc-2102	57	23	,	,	PUNCT
dpc-2102	57	24	original	original	ADJ
dpc-2102	57	25	article	article	NOUN
dpc-2102	57	26	|	|	ADV
dpc-2102	57	27	dermatol	dermatol	ADJ
dpc-2102	57	28	pract	pract	NOUN
dpc-2102	57	29	concept	concept	NOUN
dpc-2102	57	30	.	.	PUNCT
dpc-2102	58	1	2022;12(3):e2022144	2022;12(3):e2022144	NUM
dpc-2102	58	2	3	3	NUM
dpc-2102	58	3	ob	ob	NOUN
dpc-2102	58	4	was	be	AUX
dpc-2102	58	5	noted	note	VERB
dpc-2102	58	6	.	.	PUNCT
dpc-2102	59	1	patients	patient	NOUN
dpc-2102	59	2	who	who	PRON
dpc-2102	59	3	had	have	VERB
dpc-2102	59	4	physical	physical	ADJ
dpc-2102	59	5	examination	examination	NOUN
dpc-2102	59	6	and/	and/	NOUN
dpc-2102	59	7	or	or	CCONJ
dpc-2102	59	8	laboratory	laboratory	NOUN
dpc-2102	59	9	findings	finding	NOUN
dpc-2102	59	10	indicative	indicative	ADJ
dpc-2102	59	11	of	of	ADP
dpc-2102	59	12	definite	definite	ADJ
dpc-2102	59	13	disease	disease	NOUN
dpc-2102	59	14	according	accord	VERB
dpc-2102	59	15	to	to	ADP
dpc-2102	59	16	below	below	ADP
dpc-2102	59	17	mentioned	mention	VERB
dpc-2102	59	18	criteria	criterion	NOUN
dpc-2102	59	19	despite	despite	SCONJ
dpc-2102	59	20	lack	lack	NOUN
dpc-2102	59	21	of	of	ADP
dpc-2102	59	22	previous	previous	ADJ
dpc-2102	59	23	diagnosis	diagnosis	NOUN
dpc-2102	59	24	,	,	PUNCT
dpc-2102	59	25	they	they	PRON
dpc-2102	59	26	were	be	AUX
dpc-2102	59	27	referred	refer	VERB
dpc-2102	59	28	to	to	PART
dpc-2102	59	29	concordant	concordant	VERB
dpc-2102	59	30	specialist	specialist	NOUN
dpc-2102	59	31	for	for	ADP
dpc-2102	59	32	further	further	ADJ
dpc-2102	59	33	evaluation	evaluation	NOUN
dpc-2102	59	34	,	,	PUNCT
dpc-2102	59	35	the	the	DET
dpc-2102	59	36	results	result	NOUN
dpc-2102	59	37	of	of	ADP
dpc-2102	59	38	this	this	DET
dpc-2102	59	39	consultations	consultation	NOUN
dpc-2102	59	40	were	be	AUX
dpc-2102	59	41	also	also	ADV
dpc-2102	59	42	added	add	VERB
dpc-2102	59	43	to	to	ADP
dpc-2102	59	44	this	this	DET
dpc-2102	59	45	study	study	NOUN
dpc-2102	59	46	data	datum	NOUN
dpc-2102	59	47	.	.	PUNCT
dpc-2102	60	1	ht	ht	PROPN
dpc-2102	60	2	was	be	AUX
dpc-2102	60	3	accepted	accept	VERB
dpc-2102	60	4	as	as	ADP
dpc-2102	60	5	having	have	VERB
dpc-2102	60	6	systolic	systolic	ADJ
dpc-2102	60	7	blood	blood	NOUN
dpc-2102	60	8	pressure	pressure	NOUN
dpc-2102	60	9	≥	≥	NOUN
dpc-2102	60	10	150	150	NUM
dpc-2102	60	11	mmhg	mmhg	NOUN
dpc-2102	60	12	and	and	CCONJ
dpc-2102	60	13	diastolic	diastolic	ADJ
dpc-2102	60	14	blood	blood	NOUN
dpc-2102	60	15	pressure	pressure	NOUN
dpc-2102	60	16	≥	≥	NOUN
dpc-2102	60	17	90	90	NUM
dpc-2102	60	18	mmhg	mmhg	NOUN
dpc-2102	60	19	in	in	ADP
dpc-2102	60	20	patients	patient	NOUN
dpc-2102	60	21	≥	≥	NOUN
dpc-2102	60	22	60	60	NUM
dpc-2102	60	23	years	year	NOUN
dpc-2102	60	24	and	and	CCONJ
dpc-2102	60	25	systolic	systolic	ADJ
dpc-2102	60	26	blood	blood	NOUN
dpc-2102	60	27	pressure	pressure	NOUN
dpc-2102	60	28	≥	≥	NOUN
dpc-2102	60	29	140	140	NUM
dpc-2102	60	30	mmhg	mmhg	NOUN
dpc-2102	60	31	and	and	CCONJ
dpc-2102	60	32	diastolic	diastolic	ADJ
dpc-2102	60	33	blood	blood	NOUN
dpc-2102	60	34	pressure	pressure	NOUN
dpc-2102	60	35	≥	≥	NOUN
dpc-2102	60	36	90	90	NUM
dpc-2102	60	37	mmhg	mmhg	NOUN
dpc-2102	60	38	in	in	ADP
dpc-2102	60	39	patients	patient	NOUN
dpc-2102	60	40	<	<	X
dpc-2102	60	41	60	60	NUM
dpc-2102	60	42	years	year	NOUN
dpc-2102	61	1	[	[	X
dpc-2102	61	2	12	12	NUM
dpc-2102	61	3	]	]	PUNCT
dpc-2102	61	4	.	.	PUNCT
dpc-2102	62	1	fasting	fast	VERB
dpc-2102	62	2	blood	blood	NOUN
dpc-2102	62	3	glucose	glucose	NOUN
dpc-2102	62	4	≥	≥	NUM
dpc-2102	62	5	126	126	NUM
dpc-2102	62	6	mg	mg	PROPN
dpc-2102	62	7	/	/	SYM
dpc-2102	62	8	dl	dl	PROPN
dpc-2102	62	9	and	and	CCONJ
dpc-2102	62	10	random	random	ADJ
dpc-2102	62	11	blood	blood	NOUN
dpc-2102	62	12	glucose	glucose	NOUN
dpc-2102	62	13	≥	≥	NUM
dpc-2102	62	14	200	200	NUM
dpc-2102	62	15	mg	mg	PROPN
dpc-2102	62	16	/	/	SYM
dpc-2102	62	17	dl	dl	PROPN
dpc-2102	62	18	was	be	AUX
dpc-2102	62	19	accepted	accept	VERB
dpc-2102	62	20	as	as	ADP
dpc-2102	62	21	dm	dm	PROPN
dpc-2102	62	22	[	[	NOUN
dpc-2102	62	23	13	13	NUM
dpc-2102	62	24	]	]	PUNCT
dpc-2102	62	25	.	.	PUNCT
dpc-2102	63	1	dlp	dlp	PROPN
dpc-2102	63	2	was	be	AUX
dpc-2102	63	3	defined	define	VERB
dpc-2102	63	4	as	as	ADP
dpc-2102	63	5	total	total	ADJ
dpc-2102	63	6	cholesterol	cholesterol	NOUN
dpc-2102	63	7	levels	level	NOUN
dpc-2102	63	8	>	>	X
dpc-2102	63	9	200	200	NUM
dpc-2102	63	10	mg	mg	PROPN
dpc-2102	63	11	/	/	SYM
dpc-2102	63	12	dl	dl	PROPN
dpc-2102	63	13	,	,	PUNCT
dpc-2102	63	14	ldl	ldl	VERB
dpc-2102	63	15	cholesterol	cholesterol	NOUN
dpc-2102	63	16	>	>	X
dpc-2102	63	17	100	100	NUM
dpc-2102	63	18	mg/	mg/	PROPN
dpc-2102	63	19	dl	dl	PROPN
dpc-2102	63	20	,	,	PUNCT
dpc-2102	63	21	hdl	hdl	PROPN
dpc-2102	63	22	cholesterol	cholesterol	PROPN
dpc-2102	63	23	<	<	X
dpc-2102	63	24	40	40	NUM
dpc-2102	63	25	mg	mg	PROPN
dpc-2102	63	26	/	/	SYM
dpc-2102	63	27	dl	dl	PROPN
dpc-2102	63	28	,	,	PUNCT
dpc-2102	63	29	tg	tg	PROPN
dpc-2102	63	30	>	>	PROPN
dpc-2102	63	31	150	150	NUM
dpc-2102	63	32	mg	mg	PROPN
dpc-2102	63	33	/	/	SYM
dpc-2102	63	34	dl	dl	PROPN
dpc-2102	63	35	and	and	CCONJ
dpc-2102	63	36	non	non	ADJ
dpc-2102	63	37	-	-	ADJ
dpc-2102	63	38	hdl	hdl	ADJ
dpc-2102	63	39	cholesterol	cholesterol	NOUN
dpc-2102	63	40	>	>	X
dpc-2102	63	41	130	130	NUM
dpc-2102	63	42	mg	mg	NUM
dpc-2102	63	43	/	/	SYM
dpc-2102	63	44	dl	dl	PROPN
dpc-2102	63	45	,	,	PUNCT
dpc-2102	63	46	as	as	SCONJ
dpc-2102	63	47	proposed	propose	VERB
dpc-2102	63	48	by	by	ADP
dpc-2102	63	49	american	american	ADJ
dpc-2102	63	50	endocrinology	endocrinology	PROPN
dpc-2102	63	51	association	association	NOUN
dpc-2102	63	52	[	[	X
dpc-2102	63	53	14	14	NUM
dpc-2102	63	54	]	]	PUNCT
dpc-2102	63	55	.	.	PUNCT
dpc-2102	64	1	ms	ms	PROPN
dpc-2102	64	2	was	be	AUX
dpc-2102	64	3	accepted	accept	VERB
dpc-2102	64	4	as	as	ADP
dpc-2102	64	5	having	have	VERB
dpc-2102	64	6	any	any	DET
dpc-2102	64	7	three	three	NUM
dpc-2102	64	8	of	of	ADP
dpc-2102	64	9	the	the	DET
dpc-2102	64	10	following	follow	VERB
dpc-2102	64	11	five	five	NUM
dpc-2102	64	12	criteria	criterion	NOUN
dpc-2102	64	13	:	:	PUNCT
dpc-2102	64	14	1	1	X
dpc-2102	64	15	.	.	X
dpc-2102	64	16	obesity	obesity	NOUN
dpc-2102	64	17	:	:	PUNCT
dpc-2102	64	18	waist	waist	NOUN
dpc-2102	64	19	circumference	circumference	NOUN
dpc-2102	64	20	≥	≥	NUM
dpc-2102	64	21	102	102	NUM
dpc-2102	64	22	cm	cm	NOUN
dpc-2102	64	23	in	in	ADP
dpc-2102	64	24	men	man	NOUN
dpc-2102	64	25	and	and	CCONJ
dpc-2102	64	26	≥	≥	NUM
dpc-2102	64	27	88	88	NUM
dpc-2102	64	28	cm	cm	NOUN
dpc-2102	64	29	in	in	ADP
dpc-2102	64	30	women	woman	NOUN
dpc-2102	64	31	;	;	PUNCT
dpc-2102	65	1	2	2	X
dpc-2102	65	2	.	.	X
dpc-2102	65	3	dyslipidemia	dyslipidemia	NOUN
dpc-2102	65	4	:	:	PUNCT
dpc-2102	65	5	tg	tg	PROPN
dpc-2102	65	6	>	>	X
dpc-2102	65	7	150	150	NUM
dpc-2102	65	8	mg	mg	PROPN
dpc-2102	65	9	/	/	SYM
dpc-2102	65	10	dl	dl	PROPN
dpc-2102	65	11	or	or	CCONJ
dpc-2102	65	12	having	have	VERB
dpc-2102	65	13	pharmacologic	pharmacologic	ADJ
dpc-2102	65	14	treatment	treatment	NOUN
dpc-2102	65	15	(	(	PUNCT
dpc-2102	65	16	rx	rx	NOUN
dpc-2102	65	17	)	)	PUNCT
dpc-2102	65	18	;	;	PUNCT
dpc-2102	65	19	3	3	X
dpc-2102	65	20	.	.	X
dpc-2102	65	21	dyslipidemia	dyslipidemia	NOUN
dpc-2102	65	22	(	(	PUNCT
dpc-2102	65	23	second	second	ADJ
dpc-2102	65	24	,	,	PUNCT
dpc-2102	65	25	separate	separate	ADJ
dpc-2102	65	26	criteria	criterion	NOUN
dpc-2102	65	27	):	):	PUNCT
dpc-2102	65	28	hdl	hdl	PROPN
dpc-2102	65	29	cholesterol	cholesterol	PROPN
dpc-2102	65	30	<	<	X
dpc-2102	65	31	40	40	NUM
dpc-2102	65	32	mg	mg	PROPN
dpc-2102	65	33	/	/	SYM
dpc-2102	65	34	dl	dl	PROPN
dpc-2102	65	35	in	in	ADP
dpc-2102	65	36	men	man	NOUN
dpc-2102	65	37	and	and	CCONJ
dpc-2102	65	38	hdl	hdl	PROPN
dpc-2102	65	39	cholesterol	cholesterol	PROPN
dpc-2102	65	40	<	<	X
dpc-2102	65	41	35	35	NUM
dpc-2102	65	42	mg	mg	PROPN
dpc-2102	65	43	/	/	SYM
dpc-2102	65	44	dl	dl	PROPN
dpc-2102	65	45	in	in	ADP
dpc-2102	65	46	women	woman	NOUN
dpc-2102	65	47	or	or	CCONJ
dpc-2102	65	48	rx	rx	VERB
dpc-2102	65	49	;	;	PUNCT
dpc-2102	65	50	4	4	X
dpc-2102	65	51	.	.	X
dpc-2102	66	1	ht	ht	PROPN
dpc-2102	66	2	:	:	PUNCT
dpc-2102	66	3	systolic	systolic	ADJ
dpc-2102	66	4	blood	blood	NOUN
dpc-2102	66	5	pressure	pressure	NOUN
dpc-2102	66	6	≥	≥	NOUN
dpc-2102	66	7	130	130	NUM
dpc-2102	66	8	mmhg	mmhg	NOUN
dpc-2102	66	9	and	and	CCONJ
dpc-2102	66	10	diastolic	diastolic	ADJ
dpc-2102	66	11	blood	blood	NOUN
dpc-2102	66	12	pressure	pressure	NOUN
dpc-2102	66	13	≥	≥	NOUN
dpc-2102	66	14	85	85	NUM
dpc-2102	66	15	,	,	PUNCT
dpc-2102	66	16	or	or	CCONJ
dpc-2102	66	17	rx	rx	VERB
dpc-2102	66	18	;	;	PUNCT
dpc-2102	66	19	5.hyperglycemia	5.hyperglycemia	NUM
dpc-2102	66	20	fasting	fast	VERB
dpc-2102	66	21	blood	blood	NOUN
dpc-2102	66	22	glucose	glucose	NOUN
dpc-2102	66	23	≥	≥	NUM
dpc-2102	66	24	100	100	NUM
dpc-2102	66	25	mg	mg	PROPN
dpc-2102	66	26	/	/	SYM
dpc-2102	66	27	dl	dl	PROPN
dpc-2102	66	28	or	or	CCONJ
dpc-2102	66	29	rx	rx	VERB
dpc-2102	66	30	[	[	X
dpc-2102	66	31	15	15	NUM
dpc-2102	66	32	]	]	PUNCT
dpc-2102	66	33	.	.	PUNCT
dpc-2102	67	1	cvd	cvd	PROPN
dpc-2102	67	2	included	include	VERB
dpc-2102	67	3	history	history	NOUN
dpc-2102	67	4	of	of	ADP
dpc-2102	67	5	mi	mi	PROPN
dpc-2102	67	6	,	,	PUNCT
dpc-2102	67	7	coronary	coronary	ADJ
dpc-2102	67	8	artery	artery	NOUN
dpc-2102	67	9	by	by	ADP
dpc-2102	67	10	-	-	PUNCT
dpc-2102	67	11	pass	pass	VERB
dpc-2102	67	12	surgery	surgery	NOUN
dpc-2102	67	13	,	,	PUNCT
dpc-2102	67	14	balloon	balloon	NOUN
dpc-2102	67	15	angioplasty	angioplasty	NOUN
dpc-2102	67	16	or	or	CCONJ
dpc-2102	67	17	coronary	coronary	ADJ
dpc-2102	67	18	artery	artery	NOUN
dpc-2102	67	19	stent	stent	NOUN
dpc-2102	67	20	,	,	PUNCT
dpc-2102	67	21	cerebrovascular	cerebrovascular	ADJ
dpc-2102	67	22	accident	accident	NOUN
dpc-2102	67	23	or	or	CCONJ
dpc-2102	67	24	peripheral	peripheral	ADJ
dpc-2102	67	25	atherosclerotic	atherosclerotic	ADJ
dpc-2102	67	26	vascular	vascular	ADJ
dpc-2102	67	27	disease	disease	NOUN
dpc-2102	67	28	.	.	PUNCT
dpc-2102	68	1	ob	ob	PROPN
dpc-2102	68	2	was	be	AUX
dpc-2102	68	3	defined	define	VERB
dpc-2102	68	4	bmi	bmi	PROPN
dpc-2102	68	5	≥	≥	NUM
dpc-2102	68	6	30	30	NUM
dpc-2102	69	1	[	[	X
dpc-2102	69	2	16	16	NUM
dpc-2102	69	3	]	]	PUNCT
dpc-2102	69	4	.	.	PUNCT
dpc-2102	70	1	physical	physical	ADJ
dpc-2102	70	2	and	and	CCONJ
dpc-2102	70	3	dermatologic	dermatologic	ADJ
dpc-2102	70	4	examination	examination	NOUN
dpc-2102	70	5	physical	physical	ADJ
dpc-2102	70	6	and	and	CCONJ
dpc-2102	70	7	dermatological	dermatological	ADJ
dpc-2102	70	8	examination	examination	NOUN
dpc-2102	70	9	findings	finding	NOUN
dpc-2102	70	10	obtained	obtain	VERB
dpc-2102	70	11	during	during	ADP
dpc-2102	70	12	examination	examination	NOUN
dpc-2102	70	13	in	in	ADP
dpc-2102	70	14	the	the	DET
dpc-2102	70	15	last	last	ADJ
dpc-2102	70	16	6	6	NUM
dpc-2102	70	17	months	month	NOUN
dpc-2102	70	18	were	be	AUX
dpc-2102	70	19	noted	note	VERB
dpc-2102	70	20	.	.	PUNCT
dpc-2102	71	1	physical	physical	ADJ
dpc-2102	71	2	examination	examination	NOUN
dpc-2102	71	3	findings	finding	NOUN
dpc-2102	71	4	included	include	VERB
dpc-2102	71	5	blood	blood	NOUN
dpc-2102	71	6	pressure	pressure	NOUN
dpc-2102	71	7	,	,	PUNCT
dpc-2102	71	8	height	height	NOUN
dpc-2102	71	9	,	,	PUNCT
dpc-2102	71	10	weight	weight	NOUN
dpc-2102	71	11	and	and	CCONJ
dpc-2102	71	12	waist	waist	NOUN
dpc-2102	71	13	circumference	circumference	NOUN
dpc-2102	71	14	.	.	PUNCT
dpc-2102	72	1	obtained	obtain	VERB
dpc-2102	72	2	dermatologic	dermatologic	ADJ
dpc-2102	72	3	examination	examination	NOUN
dpc-2102	72	4	results	result	NOUN
dpc-2102	72	5	comprised	comprise	VERB
dpc-2102	72	6	pasi	pasi	NOUN
dpc-2102	72	7	score	score	NOUN
dpc-2102	72	8	and	and	CCONJ
dpc-2102	72	9	affected	affect	VERB
dpc-2102	72	10	body	body	NOUN
dpc-2102	72	11	surface	surface	NOUN
dpc-2102	72	12	area	area	NOUN
dpc-2102	72	13	(	(	PUNCT
dpc-2102	72	14	bsa	bsa	PROPN
dpc-2102	72	15	)	)	PUNCT
dpc-2102	72	16	.	.	PUNCT
dpc-2102	73	1	the	the	DET
dpc-2102	73	2	severity	severity	NOUN
dpc-2102	73	3	of	of	ADP
dpc-2102	73	4	psoriasis	psoriasis	NOUN
dpc-2102	73	5	was	be	AUX
dpc-2102	73	6	classified	classify	VERB
dpc-2102	73	7	as	as	ADP
dpc-2102	73	8	mild	mild	ADJ
dpc-2102	73	9	(	(	PUNCT
dpc-2102	73	10	bsa	bsa	PROPN
dpc-2102	73	11	≤	≤	PROPN
dpc-2102	73	12	10	10	NUM
dpc-2102	73	13	;	;	PUNCT
dpc-2102	73	14	pasi	pasi	VERB
dpc-2102	73	15	≤	≤	NUM
dpc-2102	73	16	10	10	NUM
dpc-2102	73	17	)	)	PUNCT
dpc-2102	73	18	or	or	CCONJ
dpc-2102	73	19	moderate	moderate	ADJ
dpc-2102	73	20	-	-	PUNCT
dpc-2102	73	21	to	to	ADP
dpc-2102	73	22	-	-	PUNCT
dpc-2102	73	23	severe	severe	ADJ
dpc-2102	73	24	(	(	PUNCT
dpc-2102	73	25	bsa	bsa	PROPN
dpc-2102	73	26	>	>	X
dpc-2102	73	27	10	10	NUM
dpc-2102	73	28	and	and	CCONJ
dpc-2102	73	29	pasi	pasi	VERB
dpc-2102	73	30	>	>	X
dpc-2102	73	31	10	10	NUM
dpc-2102	73	32	)	)	PUNCT
dpc-2102	73	33	.	.	PUNCT
dpc-2102	74	1	systemic	systemic	ADJ
dpc-2102	74	2	treatment	treatment	NOUN
dpc-2102	74	3	regimen	regiman	NOUN
dpc-2102	74	4	,	,	PUNCT
dpc-2102	74	5	duration	duration	NOUN
dpc-2102	74	6	of	of	ADP
dpc-2102	74	7	systemic	systemic	ADJ
dpc-2102	74	8	treatment	treatment	NOUN
dpc-2102	74	9	,	,	PUNCT
dpc-2102	74	10	duration	duration	NOUN
dpc-2102	74	11	of	of	ADP
dpc-2102	74	12	active	active	ADJ
dpc-2102	74	13	disease	disease	NOUN
dpc-2102	74	14	(	(	PUNCT
dpc-2102	74	15	both	both	CCONJ
dpc-2102	74	16	under	under	ADP
dpc-2102	74	17	treatment	treatment	NOUN
dpc-2102	74	18	and	and	CCONJ
dpc-2102	74	19	without	without	ADP
dpc-2102	74	20	any	any	DET
dpc-2102	74	21	treatment	treatment	NOUN
dpc-2102	74	22	)	)	PUNCT
dpc-2102	74	23	,	,	PUNCT
dpc-2102	74	24	number	number	NOUN
dpc-2102	74	25	of	of	ADP
dpc-2102	74	26	erythroderma	erythroderma	NOUN
dpc-2102	74	27	attacks	attack	NOUN
dpc-2102	74	28	and	and	CCONJ
dpc-2102	74	29	hospitalization	hospitalization	NOUN
dpc-2102	74	30	due	due	ADP
dpc-2102	74	31	to	to	ADP
dpc-2102	74	32	psoriasis	psoriasis	NOUN
dpc-2102	74	33	were	be	AUX
dpc-2102	74	34	also	also	ADV
dpc-2102	74	35	collected	collect	VERB
dpc-2102	74	36	to	to	PART
dpc-2102	74	37	assess	assess	VERB
dpc-2102	74	38	the	the	DET
dpc-2102	74	39	severity	severity	NOUN
dpc-2102	74	40	of	of	ADP
dpc-2102	74	41	psoriasis	psoriasis	NOUN
dpc-2102	74	42	.	.	PUNCT
dpc-2102	75	1	laboratory	laboratory	NOUN
dpc-2102	75	2	studies	study	NOUN
dpc-2102	75	3	obtained	obtain	VERB
dpc-2102	75	4	laboratory	laboratory	NOUN
dpc-2102	75	5	test	test	NOUN
dpc-2102	75	6	results	result	NOUN
dpc-2102	75	7	conducted	conduct	VERB
dpc-2102	75	8	during	during	ADP
dpc-2102	75	9	the	the	DET
dpc-2102	75	10	last	last	ADJ
dpc-2102	75	11	6	6	NUM
dpc-2102	75	12	months	month	NOUN
dpc-2102	75	13	including	include	VERB
dpc-2102	75	14	complete	complete	ADJ
dpc-2102	75	15	blood	blood	NOUN
dpc-2102	75	16	count	count	NOUN
dpc-2102	75	17	,	,	PUNCT
dpc-2102	75	18	fasting	fast	VERB
dpc-2102	75	19	blood	blood	NOUN
dpc-2102	75	20	glucose	glucose	NOUN
dpc-2102	75	21	,	,	PUNCT
dpc-2102	75	22	c	c	NOUN
dpc-2102	75	23	-	-	PUNCT
dpc-2102	75	24	reactive	reactive	ADJ
dpc-2102	75	25	protein	protein	NOUN
dpc-2102	75	26	(	(	PUNCT
dpc-2102	75	27	crp	crp	PROPN
dpc-2102	75	28	)	)	PUNCT
dpc-2102	75	29	,	,	PUNCT
dpc-2102	75	30	total	total	ADJ
dpc-2102	75	31	cholesterol	cholesterol	NOUN
dpc-2102	75	32	(	(	PUNCT
dpc-2102	75	33	tc	tc	NOUN
dpc-2102	75	34	)	)	PUNCT
dpc-2102	75	35	,	,	PUNCT
dpc-2102	75	36	high	high	ADJ
dpc-2102	75	37	density	density	NOUN
dpc-2102	75	38	lipoprotein	lipoprotein	ADJ
dpc-2102	75	39	cholesterol	cholesterol	NOUN
dpc-2102	75	40	(	(	PUNCT
dpc-2102	75	41	hdl	hdl	PROPN
dpc-2102	75	42	)	)	PUNCT
dpc-2102	75	43	,	,	PUNCT
dpc-2102	75	44	low	low	ADJ
dpc-2102	75	45	density	density	NOUN
dpc-2102	75	46	lipoprotein	lipoprotein	ADJ
dpc-2102	75	47	cholesterol	cholesterol	NOUN
dpc-2102	75	48	(	(	PUNCT
dpc-2102	75	49	ldl	ldl	NOUN
dpc-2102	75	50	)	)	PUNCT
dpc-2102	75	51	,	,	PUNCT
dpc-2102	75	52	triglycerides	triglyceride	NOUN
dpc-2102	75	53	(	(	PUNCT
dpc-2102	75	54	tg	tg	NOUN
dpc-2102	75	55	)	)	PUNCT
dpc-2102	75	56	,	,	PUNCT
dpc-2102	75	57	blood	blood	NOUN
dpc-2102	75	58	urea	urea	NOUN
dpc-2102	75	59	nitrogen	nitrogen	PROPN
dpc-2102	75	60	(	(	PUNCT
dpc-2102	75	61	bun	bun	PROPN
dpc-2102	75	62	)	)	PUNCT
dpc-2102	75	63	were	be	AUX
dpc-2102	75	64	recorded	record	VERB
dpc-2102	75	65	.	.	PUNCT
dpc-2102	76	1	statistical	statistical	ADJ
dpc-2102	76	2	analysis	analysis	NOUN
dpc-2102	76	3	statistical	statistical	ADJ
dpc-2102	76	4	analysis	analysis	NOUN
dpc-2102	76	5	was	be	AUX
dpc-2102	76	6	performed	perform	VERB
dpc-2102	76	7	using	use	VERB
dpc-2102	76	8	statistical	statistical	ADJ
dpc-2102	76	9	package	package	NOUN
dpc-2102	76	10	for	for	ADP
dpc-2102	76	11	the	the	DET
dpc-2102	76	12	social	social	ADJ
dpc-2102	76	13	science	science	NOUN
dpc-2102	76	14	(	(	PUNCT
dpc-2102	76	15	spss	spss	PROPN
dpc-2102	76	16	)	)	PUNCT
dpc-2102	76	17	version	version	NOUN
dpc-2102	76	18	20.0	20.0	NUM
dpc-2102	76	19	.	.	PUNCT
dpc-2102	77	1	patient	patient	ADJ
dpc-2102	77	2	group	group	NOUN
dpc-2102	77	3	data	datum	NOUN
dpc-2102	77	4	were	be	AUX
dpc-2102	77	5	presented	present	VERB
dpc-2102	77	6	as	as	ADP
dpc-2102	77	7	mean	mean	NOUN
dpc-2102	77	8	±	±	NUM
dpc-2102	77	9	standard	standard	ADJ
dpc-2102	77	10	deviation	deviation	NOUN
dpc-2102	77	11	(	(	PUNCT
dpc-2102	77	12	sd	sd	NOUN
dpc-2102	77	13	)	)	PUNCT
dpc-2102	77	14	or	or	CCONJ
dpc-2102	77	15	median	median	ADJ
dpc-2102	77	16	(	(	PUNCT
dpc-2102	77	17	range	range	NOUN
dpc-2102	77	18	)	)	PUNCT
dpc-2102	77	19	,	,	PUNCT
dpc-2102	77	20	as	as	ADP
dpc-2102	77	21	appropriate	appropriate	ADJ
dpc-2102	77	22	and	and	CCONJ
dpc-2102	77	23	compared	compare	VERB
dpc-2102	77	24	with	with	ADP
dpc-2102	77	25	adjustments	adjustment	NOUN
dpc-2102	77	26	using	use	VERB
dpc-2102	77	27	fisher	fisher	PROPN
dpc-2102	77	28	exact	exact	ADJ
dpc-2102	77	29	tests	test	NOUN
dpc-2102	77	30	(	(	PUNCT
dpc-2102	77	31	for	for	ADP
dpc-2102	77	32	categorical	categorical	ADJ
dpc-2102	77	33	variables	variable	NOUN
dpc-2102	77	34	)	)	PUNCT
dpc-2102	77	35	and	and	CCONJ
dpc-2102	77	36	student	student	NOUN
dpc-2102	77	37	two	two	NUM
dpc-2102	77	38	-	-	PUNCT
dpc-2102	77	39	sample	sample	NOUN
dpc-2102	77	40	t	t	NOUN
dpc-2102	77	41	tests	test	NOUN
dpc-2102	77	42	or	or	CCONJ
dpc-2102	77	43	wilcoxon	wilcoxon	ADJ
dpc-2102	77	44	rank	rank	NOUN
dpc-2102	77	45	-	-	PUNCT
dpc-2102	77	46	sum	sum	NOUN
dpc-2102	77	47	tests	test	NOUN
dpc-2102	77	48	(	(	PUNCT
dpc-2102	77	49	for	for	ADP
dpc-2102	77	50	continuous	continuous	ADJ
dpc-2102	77	51	variables	variable	NOUN
dpc-2102	77	52	)	)	PUNCT
dpc-2102	77	53	,	,	PUNCT
dpc-2102	77	54	subject	subject	ADJ
dpc-2102	77	55	to	to	ADP
dpc-2102	77	56	normality	normality	NOUN
dpc-2102	77	57	assumptions	assumption	NOUN
dpc-2102	77	58	being	be	AUX
dpc-2102	77	59	satisfied	satisfied	ADJ
dpc-2102	77	60	.	.	PUNCT
dpc-2102	78	1	associations	association	NOUN
dpc-2102	78	2	between	between	ADP
dpc-2102	78	3	the	the	DET
dpc-2102	78	4	age	age	NOUN
dpc-2102	78	5	at	at	ADP
dpc-2102	78	6	the	the	DET
dpc-2102	78	7	time	time	NOUN
dpc-2102	78	8	of	of	ADP
dpc-2102	78	9	diagnosis	diagnosis	NOUN
dpc-2102	78	10	and	and	CCONJ
dpc-2102	78	11	binary	binary	ADJ
dpc-2102	78	12	comorbidity	comorbidity	NOUN
dpc-2102	78	13	outcomes	outcome	NOUN
dpc-2102	78	14	were	be	AUX
dpc-2102	78	15	evaluated	evaluate	VERB
dpc-2102	78	16	using	use	VERB
dpc-2102	78	17	multiple	multiple	ADJ
dpc-2102	78	18	logistic	logistic	ADJ
dpc-2102	78	19	regression	regression	NOUN
dpc-2102	78	20	adjusted	adjust	VERB
dpc-2102	78	21	for	for	ADP
dpc-2102	78	22	age	age	NOUN
dpc-2102	78	23	and	and	CCONJ
dpc-2102	78	24	other	other	ADJ
dpc-2102	78	25	relevant	relevant	ADJ
dpc-2102	78	26	confounders	confounder	NOUN
dpc-2102	78	27	.	.	PUNCT
dpc-2102	79	1	results	result	VERB
dpc-2102	79	2	demographic	demographic	ADJ
dpc-2102	79	3	data	datum	NOUN
dpc-2102	79	4	and	and	CCONJ
dpc-2102	79	5	disease	disease	NOUN
dpc-2102	79	6	characteristics	characteristic	NOUN
dpc-2102	79	7	in	in	ADP
dpc-2102	79	8	eop	eop	PROPN
dpc-2102	79	9	and	and	CCONJ
dpc-2102	79	10	lop	lop	PROPN
dpc-2102	79	11	data	datum	NOUN
dpc-2102	79	12	of	of	ADP
dpc-2102	79	13	160	160	NUM
dpc-2102	79	14	patients	patient	NOUN
dpc-2102	79	15	;	;	PUNCT
dpc-2102	79	16	75.62	75.62	NUM
dpc-2102	79	17	%	%	NOUN
dpc-2102	79	18	(	(	PUNCT
dpc-2102	79	19	n	n	NOUN
dpc-2102	79	20	=	=	SYM
dpc-2102	79	21	121	121	NUM
dpc-2102	79	22	)	)	PUNCT
dpc-2102	79	23	with	with	ADP
dpc-2102	79	24	eop	eop	PROPN
dpc-2102	79	25	and	and	CCONJ
dpc-2102	79	26	24.38	24.38	NUM
dpc-2102	79	27	%	%	NOUN
dpc-2102	79	28	(	(	PUNCT
dpc-2102	79	29	n	n	NOUN
dpc-2102	79	30	=	=	SYM
dpc-2102	79	31	39	39	NUM
dpc-2102	79	32	)	)	PUNCT
dpc-2102	79	33	with	with	ADP
dpc-2102	79	34	lop	lop	PROPN
dpc-2102	79	35	was	be	AUX
dpc-2102	79	36	analyzed	analyze	VERB
dpc-2102	79	37	and	and	CCONJ
dpc-2102	79	38	shown	show	VERB
dpc-2102	79	39	in	in	ADP
dpc-2102	79	40	table	table	NOUN
dpc-2102	79	41	1	1	NUM
dpc-2102	79	42	.	.	PUNCT
dpc-2102	79	43	family	family	NOUN
dpc-2102	79	44	history	history	NOUN
dpc-2102	79	45	of	of	ADP
dpc-2102	79	46	psoriasis	psoriasis	NOUN
dpc-2102	79	47	was	be	AUX
dpc-2102	79	48	more	more	ADV
dpc-2102	79	49	frequent	frequent	ADJ
dpc-2102	79	50	in	in	ADP
dpc-2102	79	51	eop	eop	PROPN
dpc-2102	79	52	significantly	significantly	ADV
dpc-2102	79	53	.	.	PUNCT
dpc-2102	80	1	family	family	NOUN
dpc-2102	80	2	history	history	NOUN
dpc-2102	80	3	of	of	ADP
dpc-2102	80	4	psoriasis	psoriasis	NOUN
dpc-2102	80	5	was	be	AUX
dpc-2102	80	6	most	most	ADV
dpc-2102	80	7	frequently	frequently	ADV
dpc-2102	80	8	positive	positive	ADJ
dpc-2102	80	9	in	in	ADP
dpc-2102	80	10	the	the	DET
dpc-2102	80	11	first	first	ADJ
dpc-2102	80	12	-	-	PUNCT
dpc-2102	80	13	degree	degree	NOUN
dpc-2102	80	14	relatives	relative	NOUN
dpc-2102	80	15	in	in	ADP
dpc-2102	80	16	eop	eop	PROPN
dpc-2102	80	17	and	and	CCONJ
dpc-2102	80	18	lop	lop	PROPN
dpc-2102	80	19	:	:	PUNCT
dpc-2102	80	20	23.1	23.1	NUM
dpc-2102	80	21	%	%	NOUN
dpc-2102	80	22	,	,	PUNCT
dpc-2102	80	23	n	n	PROPN
dpc-2102	80	24	=	=	SYM
dpc-2102	80	25	28	28	NUM
dpc-2102	80	26	and	and	CCONJ
dpc-2102	80	27	10.3	10.3	NUM
dpc-2102	80	28	%	%	NOUN
dpc-2102	80	29	,	,	PUNCT
dpc-2102	80	30	n	n	NOUN
dpc-2102	80	31	=	=	SYM
dpc-2102	80	32	4	4	NUM
dpc-2102	80	33	,	,	PUNCT
dpc-2102	80	34	respectively	respectively	ADV
dpc-2102	80	35	.	.	PUNCT
dpc-2102	81	1	assessment	assessment	NOUN
dpc-2102	81	2	of	of	ADP
dpc-2102	81	3	severity	severity	NOUN
dpc-2102	81	4	of	of	ADP
dpc-2102	81	5	psoriasis	psoriasis	NOUN
dpc-2102	81	6	in	in	ADP
dpc-2102	81	7	eop	eop	PROPN
dpc-2102	81	8	and	and	CCONJ
dpc-2102	81	9	lop	lop	PROPN
dpc-2102	81	10	severity	severity	NOUN
dpc-2102	81	11	of	of	ADP
dpc-2102	81	12	psoriasis	psoriasis	NOUN
dpc-2102	81	13	was	be	AUX
dpc-2102	81	14	accessed	access	VERB
dpc-2102	81	15	depending	depend	VERB
dpc-2102	81	16	on	on	ADP
dpc-2102	81	17	bsa	bsa	PROPN
dpc-2102	81	18	percentage	percentage	NOUN
dpc-2102	81	19	,	,	PUNCT
dpc-2102	81	20	pasi	pasi	NOUN
dpc-2102	81	21	score	score	NOUN
dpc-2102	81	22	,	,	PUNCT
dpc-2102	81	23	active	active	ADJ
dpc-2102	81	24	duration	duration	NOUN
dpc-2102	81	25	of	of	ADP
dpc-2102	81	26	the	the	DET
dpc-2102	81	27	disease	disease	NOUN
dpc-2102	81	28	without	without	ADP
dpc-2102	81	29	any	any	DET
dpc-2102	81	30	treatment	treatment	NOUN
dpc-2102	81	31	and	and	CCONJ
dpc-2102	81	32	under	under	ADP
dpc-2102	81	33	treatment	treatment	NOUN
dpc-2102	81	34	,	,	PUNCT
dpc-2102	81	35	history	history	NOUN
dpc-2102	81	36	of	of	ADP
dpc-2102	81	37	hospitalizations	hospitalization	NOUN
dpc-2102	81	38	due	due	ADP
dpc-2102	81	39	to	to	ADP
dpc-2102	81	40	psoriasis	psoriasis	NOUN
dpc-2102	81	41	and	and	CCONJ
dpc-2102	81	42	number	number	NOUN
dpc-2102	81	43	of	of	ADP
dpc-2102	81	44	erythroderma	erythroderma	NOUN
dpc-2102	81	45	attacks	attack	NOUN
dpc-2102	81	46	and	and	CCONJ
dpc-2102	81	47	no	no	DET
dpc-2102	81	48	statistically	statistically	ADV
dpc-2102	81	49	significant	significant	ADJ
dpc-2102	81	50	difference	difference	NOUN
dpc-2102	81	51	was	be	AUX
dpc-2102	81	52	found	find	VERB
dpc-2102	81	53	in	in	ADP
dpc-2102	81	54	any	any	DET
dpc-2102	81	55	parameters	parameter	NOUN
dpc-2102	81	56	between	between	ADP
dpc-2102	81	57	eop	eop	PROPN
dpc-2102	81	58	and	and	CCONJ
dpc-2102	81	59	lop	lop	PROPN
dpc-2102	81	60	(	(	PUNCT
dpc-2102	81	61	table	table	NOUN
dpc-2102	81	62	2	2	NUM
dpc-2102	81	63	)	)	PUNCT
dpc-2102	81	64	.	.	PUNCT
dpc-2102	82	1	physical	physical	ADJ
dpc-2102	82	2	examination	examination	NOUN
dpc-2102	82	3	findings	finding	NOUN
dpc-2102	82	4	in	in	ADP
dpc-2102	82	5	eop	eop	PROPN
dpc-2102	82	6	and	and	CCONJ
dpc-2102	82	7	lop	lop	PROPN
dpc-2102	82	8	physical	physical	ADJ
dpc-2102	82	9	examination	examination	NOUN
dpc-2102	82	10	findings	finding	NOUN
dpc-2102	82	11	in	in	ADP
dpc-2102	82	12	eop	eop	PROPN
dpc-2102	82	13	and	and	CCONJ
dpc-2102	82	14	lop	lop	PROPN
dpc-2102	82	15	are	be	AUX
dpc-2102	82	16	shown	show	VERB
dpc-2102	82	17	in	in	ADP
dpc-2102	82	18	table	table	NOUN
dpc-2102	82	19	3	3	NUM
dpc-2102	82	20	.	.	PUNCT
dpc-2102	82	21	indicative	indicative	ADJ
dpc-2102	82	22	findings	finding	NOUN
dpc-2102	82	23	of	of	ADP
dpc-2102	82	24	comorbidities	comorbiditie	NOUN
dpc-2102	82	25	such	such	ADJ
dpc-2102	82	26	as	as	ADP
dpc-2102	82	27	ht	ht	PROPN
dpc-2102	82	28	and	and	CCONJ
dpc-2102	82	29	ob	ob	ADJ
dpc-2102	82	30	,	,	PUNCT
dpc-2102	82	31	eg	eg	NOUN
dpc-2102	82	32	systolic	systolic	ADJ
dpc-2102	82	33	and	and	CCONJ
dpc-2102	82	34	diastolic	diastolic	ADJ
dpc-2102	82	35	blood	blood	NOUN
dpc-2102	82	36	pressure	pressure	NOUN
dpc-2102	82	37	and	and	CCONJ
dpc-2102	82	38	bmi	bmi	NOUN
dpc-2102	82	39	were	be	AUX
dpc-2102	82	40	significantly	significantly	ADV
dpc-2102	82	41	higher	high	ADJ
dpc-2102	82	42	in	in	ADP
dpc-2102	82	43	lop	lop	NOUN
dpc-2102	82	44	than	than	SCONJ
dpc-2102	82	45	eop	eop	PROPN
dpc-2102	82	46	statistically	statistically	ADV
dpc-2102	82	47	(	(	PUNCT
dpc-2102	82	48	p	p	X
dpc-2102	82	49	=	=	NOUN
dpc-2102	82	50	0.005	0.005	NUM
dpc-2102	82	51	,	,	PUNCT
dpc-2102	82	52	p	p	X
dpc-2102	82	53	=	=	NOUN
dpc-2102	82	54	0.047	0.047	NUM
dpc-2102	82	55	and	and	CCONJ
dpc-2102	82	56	p	p	NOUN
dpc-2102	82	57	=	=	PROPN
dpc-2102	82	58	0.020	0.020	NUM
dpc-2102	82	59	)	)	PUNCT
dpc-2102	82	60	.	.	PUNCT
dpc-2102	83	1	laboratory	laboratory	NOUN
dpc-2102	83	2	studies	study	NOUN
dpc-2102	83	3	in	in	ADP
dpc-2102	83	4	eop	eop	PROPN
dpc-2102	83	5	and	and	CCONJ
dpc-2102	83	6	lop	lop	PROPN
dpc-2102	83	7	laboratory	laboratory	NOUN
dpc-2102	83	8	work	work	NOUN
dpc-2102	83	9	-	-	PUNCT
dpc-2102	83	10	up	up	ADP
dpc-2102	83	11	findings	finding	NOUN
dpc-2102	83	12	of	of	ADP
dpc-2102	83	13	the	the	DET
dpc-2102	83	14	patients	patient	NOUN
dpc-2102	83	15	are	be	AUX
dpc-2102	83	16	shown	show	VERB
dpc-2102	83	17	in	in	ADP
dpc-2102	83	18	table	table	NOUN
dpc-2102	83	19	4	4	NUM
dpc-2102	83	20	.	.	PUNCT
dpc-2102	84	1	parameters	parameter	NOUN
dpc-2102	84	2	indicating	indicate	VERB
dpc-2102	84	3	increased	increase	VERB
dpc-2102	84	4	systemic	systemic	ADJ
dpc-2102	84	5	inflammation	inflammation	NOUN
dpc-2102	84	6	,	,	PUNCT
dpc-2102	84	7	eg	eg	NOUN
dpc-2102	84	8	red	red	ADJ
dpc-2102	84	9	cell	cell	NOUN
dpc-2102	84	10	distribution	distribution	NOUN
dpc-2102	84	11	width	width	NOUN
dpc-2102	84	12	(	(	PUNCT
dpc-2102	84	13	rdw	rdw	ADJ
dpc-2102	84	14	)	)	PUNCT
dpc-2102	84	15	,	,	PUNCT
dpc-2102	84	16	c	c	NOUN
dpc-2102	84	17	-	-	PUNCT
dpc-2102	84	18	reactive	reactive	ADJ
dpc-2102	84	19	protein	protein	NOUN
dpc-2102	84	20	(	(	PUNCT
dpc-2102	84	21	crp	crp	NOUN
dpc-2102	84	22	)	)	PUNCT
dpc-2102	84	23	and	and	CCONJ
dpc-2102	84	24	erythrocyte	erythrocyte	PROPN
dpc-2102	84	25	sedimentation	sedimentation	NOUN
dpc-2102	84	26	rate	rate	NOUN
dpc-2102	84	27	(	(	PUNCT
dpc-2102	84	28	esr	esr	PROPN
dpc-2102	84	29	)	)	PUNCT
dpc-2102	84	30	were	be	AUX
dpc-2102	84	31	statistically	statistically	ADV
dpc-2102	84	32	higher	high	ADJ
dpc-2102	84	33	in	in	ADP
dpc-2102	84	34	lop	lop	NOUN
dpc-2102	84	35	than	than	ADP
dpc-2102	84	36	in	in	ADP
dpc-2102	84	37	eop	eop	PROPN
dpc-2102	84	38	respectively	respectively	ADV
dpc-2102	84	39	(	(	PUNCT
dpc-2102	84	40	p	p	X
dpc-2102	84	41	=	=	PROPN
dpc-2102	84	42	0.017	0.017	NUM
dpc-2102	84	43	,	,	PUNCT
dpc-2102	84	44	p	p	X
dpc-2102	84	45	=	=	NOUN
dpc-2102	84	46	0.006	0.006	NUM
dpc-2102	84	47	,	,	PUNCT
dpc-2102	84	48	p	p	NOUN
dpc-2102	84	49	=	=	NOUN
dpc-2102	84	50	0.001	0.001	NUM
dpc-2102	84	51	)	)	PUNCT
dpc-2102	84	52	.	.	PUNCT
dpc-2102	85	1	fasting	fast	VERB
dpc-2102	85	2	blood	blood	NOUN
dpc-2102	85	3	glucose	glucose	NOUN
dpc-2102	85	4	was	be	AUX
dpc-2102	85	5	also	also	ADV
dpc-2102	85	6	higher	high	ADJ
dpc-2102	85	7	in	in	ADP
dpc-2102	85	8	lop	lop	NOUN
dpc-2102	85	9	(	(	PUNCT
dpc-2102	85	10	p	p	NOUN
dpc-2102	85	11	=	=	NOUN
dpc-2102	85	12	0.002	0.002	NUM
dpc-2102	85	13	)	)	PUNCT
dpc-2102	85	14	.	.	PUNCT
dpc-2102	86	1	systemic	systemic	ADJ
dpc-2102	86	2	treatments	treatment	NOUN
dpc-2102	86	3	in	in	ADP
dpc-2102	86	4	eop	eop	PROPN
dpc-2102	86	5	and	and	CCONJ
dpc-2102	86	6	lop	lop	PROPN
dpc-2102	86	7	duration	duration	NOUN
dpc-2102	86	8	of	of	ADP
dpc-2102	86	9	systemic	systemic	ADJ
dpc-2102	86	10	treatment	treatment	NOUN
dpc-2102	86	11	was	be	AUX
dpc-2102	86	12	42.09	42.09	NUM
dpc-2102	86	13	±	±	NUM
dpc-2102	86	14	44.41	44.41	NUM
dpc-2102	86	15	months	month	NOUN
dpc-2102	86	16	in	in	ADP
dpc-2102	86	17	all	all	DET
dpc-2102	86	18	patients	patient	NOUN
dpc-2102	86	19	,	,	PUNCT
dpc-2102	86	20	44.41	44.41	NUM
dpc-2102	86	21	±	±	NUM
dpc-2102	86	22	45.76	45.76	NUM
dpc-2102	86	23	in	in	ADP
dpc-2102	86	24	eop	eop	PROPN
dpc-2102	86	25	and	and	CCONJ
dpc-2102	86	26	34.91	34.91	NUM
dpc-2102	86	27	±	±	NUM
dpc-2102	86	28	39.65	39.65	NUM
dpc-2102	86	29	months	month	NOUN
dpc-2102	86	30	in	in	ADP
dpc-2102	86	31	lop	lop	NOUN
dpc-2102	86	32	showing	show	VERB
dpc-2102	86	33	no	no	DET
dpc-2102	86	34	significant	significant	ADJ
dpc-2102	86	35	difference	difference	NOUN
dpc-2102	86	36	(	(	PUNCT
dpc-2102	86	37	p	p	X
dpc-2102	86	38	=	=	NOUN
dpc-2102	86	39	0.158	0.158	NUM
dpc-2102	86	40	)	)	PUNCT
dpc-2102	86	41	.	.	PUNCT
dpc-2102	87	1	4	4	NUM
dpc-2102	87	2	original	original	ADJ
dpc-2102	87	3	article	article	NOUN
dpc-2102	87	4	|	|	ADV
dpc-2102	87	5	dermatol	dermatol	ADJ
dpc-2102	87	6	pract	pract	NOUN
dpc-2102	87	7	concept	concept	NOUN
dpc-2102	87	8	.	.	PUNCT
dpc-2102	88	1	2022;12(3):e2022144	2022;12(3):e2022144	NUM
dpc-2102	88	2	table	table	NOUN
dpc-2102	88	3	1	1	NUM
dpc-2102	88	4	.	.	PUNCT
dpc-2102	89	1	demographics	demographic	NOUN
dpc-2102	89	2	and	and	CCONJ
dpc-2102	89	3	family	family	NOUN
dpc-2102	89	4	history	history	NOUN
dpc-2102	89	5	of	of	ADP
dpc-2102	89	6	psoriasis	psoriasis	NOUN
dpc-2102	89	7	in	in	ADP
dpc-2102	89	8	eop	eop	PROPN
dpc-2102	89	9	and	and	CCONJ
dpc-2102	89	10	lop	lop	PROPN
dpc-2102	89	11	variables	variable	NOUN
dpc-2102	89	12	total	total	ADJ
dpc-2102	89	13	patients	patient	NOUN
dpc-2102	89	14	(	(	PUNCT
dpc-2102	89	15	n	n	NOUN
dpc-2102	89	16	=	=	SYM
dpc-2102	89	17	160	160	NUM
dpc-2102	89	18	)	)	PUNCT
dpc-2102	89	19	eop	eop	PROPN
dpc-2102	89	20	(	(	PUNCT
dpc-2102	89	21	n	n	NOUN
dpc-2102	89	22	=	=	SYM
dpc-2102	89	23	121	121	NUM
dpc-2102	89	24	)	)	PUNCT
dpc-2102	89	25	lop	lop	NOUN
dpc-2102	89	26	(	(	PUNCT
dpc-2102	89	27	n	n	NOUN
dpc-2102	89	28	=	=	SYM
dpc-2102	89	29	39	39	NUM
dpc-2102	89	30	)	)	PUNCT
dpc-2102	89	31	p	p	NOUN
dpc-2102	89	32	gender	gender	NOUN
dpc-2102	89	33	0.144male	0.144male	NOUN
dpc-2102	89	34	,	,	PUNCT
dpc-2102	89	35	n	n	CCONJ
dpc-2102	89	36	(	(	PUNCT
dpc-2102	89	37	%	%	INTJ
dpc-2102	89	38	)	)	PUNCT
dpc-2102	89	39	90	90	NUM
dpc-2102	89	40	(	(	PUNCT
dpc-2102	89	41	56.3	56.3	NUM
dpc-2102	89	42	)	)	PUNCT
dpc-2102	89	43	72	72	NUM
dpc-2102	89	44	(	(	PUNCT
dpc-2102	89	45	59.5	59.5	NUM
dpc-2102	89	46	)	)	PUNCT
dpc-2102	89	47	18	18	NUM
dpc-2102	89	48	(	(	PUNCT
dpc-2102	89	49	46.2	46.2	NUM
dpc-2102	89	50	)	)	PUNCT
dpc-2102	89	51	female	female	NOUN
dpc-2102	89	52	,	,	PUNCT
dpc-2102	89	53	n	n	CCONJ
dpc-2102	89	54	(	(	PUNCT
dpc-2102	89	55	%	%	INTJ
dpc-2102	89	56	)	)	PUNCT
dpc-2102	89	57	70	70	NUM
dpc-2102	89	58	(	(	PUNCT
dpc-2102	89	59	43.8	43.8	NUM
dpc-2102	89	60	)	)	PUNCT
dpc-2102	89	61	40	40	NUM
dpc-2102	89	62	(	(	PUNCT
dpc-2102	89	63	40.5	40.5	NUM
dpc-2102	89	64	)	)	PUNCT
dpc-2102	89	65	21	21	NUM
dpc-2102	89	66	(	(	PUNCT
dpc-2102	89	67	53.8	53.8	NUM
dpc-2102	89	68	)	)	PUNCT
dpc-2102	89	69	age	age	NOUN
dpc-2102	89	70	,	,	PUNCT
dpc-2102	89	71	years	year	NOUN
dpc-2102	89	72	,	,	PUNCT
dpc-2102	89	73	44.73	44.73	NUM
dpc-2102	89	74	±	±	NUM
dpc-2102	89	75	13.66	13.66	NUM
dpc-2102	89	76	40.46	40.46	NUM
dpc-2102	89	77	±12.24	±12.24	ADP
dpc-2102	89	78	57.95±8.40	57.95±8.40	NUM
dpc-2102	89	79	<	<	NOUN
dpc-2102	89	80	0.01	0.01	NUM
dpc-2102	89	81	mean±sd	mean±sd	PROPN
dpc-2102	89	82	(	(	PUNCT
dpc-2102	89	83	range	range	NOUN
dpc-2102	89	84	)	)	PUNCT
dpc-2102	89	85	(	(	PUNCT
dpc-2102	89	86	18	18	NUM
dpc-2102	89	87	-	-	SYM
dpc-2102	89	88	75	75	NUM
dpc-2102	89	89	)	)	PUNCT
dpc-2102	89	90	(	(	PUNCT
dpc-2102	89	91	18	18	NUM
dpc-2102	89	92	-	-	SYM
dpc-2102	89	93	65	65	NUM
dpc-2102	89	94	)	)	PUNCT
dpc-2102	89	95	(	(	PUNCT
dpc-2102	89	96	41	41	NUM
dpc-2102	89	97	-	-	SYM
dpc-2102	89	98	75	75	NUM
dpc-2102	89	99	)	)	PUNCT
dpc-2102	89	100	age	age	NOUN
dpc-2102	89	101	at	at	ADP
dpc-2102	89	102	onset	onset	NOUN
dpc-2102	89	103	of	of	ADP
dpc-2102	89	104	psoriasis	psoriasis	NOUN
dpc-2102	89	105	,	,	PUNCT
dpc-2102	89	106	years	year	NOUN
dpc-2102	89	107	,	,	PUNCT
dpc-2102	89	108	27.24±15.06	27.24±15.06	NOUN
dpc-2102	89	109	20.07±8.45	20.07±8.45	PROPN
dpc-2102	89	110	49.49±7.20	49.49±7.20	X
dpc-2102	89	111	<	<	X
dpc-2102	89	112	0.01	0.01	NUM
dpc-2102	89	113	mean±sd	mean±sd	PROPN
dpc-2102	89	114	(	(	PUNCT
dpc-2102	89	115	range	range	NOUN
dpc-2102	89	116	)	)	PUNCT
dpc-2102	89	117	(	(	PUNCT
dpc-2102	89	118	4	4	NUM
dpc-2102	89	119	-	-	SYM
dpc-2102	89	120	67	67	NUM
dpc-2102	89	121	)	)	PUNCT
dpc-2102	89	122	(	(	PUNCT
dpc-2102	89	123	4	4	NUM
dpc-2102	89	124	-	-	SYM
dpc-2102	89	125	38	38	NUM
dpc-2102	89	126	)	)	PUNCT
dpc-2102	89	127	(	(	PUNCT
dpc-2102	89	128	41	41	NUM
dpc-2102	89	129	-	-	SYM
dpc-2102	89	130	67	67	NUM
dpc-2102	89	131	)	)	PUNCT
dpc-2102	89	132	family	family	NOUN
dpc-2102	89	133	history	history	NOUN
dpc-2102	89	134	of	of	ADP
dpc-2102	89	135	psoriasis	psoriasis	NOUN
dpc-2102	89	136	,	,	PUNCT
dpc-2102	89	137	n	n	CCONJ
dpc-2102	89	138	(	(	PUNCT
dpc-2102	89	139	%	%	INTJ
dpc-2102	89	140	)	)	PUNCT
dpc-2102	89	141	64	64	NUM
dpc-2102	89	142	(	(	PUNCT
dpc-2102	89	143	40	40	NUM
dpc-2102	89	144	)	)	SYM
dpc-2102	89	145	57	57	NUM
dpc-2102	89	146	(	(	PUNCT
dpc-2102	89	147	47.1	47.1	NUM
dpc-2102	89	148	)	)	PUNCT
dpc-2102	89	149	7	7	NUM
dpc-2102	89	150	(	(	PUNCT
dpc-2102	89	151	17.9	17.9	NUM
dpc-2102	89	152	)	)	PUNCT
dpc-2102	89	153	0.001	0.001	NUM
dpc-2102	89	154	eop	eop	PROPN
dpc-2102	89	155	=	=	PUNCT
dpc-2102	89	156	early	early	ADJ
dpc-2102	89	157	onset	onset	NOUN
dpc-2102	89	158	psoriasis	psoriasis	NOUN
dpc-2102	89	159	;	;	PUNCT
dpc-2102	89	160	lop	lop	NOUN
dpc-2102	89	161	=	=	PUNCT
dpc-2102	89	162	late	late	ADJ
dpc-2102	89	163	onset	onset	NOUN
dpc-2102	89	164	psoriasis	psoriasis	NOUN
dpc-2102	89	165	;	;	PUNCT
dpc-2102	89	166	sd	sd	NOUN
dpc-2102	89	167	=	=	SYM
dpc-2102	89	168	standard	standard	ADJ
dpc-2102	89	169	deviation	deviation	NOUN
dpc-2102	89	170	.	.	PUNCT
dpc-2102	90	1	table	table	NOUN
dpc-2102	90	2	2	2	NUM
dpc-2102	90	3	.	.	PUNCT
dpc-2102	90	4	comparison	comparison	NOUN
dpc-2102	90	5	of	of	ADP
dpc-2102	90	6	disease	disease	NOUN
dpc-2102	90	7	severity	severity	NOUN
dpc-2102	90	8	in	in	ADP
dpc-2102	90	9	eop	eop	PROPN
dpc-2102	90	10	and	and	CCONJ
dpc-2102	90	11	lop	lop	PROPN
dpc-2102	90	12	variables	variable	NOUN
dpc-2102	90	13	total	total	ADJ
dpc-2102	90	14	patients	patient	NOUN
dpc-2102	90	15	(	(	PUNCT
dpc-2102	90	16	n	n	NOUN
dpc-2102	90	17	=	=	SYM
dpc-2102	90	18	160	160	NUM
dpc-2102	90	19	)	)	PUNCT
dpc-2102	90	20	eop	eop	PROPN
dpc-2102	90	21	(	(	PUNCT
dpc-2102	90	22	n	n	NOUN
dpc-2102	90	23	=	=	SYM
dpc-2102	90	24	121	121	NUM
dpc-2102	90	25	)	)	PUNCT
dpc-2102	90	26	lop	lop	NOUN
dpc-2102	90	27	(	(	PUNCT
dpc-2102	90	28	n	n	NOUN
dpc-2102	90	29	=	=	SYM
dpc-2102	90	30	39	39	NUM
dpc-2102	90	31	)	)	PUNCT
dpc-2102	90	32	p	p	PROPN
dpc-2102	90	33	bsa	bsa	NOUN
dpc-2102	90	34	,	,	PUNCT
dpc-2102	90	35	%	%	NOUN
dpc-2102	90	36	3.50	3.50	NUM
dpc-2102	90	37	±	±	NUM
dpc-2102	90	38	8.65	8.65	NUM
dpc-2102	90	39	3.34	3.34	NUM
dpc-2102	90	40	±	±	NUM
dpc-2102	90	41	8.58	8.58	NUM
dpc-2102	90	42	3.99	3.99	NUM
dpc-2102	90	43	±	±	NUM
dpc-2102	90	44	8.96	8.96	NUM
dpc-2102	90	45	mean±sd	mean±sd	PROPN
dpc-2102	90	46	(	(	PUNCT
dpc-2102	90	47	range	range	NOUN
dpc-2102	90	48	)	)	PUNCT
dpc-2102	90	49	(	(	PUNCT
dpc-2102	90	50	0	0	NUM
dpc-2102	90	51	-	-	SYM
dpc-2102	90	52	74.5	74.5	NUM
dpc-2102	90	53	)	)	PUNCT
dpc-2102	90	54	(	(	PUNCT
dpc-2102	90	55	0.1	0.1	NUM
dpc-2102	90	56	-	-	SYM
dpc-2102	90	57	74.7	74.7	NUM
dpc-2102	90	58	)	)	PUNCT
dpc-2102	90	59	(	(	PUNCT
dpc-2102	90	60	0	0	NUM
dpc-2102	90	61	-	-	SYM
dpc-2102	90	62	37.8	37.8	NUM
dpc-2102	90	63	)	)	PUNCT
dpc-2102	90	64	0.636	0.636	NUM
dpc-2102	90	65	pasi	pasi	NOUN
dpc-2102	90	66	3.46	3.46	NUM
dpc-2102	90	67	±	±	NUM
dpc-2102	90	68	6.42	6.42	NUM
dpc-2102	90	69	3.16	3.16	NUM
dpc-2102	90	70	±	±	NUM
dpc-2102	90	71	6.07	6.07	NUM
dpc-2102	90	72	4.37	4.37	NUM
dpc-2102	90	73	±	±	NUM
dpc-2102	90	74	7.43	7.43	NUM
dpc-2102	90	75	mean±sd	mean±sd	PROPN
dpc-2102	90	76	(	(	PUNCT
dpc-2102	90	77	range	range	NOUN
dpc-2102	90	78	)	)	PUNCT
dpc-2102	90	79	(	(	PUNCT
dpc-2102	90	80	0	0	NUM
dpc-2102	90	81	-	-	SYM
dpc-2102	90	82	53.10	53.10	NUM
dpc-2102	90	83	)	)	PUNCT
dpc-2102	90	84	(	(	PUNCT
dpc-2102	90	85	0.2	0.2	NUM
dpc-2102	90	86	-	-	PUNCT
dpc-2102	90	87	53.10	53.10	NUM
dpc-2102	90	88	)	)	PUNCT
dpc-2102	90	89	(	(	PUNCT
dpc-2102	90	90	0	0	NUM
dpc-2102	90	91	-	-	SYM
dpc-2102	90	92	36	36	NUM
dpc-2102	90	93	)	)	PUNCT
dpc-2102	90	94	0.460	0.460	NUM
dpc-2102	90	95	active	active	ADJ
dpc-2102	90	96	disease	disease	NOUN
dpc-2102	90	97	without	without	ADP
dpc-2102	90	98	rx	rx	NOUN
dpc-2102	90	99	,	,	PUNCT
dpc-2102	90	100	months	month	NOUN
dpc-2102	90	101	24.46	24.46	NUM
dpc-2102	90	102	±	±	NUM
dpc-2102	90	103	49.59	49.59	NUM
dpc-2102	90	104	28.62	28.62	NUM
dpc-2102	90	105	±	±	NUM
dpc-2102	90	106	55.26	55.26	NUM
dpc-2102	90	107	11.54	11.54	NUM
dpc-2102	90	108	±	±	NUM
dpc-2102	90	109	20.57	20.57	NUM
dpc-2102	90	110	mean±sd	mean±sd	PROPN
dpc-2102	90	111	(	(	PUNCT
dpc-2102	90	112	range	range	NOUN
dpc-2102	90	113	)	)	PUNCT
dpc-2102	90	114	(	(	PUNCT
dpc-2102	90	115	0	0	NUM
dpc-2102	90	116	-	-	SYM
dpc-2102	90	117	360	360	NUM
dpc-2102	90	118	)	)	PUNCT
dpc-2102	90	119	(	(	PUNCT
dpc-2102	90	120	0	0	NUM
dpc-2102	90	121	-	-	SYM
dpc-2102	90	122	360	360	NUM
dpc-2102	90	123	)	)	PUNCT
dpc-2102	90	124	(	(	PUNCT
dpc-2102	90	125	0	0	NUM
dpc-2102	90	126	-	-	SYM
dpc-2102	90	127	96	96	NUM
dpc-2102	90	128	)	)	PUNCT
dpc-2102	90	129	0.083	0.083	NUM
dpc-2102	90	130	active	active	ADJ
dpc-2102	90	131	disease	disease	NOUN
dpc-2102	90	132	with	with	ADP
dpc-2102	90	133	rx	rx	NOUN
dpc-2102	90	134	,	,	PUNCT
dpc-2102	90	135	months	month	NOUN
dpc-2102	90	136	28.29	28.29	NUM
dpc-2102	90	137	±	±	NUM
dpc-2102	90	138	68.68	68.68	NUM
dpc-2102	90	139	33.78	33.78	NUM
dpc-2102	90	140	±	±	NUM
dpc-2102	90	141	77.57	77.57	NUM
dpc-2102	90	142	11.26	11.26	NUM
dpc-2102	90	143	±	±	NUM
dpc-2102	90	144	18.32	18.32	NUM
dpc-2102	90	145	mean±sd	mean±sd	PROPN
dpc-2102	90	146	(	(	PUNCT
dpc-2102	90	147	range	range	NOUN
dpc-2102	90	148	)	)	PUNCT
dpc-2102	90	149	(	(	PUNCT
dpc-2102	90	150	0	0	NUM
dpc-2102	90	151	-	-	SYM
dpc-2102	90	152	492	492	NUM
dpc-2102	90	153	)	)	PUNCT
dpc-2102	90	154	(	(	PUNCT
dpc-2102	90	155	0	0	NUM
dpc-2102	90	156	-	-	SYM
dpc-2102	90	157	492	492	NUM
dpc-2102	90	158	)	)	PUNCT
dpc-2102	90	159	(	(	PUNCT
dpc-2102	90	160	0	0	NUM
dpc-2102	90	161	-	-	SYM
dpc-2102	90	162	72	72	NUM
dpc-2102	90	163	)	)	PUNCT
dpc-2102	90	164	0.334	0.334	NUM
dpc-2102	90	165	history	history	NOUN
dpc-2102	90	166	of	of	ADP
dpc-2102	90	167	hospitalization	hospitalization	NOUN
dpc-2102	90	168	number	number	NOUN
dpc-2102	90	169	of	of	ADP
dpc-2102	90	170	positive	positive	ADJ
dpc-2102	90	171	history	history	NOUN
dpc-2102	90	172	,	,	PUNCT
dpc-2102	90	173	n	n	CCONJ
dpc-2102	90	174	(	(	PUNCT
dpc-2102	90	175	%	%	INTJ
dpc-2102	90	176	)	)	PUNCT
dpc-2102	90	177	28	28	NUM
dpc-2102	90	178	(	(	PUNCT
dpc-2102	90	179	17.5	17.5	NUM
dpc-2102	90	180	)	)	PUNCT
dpc-2102	90	181	24	24	NUM
dpc-2102	90	182	(	(	PUNCT
dpc-2102	90	183	19.8	19.8	NUM
dpc-2102	90	184	)	)	PUNCT
dpc-2102	90	185	4	4	NUM
dpc-2102	90	186	(	(	PUNCT
dpc-2102	90	187	10.3	10.3	NUM
dpc-2102	90	188	)	)	PUNCT
dpc-2102	90	189	0.171	0.171	NUM
dpc-2102	90	190	number	number	NOUN
dpc-2102	90	191	of	of	ADP
dpc-2102	90	192	hospitalizations	hospitalization	NOUN
dpc-2102	90	193	0.38	0.38	NUM
dpc-2102	90	194	±	±	NUM
dpc-2102	90	195	1.25	1.25	NUM
dpc-2102	90	196	0.35	0.35	NUM
dpc-2102	90	197	±	±	NUM
dpc-2102	90	198	0.90	0.90	NUM
dpc-2102	90	199	0.49	0.49	NUM
dpc-2102	90	200	±	±	NUM
dpc-2102	90	201	1.99	1.99	NUM
dpc-2102	90	202	mean±sd	mean±sd	PROPN
dpc-2102	90	203	(	(	PUNCT
dpc-2102	90	204	range	range	NOUN
dpc-2102	90	205	)	)	PUNCT
dpc-2102	90	206	(	(	PUNCT
dpc-2102	90	207	0	0	NUM
dpc-2102	90	208	-	-	SYM
dpc-2102	90	209	12	12	NUM
dpc-2102	90	210	)	)	PUNCT
dpc-2102	90	211	(	(	PUNCT
dpc-2102	90	212	0	0	NUM
dpc-2102	90	213	-	-	SYM
dpc-2102	90	214	5	5	NUM
dpc-2102	90	215	)	)	PUNCT
dpc-2102	90	216	(	(	PUNCT
dpc-2102	90	217	0	0	NUM
dpc-2102	90	218	-	-	SYM
dpc-2102	90	219	12	12	NUM
dpc-2102	90	220	)	)	PUNCT
dpc-2102	90	221	0.380	0.380	NUM
dpc-2102	90	222	history	history	NOUN
dpc-2102	90	223	of	of	ADP
dpc-2102	90	224	erythroderma	erythroderma	NOUN
dpc-2102	90	225	number	number	NOUN
dpc-2102	90	226	of	of	ADP
dpc-2102	90	227	positive	positive	ADJ
dpc-2102	90	228	history	history	NOUN
dpc-2102	90	229	,	,	PUNCT
dpc-2102	90	230	n	n	CCONJ
dpc-2102	90	231	(	(	PUNCT
dpc-2102	90	232	%	%	INTJ
dpc-2102	90	233	)	)	PUNCT
dpc-2102	90	234	12	12	NUM
dpc-2102	90	235	(	(	PUNCT
dpc-2102	90	236	7.5	7.5	NUM
dpc-2102	90	237	)	)	PUNCT
dpc-2102	90	238	11	11	NUM
dpc-2102	90	239	(	(	PUNCT
dpc-2102	90	240	9.1	9.1	NUM
dpc-2102	90	241	)	)	SYM
dpc-2102	90	242	1	1	NUM
dpc-2102	90	243	(	(	PUNCT
dpc-2102	90	244	2.6	2.6	NUM
dpc-2102	90	245	)	)	PUNCT
dpc-2102	90	246	0.296	0.296	NUM
dpc-2102	90	247	number	number	NOUN
dpc-2102	90	248	of	of	ADP
dpc-2102	90	249	erythroderma	erythroderma	NOUN
dpc-2102	90	250	0.13	0.13	NUM
dpc-2102	90	251	±	±	NUM
dpc-2102	90	252	0.55	0.55	NUM
dpc-2102	90	253	0.16	0.16	NUM
dpc-2102	90	254	±	±	NUM
dpc-2102	90	255	0.61	0.61	NUM
dpc-2102	90	256	0.05	0.05	NUM
dpc-2102	90	257	±	±	NUM
dpc-2102	90	258	0.32	0.32	NUM
dpc-2102	90	259	mean±sd	mean±sd	PROPN
dpc-2102	90	260	(	(	PUNCT
dpc-2102	90	261	range	range	NOUN
dpc-2102	90	262	)	)	PUNCT
dpc-2102	90	263	(	(	PUNCT
dpc-2102	90	264	0	0	NUM
dpc-2102	90	265	-	-	SYM
dpc-2102	90	266	5	5	NUM
dpc-2102	90	267	)	)	PUNCT
dpc-2102	90	268	(	(	PUNCT
dpc-2102	90	269	0	0	NUM
dpc-2102	90	270	-	-	SYM
dpc-2102	90	271	5	5	NUM
dpc-2102	90	272	)	)	PUNCT
dpc-2102	90	273	(	(	PUNCT
dpc-2102	90	274	0	0	NUM
dpc-2102	90	275	-	-	SYM
dpc-2102	90	276	2	2	NUM
dpc-2102	90	277	)	)	PUNCT
dpc-2102	90	278	0.187	0.187	NUM
dpc-2102	90	279	bsa	bsa	PROPN
dpc-2102	90	280	=	=	SYM
dpc-2102	90	281	body	body	PROPN
dpc-2102	90	282	surface	surface	NOUN
dpc-2102	90	283	area	area	NOUN
dpc-2102	90	284	;	;	PUNCT
dpc-2102	91	1	eop	eop	PROPN
dpc-2102	91	2	=	=	PROPN
dpc-2102	91	3	early	early	ADJ
dpc-2102	91	4	onset	onset	VERB
dpc-2102	91	5	psoriasis	psoriasis	NOUN
dpc-2102	91	6	;	;	PUNCT
dpc-2102	91	7	lop	lop	NOUN
dpc-2102	91	8	=	=	PUNCT
dpc-2102	91	9	late	late	ADJ
dpc-2102	91	10	onset	onset	NOUN
dpc-2102	91	11	psoriasis	psoriasis	NOUN
dpc-2102	91	12	;	;	PUNCT
dpc-2102	91	13	pasi	pasi	NOUN
dpc-2102	91	14	=	=	SYM
dpc-2102	91	15	psoriasis	psoriasis	NOUN
dpc-2102	91	16	area	area	NOUN
dpc-2102	91	17	and	and	CCONJ
dpc-2102	91	18	severity	severity	NOUN
dpc-2102	91	19	index	index	NOUN
dpc-2102	91	20	;	;	PUNCT
dpc-2102	91	21	rx	rx	VERB
dpc-2102	91	22	=	=	VERB
dpc-2102	91	23	systemic	systemic	ADJ
dpc-2102	91	24	treatment	treatment	NOUN
dpc-2102	91	25	;	;	PUNCT
dpc-2102	91	26	sd	sd	NOUN
dpc-2102	91	27	=	=	SYM
dpc-2102	91	28	standard	standard	ADJ
dpc-2102	91	29	deviation	deviation	NOUN
dpc-2102	91	30	.	.	PUNCT
dpc-2102	92	1	table	table	NOUN
dpc-2102	92	2	3	3	NUM
dpc-2102	92	3	.	.	PUNCT
dpc-2102	93	1	physical	physical	ADJ
dpc-2102	93	2	examination	examination	NOUN
dpc-2102	93	3	findings	finding	NOUN
dpc-2102	93	4	in	in	ADP
dpc-2102	93	5	eop	eop	PROPN
dpc-2102	93	6	and	and	CCONJ
dpc-2102	93	7	lop	lop	PROPN
dpc-2102	93	8	variables	variable	NOUN
dpc-2102	93	9	total	total	ADJ
dpc-2102	93	10	patients	patient	NOUN
dpc-2102	93	11	(	(	PUNCT
dpc-2102	93	12	n	n	NOUN
dpc-2102	93	13	=	=	SYM
dpc-2102	93	14	160	160	NUM
dpc-2102	93	15	)	)	PUNCT
dpc-2102	93	16	eop	eop	PROPN
dpc-2102	93	17	(	(	PUNCT
dpc-2102	93	18	n	n	NOUN
dpc-2102	93	19	=	=	SYM
dpc-2102	93	20	121	121	NUM
dpc-2102	93	21	)	)	PUNCT
dpc-2102	93	22	lop	lop	NOUN
dpc-2102	93	23	(	(	PUNCT
dpc-2102	93	24	n	n	NOUN
dpc-2102	93	25	=	=	SYM
dpc-2102	93	26	39	39	NUM
dpc-2102	93	27	)	)	PUNCT
dpc-2102	93	28	p	p	X
dpc-2102	93	29	systolic	systolic	ADJ
dpc-2102	93	30	bp	bp	PROPN
dpc-2102	93	31	,	,	PUNCT
dpc-2102	93	32	mm	mm	PROPN
dpc-2102	93	33	/	/	SYM
dpc-2102	93	34	hg	hg	NOUN
dpc-2102	93	35	118.17	118.17	NUM
dpc-2102	93	36	±	±	NUM
dpc-2102	93	37	13.39	13.39	NUM
dpc-2102	93	38	116.24	116.24	NUM
dpc-2102	93	39	±	±	NUM
dpc-2102	93	40	12.46	12.46	NUM
dpc-2102	93	41	124.18	124.18	NUM
dpc-2102	93	42	±	±	NUM
dpc-2102	93	43	14.55	14.55	NUM
dpc-2102	93	44	mean±sd	mean±sd	PROPN
dpc-2102	93	45	(	(	PUNCT
dpc-2102	93	46	range	range	NOUN
dpc-2102	93	47	)	)	PUNCT
dpc-2102	93	48	(	(	PUNCT
dpc-2102	93	49	90	90	NUM
dpc-2102	93	50	-	-	SYM
dpc-2102	93	51	160	160	NUM
dpc-2102	93	52	)	)	PUNCT
dpc-2102	93	53	(	(	PUNCT
dpc-2102	93	54	90	90	NUM
dpc-2102	93	55	-	-	SYM
dpc-2102	93	56	150	150	NUM
dpc-2102	93	57	)	)	PUNCT
dpc-2102	93	58	(	(	PUNCT
dpc-2102	93	59	100	100	NUM
dpc-2102	93	60	-	-	SYM
dpc-2102	93	61	160	160	NUM
dpc-2102	93	62	)	)	PUNCT
dpc-2102	93	63	0.005	0.005	NUM
dpc-2102	93	64	diastolic	diastolic	NOUN
dpc-2102	93	65	bp	bp	PROPN
dpc-2102	93	66	,	,	PUNCT
dpc-2102	93	67	mm	mm	PROPN
dpc-2102	93	68	/	/	SYM
dpc-2102	93	69	hg	hg	PROPN
dpc-2102	93	70	79.31	79.31	NUM
dpc-2102	93	71	±	±	NUM
dpc-2102	93	72	10.94	10.94	NUM
dpc-2102	93	73	78.14	78.14	NUM
dpc-2102	93	74	±	±	NUM
dpc-2102	93	75	10.02	10.02	NUM
dpc-2102	93	76	82.95	82.95	NUM
dpc-2102	93	77	±	±	NUM
dpc-2102	93	78	12.86	12.86	NUM
dpc-2102	93	79	mean±sd	mean±sd	PROPN
dpc-2102	93	80	(	(	PUNCT
dpc-2102	93	81	range	range	NOUN
dpc-2102	93	82	)	)	PUNCT
dpc-2102	93	83	(	(	PUNCT
dpc-2102	93	84	50	50	NUM
dpc-2102	93	85	-	-	SYM
dpc-2102	93	86	120	120	NUM
dpc-2102	93	87	)	)	PUNCT
dpc-2102	93	88	(	(	PUNCT
dpc-2102	93	89	50	50	NUM
dpc-2102	93	90	-	-	SYM
dpc-2102	93	91	100	100	NUM
dpc-2102	93	92	)	)	PUNCT
dpc-2102	93	93	(	(	PUNCT
dpc-2102	93	94	60	60	NUM
dpc-2102	93	95	-	-	SYM
dpc-2102	93	96	120	120	NUM
dpc-2102	93	97	)	)	PUNCT
dpc-2102	93	98	0.047	0.047	NUM
dpc-2102	93	99	bmi	bmi	NOUN
dpc-2102	93	100	,	,	PUNCT
dpc-2102	93	101	kg	kg	PROPN
dpc-2102	93	102	/	/	SYM
dpc-2102	93	103	m2	m2	PROPN
dpc-2102	93	104	28.02	28.02	NUM
dpc-2102	93	105	±	±	NUM
dpc-2102	93	106	4.93	4.93	NUM
dpc-2102	93	107	27.62	27.62	NUM
dpc-2102	93	108	±	±	NUM
dpc-2102	93	109	5.16	5.16	NUM
dpc-2102	93	110	29.27	29.27	NUM
dpc-2102	93	111	±	±	NUM
dpc-2102	93	112	3.94	3.94	NUM
dpc-2102	93	113	mean±sd	mean±sd	PROPN
dpc-2102	93	114	(	(	PUNCT
dpc-2102	93	115	range	range	NOUN
dpc-2102	93	116	)	)	PUNCT
dpc-2102	93	117	(	(	PUNCT
dpc-2102	93	118	16.67	16.67	NUM
dpc-2102	93	119	-	-	SYM
dpc-2102	93	120	46.90	46.90	NUM
dpc-2102	93	121	)	)	PUNCT
dpc-2102	93	122	(	(	PUNCT
dpc-2102	93	123	16.67	16.67	NUM
dpc-2102	93	124	-	-	SYM
dpc-2102	93	125	46.90	46.90	NUM
dpc-2102	93	126	)	)	PUNCT
dpc-2102	93	127	(	(	PUNCT
dpc-2102	93	128	21.39	21.39	NUM
dpc-2102	93	129	-	-	SYM
dpc-2102	93	130	39.40	39.40	NUM
dpc-2102	93	131	)	)	PUNCT
dpc-2102	93	132	0.020	0.020	NUM
dpc-2102	93	133	waist	waist	NOUN
dpc-2102	93	134	circumference	circumference	NOUN
dpc-2102	93	135	/	/	SYM
dpc-2102	93	136	men	man	NOUN
dpc-2102	93	137	,	,	PUNCT
dpc-2102	93	138	cm	cm	NOUN
dpc-2102	94	1	102.07	102.07	NUM
dpc-2102	94	2	±13.55	±13.55	NOUN
dpc-2102	94	3	101.13	101.13	NUM
dpc-2102	94	4	±13.97	±13.97	PROPN
dpc-2102	94	5	105.83	105.83	NUM
dpc-2102	94	6	±11.31	±11.31	PROPN
dpc-2102	94	7	mean±sd	mean±sd	ADP
dpc-2102	94	8	(	(	PUNCT
dpc-2102	94	9	range	range	NOUN
dpc-2102	94	10	)	)	PUNCT
dpc-2102	94	11	(	(	PUNCT
dpc-2102	94	12	76	76	NUM
dpc-2102	94	13	-	-	SYM
dpc-2102	94	14	143	143	NUM
dpc-2102	94	15	)	)	PUNCT
dpc-2102	94	16	(	(	PUNCT
dpc-2102	94	17	76	76	NUM
dpc-2102	94	18	-	-	SYM
dpc-2102	94	19	143	143	NUM
dpc-2102	94	20	)	)	PUNCT
dpc-2102	94	21	(	(	PUNCT
dpc-2102	94	22	79	79	NUM
dpc-2102	94	23	-	-	SYM
dpc-2102	94	24	129	129	NUM
dpc-2102	94	25	)	)	PUNCT
dpc-2102	94	26	0.190	0.190	NUM
dpc-2102	94	27	waist	waist	NOUN
dpc-2102	94	28	circumference	circumference	NOUN
dpc-2102	94	29	/	/	SYM
dpc-2102	94	30	women	woman	NOUN
dpc-2102	94	31	,	,	PUNCT
dpc-2102	94	32	cm	cm	NOUN
dpc-2102	94	33	99.80	99.80	NUM
dpc-2102	94	34	±	±	NUM
dpc-2102	94	35	13.29	13.29	NUM
dpc-2102	94	36	98.67	98.67	NUM
dpc-2102	94	37	±14.62	±14.62	PROPN
dpc-2102	94	38	102.42	102.42	NUM
dpc-2102	94	39	±	±	NUM
dpc-2102	94	40	9.29	9.29	NUM
dpc-2102	94	41	mean±sd	mean±sd	PROPN
dpc-2102	94	42	(	(	PUNCT
dpc-2102	94	43	range	range	NOUN
dpc-2102	94	44	)	)	PUNCT
dpc-2102	94	45	(	(	PUNCT
dpc-2102	94	46	76	76	NUM
dpc-2102	94	47	-	-	SYM
dpc-2102	94	48	149	149	NUM
dpc-2102	94	49	)	)	PUNCT
dpc-2102	94	50	(	(	PUNCT
dpc-2102	94	51	76	76	NUM
dpc-2102	94	52	-	-	SYM
dpc-2102	94	53	149	149	NUM
dpc-2102	94	54	)	)	PUNCT
dpc-2102	94	55	(	(	PUNCT
dpc-2102	94	56	84	84	NUM
dpc-2102	94	57	-	-	SYM
dpc-2102	94	58	127	127	NUM
dpc-2102	94	59	)	)	PUNCT
dpc-2102	94	60	0.282	0.282	NUM
dpc-2102	94	61	bmi	bmi	NOUN
dpc-2102	94	62	=	=	SYM
dpc-2102	94	63	body	body	NOUN
dpc-2102	94	64	mass	mass	PROPN
dpc-2102	94	65	index	index	NOUN
dpc-2102	94	66	;	;	PUNCT
dpc-2102	94	67	bp	bp	PROPN
dpc-2102	94	68	=	=	SYM
dpc-2102	94	69	blood	blood	NOUN
dpc-2102	94	70	pressure	pressure	NOUN
dpc-2102	94	71	;	;	PUNCT
dpc-2102	95	1	eop	eop	PROPN
dpc-2102	95	2	=	=	PROPN
dpc-2102	95	3	early	early	ADJ
dpc-2102	95	4	onset	onset	VERB
dpc-2102	95	5	psoriasis	psoriasis	NOUN
dpc-2102	95	6	;	;	PUNCT
dpc-2102	95	7	lop	lop	NOUN
dpc-2102	95	8	=	=	PUNCT
dpc-2102	95	9	late	late	ADJ
dpc-2102	95	10	onset	onset	NOUN
dpc-2102	95	11	psoriasis	psoriasis	NOUN
dpc-2102	95	12	;	;	PUNCT
dpc-2102	95	13	sd	sd	NOUN
dpc-2102	95	14	=	=	SYM
dpc-2102	95	15	standard	standard	ADJ
dpc-2102	95	16	deviation	deviation	NOUN
dpc-2102	95	17	.	.	PUNCT
dpc-2102	96	1	original	original	ADJ
dpc-2102	96	2	article	article	NOUN
dpc-2102	96	3	|	|	ADV
dpc-2102	96	4	dermatol	dermatol	ADJ
dpc-2102	96	5	pract	pract	NOUN
dpc-2102	96	6	concept	concept	NOUN
dpc-2102	96	7	.	.	PUNCT
dpc-2102	97	1	2022;12(3):e2022144	2022;12(3):e2022144	NUM
dpc-2102	97	2	5	5	NUM
dpc-2102	97	3	nail	nail	NOUN
dpc-2102	97	4	involvement	involvement	NOUN
dpc-2102	97	5	in	in	ADP
dpc-2102	97	6	eop	eop	PROPN
dpc-2102	97	7	and	and	CCONJ
dpc-2102	97	8	lop	lop	NOUN
dpc-2102	97	9	psoriatic	psoriatic	ADJ
dpc-2102	97	10	nail	nail	NOUN
dpc-2102	97	11	involvement	involvement	NOUN
dpc-2102	97	12	was	be	AUX
dpc-2102	97	13	compared	compare	VERB
dpc-2102	97	14	in	in	ADP
dpc-2102	97	15	eop	eop	PROPN
dpc-2102	97	16	and	and	CCONJ
dpc-2102	97	17	lop	lop	PROPN
dpc-2102	97	18	,	,	PUNCT
dpc-2102	97	19	and	and	CCONJ
dpc-2102	97	20	results	result	NOUN
dpc-2102	97	21	are	be	AUX
dpc-2102	97	22	shown	show	VERB
dpc-2102	97	23	in	in	ADP
dpc-2102	97	24	table	table	NOUN
dpc-2102	97	25	5	5	NUM
dpc-2102	97	26	.	.	PUNCT
dpc-2102	98	1	the	the	DET
dpc-2102	98	2	duration	duration	NOUN
dpc-2102	98	3	of	of	ADP
dpc-2102	98	4	disease	disease	NOUN
dpc-2102	98	5	between	between	ADP
dpc-2102	98	6	onset	onset	NOUN
dpc-2102	98	7	of	of	ADP
dpc-2102	98	8	psoriasis	psoriasis	NOUN
dpc-2102	98	9	and	and	CCONJ
dpc-2102	98	10	nail	nail	NOUN
dpc-2102	98	11	involvement	involvement	NOUN
dpc-2102	98	12	was	be	AUX
dpc-2102	98	13	statistically	statistically	ADV
dpc-2102	98	14	significantly	significantly	ADV
dpc-2102	98	15	shorter	short	ADJ
dpc-2102	98	16	in	in	ADP
dpc-2102	98	17	lop	lop	NOUN
dpc-2102	98	18	than	than	ADP
dpc-2102	98	19	eop	eop	PROPN
dpc-2102	98	20	(	(	PUNCT
dpc-2102	98	21	p	p	X
dpc-2102	98	22	<	<	X
dpc-2102	98	23	0.01	0.01	NUM
dpc-2102	98	24	)	)	PUNCT
dpc-2102	98	25	.	.	PUNCT
dpc-2102	99	1	duration	duration	NOUN
dpc-2102	99	2	of	of	ADP
dpc-2102	99	3	active	active	ADJ
dpc-2102	99	4	psoriatic	psoriatic	ADJ
dpc-2102	99	5	disease	disease	NOUN
dpc-2102	99	6	in	in	ADP
dpc-2102	99	7	patients	patient	NOUN
dpc-2102	99	8	with	with	ADP
dpc-2102	99	9	nail	nail	NOUN
dpc-2102	99	10	involvement	involvement	NOUN
dpc-2102	99	11	was	be	AUX
dpc-2102	99	12	also	also	ADV
dpc-2102	99	13	significantly	significantly	ADV
dpc-2102	99	14	shorter	short	ADJ
dpc-2102	99	15	in	in	ADP
dpc-2102	99	16	lop	lop	NOUN
dpc-2102	99	17	than	than	ADP
dpc-2102	99	18	in	in	ADP
dpc-2102	99	19	eop	eop	PROPN
dpc-2102	99	20	(	(	PUNCT
dpc-2102	99	21	p	p	X
dpc-2102	99	22	<	<	X
dpc-2102	99	23	0.01	0.01	NUM
dpc-2102	99	24	,	,	PUNCT
dpc-2102	99	25	p	p	X
dpc-2102	99	26	<	<	X
dpc-2102	99	27	0.01	0.01	NUM
dpc-2102	99	28	)	)	PUNCT
dpc-2102	99	29	.	.	PUNCT
dpc-2102	100	1	the	the	DET
dpc-2102	100	2	most	most	ADV
dpc-2102	100	3	frequent	frequent	ADJ
dpc-2102	100	4	psoriatic	psoriatic	ADJ
dpc-2102	100	5	nail	nail	NOUN
dpc-2102	100	6	involvement	involvement	NOUN
dpc-2102	100	7	was	be	AUX
dpc-2102	100	8	seen	see	VERB
dpc-2102	100	9	as	as	ADP
dpc-2102	100	10	pitting	pitting	NOUN
dpc-2102	100	11	,	,	PUNCT
dpc-2102	100	12	observed	observe	VERB
dpc-2102	100	13	in	in	ADP
dpc-2102	100	14	14	14	NUM
dpc-2102	100	15	%	%	NOUN
dpc-2102	100	16	(	(	PUNCT
dpc-2102	100	17	n	n	NOUN
dpc-2102	100	18	=	=	SYM
dpc-2102	100	19	17	17	NUM
dpc-2102	100	20	)	)	PUNCT
dpc-2102	100	21	of	of	ADP
dpc-2102	100	22	eop	eop	PROPN
dpc-2102	100	23	and	and	CCONJ
dpc-2102	100	24	12.8	12.8	NUM
dpc-2102	100	25	%	%	NOUN
dpc-2102	100	26	(	(	PUNCT
dpc-2102	100	27	n	n	NOUN
dpc-2102	100	28	=	=	SYM
dpc-2102	100	29	5	5	NUM
dpc-2102	100	30	)	)	PUNCT
dpc-2102	100	31	in	in	ADP
dpc-2102	100	32	lop	lop	PROPN
dpc-2102	100	33	.	.	PUNCT
dpc-2102	101	1	subungual	subungual	ADJ
dpc-2102	101	2	hyperkeratosis	hyperkeratosis	PROPN
dpc-2102	101	3	was	be	AUX
dpc-2102	101	4	only	only	ADV
dpc-2102	101	5	observed	observe	VERB
dpc-2102	101	6	in	in	ADP
dpc-2102	101	7	5	5	NUM
dpc-2102	101	8	%	%	NOUN
dpc-2102	101	9	(	(	PUNCT
dpc-2102	101	10	n	n	NOUN
dpc-2102	101	11	=	=	SYM
dpc-2102	101	12	6	6	NUM
dpc-2102	101	13	)	)	PUNCT
dpc-2102	101	14	of	of	ADP
dpc-2102	101	15	eop	eop	PROPN
dpc-2102	101	16	,	,	PUNCT
dpc-2102	101	17	distal	distal	ADJ
dpc-2102	101	18	onycholysis	onycholysis	NOUN
dpc-2102	101	19	was	be	AUX
dpc-2102	101	20	observed	observe	VERB
dpc-2102	101	21	in	in	ADP
dpc-2102	101	22	5	5	NUM
dpc-2102	101	23	%	%	NOUN
dpc-2102	101	24	(	(	PUNCT
dpc-2102	101	25	n	n	NOUN
dpc-2102	101	26	=	=	SYM
dpc-2102	101	27	6	6	NUM
dpc-2102	101	28	)	)	PUNCT
dpc-2102	101	29	and	and	CCONJ
dpc-2102	101	30	10.3	10.3	NUM
dpc-2102	101	31	%	%	NOUN
dpc-2102	101	32	(	(	PUNCT
dpc-2102	101	33	n	n	NOUN
dpc-2102	101	34	=	=	SYM
dpc-2102	101	35	4	4	NUM
dpc-2102	101	36	)	)	PUNCT
dpc-2102	101	37	,	,	PUNCT
dpc-2102	101	38	oil	oil	NOUN
dpc-2102	101	39	-	-	PUNCT
dpc-2102	101	40	drop	drop	NOUN
dpc-2102	101	41	sign	sign	NOUN
dpc-2102	101	42	was	be	AUX
dpc-2102	101	43	observed	observe	VERB
dpc-2102	101	44	in	in	ADP
dpc-2102	101	45	5	5	NUM
dpc-2102	101	46	%	%	NOUN
dpc-2102	101	47	(	(	PUNCT
dpc-2102	101	48	n	n	NOUN
dpc-2102	101	49	=	=	SYM
dpc-2102	101	50	6	6	NUM
dpc-2102	101	51	)	)	PUNCT
dpc-2102	101	52	and	and	CCONJ
dpc-2102	101	53	2.3	2.3	NUM
dpc-2102	101	54	%	%	NOUN
dpc-2102	101	55	(	(	PUNCT
dpc-2102	101	56	n	n	NOUN
dpc-2102	101	57	=	=	SYM
dpc-2102	101	58	1	1	NUM
dpc-2102	101	59	)	)	PUNCT
dpc-2102	101	60	of	of	ADP
dpc-2102	101	61	eop	eop	PROPN
dpc-2102	101	62	and	and	CCONJ
dpc-2102	101	63	lop	lop	PROPN
dpc-2102	101	64	,	,	PUNCT
dpc-2102	101	65	respectively	respectively	ADV
dpc-2102	101	66	.	.	PUNCT
dpc-2102	102	1	psa	psa	VERB
dpc-2102	102	2	in	in	ADP
dpc-2102	102	3	eop	eop	PROPN
dpc-2102	102	4	and	and	CCONJ
dpc-2102	102	5	lop	lop	PROPN
dpc-2102	102	6	data	datum	NOUN
dpc-2102	102	7	regarding	regard	VERB
dpc-2102	102	8	prevalence	prevalence	NOUN
dpc-2102	102	9	of	of	ADP
dpc-2102	102	10	psa	psa	NOUN
dpc-2102	102	11	,	,	PUNCT
dpc-2102	102	12	age	age	NOUN
dpc-2102	102	13	at	at	ADP
dpc-2102	102	14	onset	onset	NOUN
dpc-2102	102	15	of	of	ADP
dpc-2102	102	16	psa	psa	NOUN
dpc-2102	102	17	,	,	PUNCT
dpc-2102	102	18	duration	duration	NOUN
dpc-2102	102	19	between	between	ADP
dpc-2102	102	20	onset	onset	NOUN
dpc-2102	102	21	of	of	ADP
dpc-2102	102	22	psoriasis	psoriasis	NOUN
dpc-2102	102	23	and	and	CCONJ
dpc-2102	102	24	psa	psa	VERB
dpc-2102	102	25	,	,	PUNCT
dpc-2102	102	26	and	and	CCONJ
dpc-2102	102	27	active	active	ADJ
dpc-2102	102	28	disease	disease	NOUN
dpc-2102	102	29	duration	duration	NOUN
dpc-2102	102	30	of	of	ADP
dpc-2102	102	31	patients	patient	NOUN
dpc-2102	102	32	with	with	ADP
dpc-2102	102	33	psa	psa	NOUN
dpc-2102	102	34	with	with	ADP
dpc-2102	102	35	and	and	CCONJ
dpc-2102	102	36	without	without	ADP
dpc-2102	102	37	treatment	treatment	NOUN
dpc-2102	102	38	are	be	AUX
dpc-2102	102	39	shown	show	VERB
dpc-2102	102	40	in	in	ADP
dpc-2102	102	41	table	table	NOUN
dpc-2102	102	42	6	6	NUM
dpc-2102	102	43	.	.	PUNCT
dpc-2102	103	1	duration	duration	NOUN
dpc-2102	103	2	between	between	ADP
dpc-2102	103	3	onset	onset	NOUN
dpc-2102	103	4	of	of	ADP
dpc-2102	103	5	psoriasis	psoriasis	NOUN
dpc-2102	103	6	and	and	CCONJ
dpc-2102	103	7	psa	psa	NOUN
dpc-2102	103	8	was	be	AUX
dpc-2102	103	9	significantly	significantly	ADV
dpc-2102	103	10	shorter	short	ADJ
dpc-2102	103	11	in	in	ADP
dpc-2102	103	12	lop	lop	NOUN
dpc-2102	103	13	than	than	ADP
dpc-2102	103	14	eop	eop	PROPN
dpc-2102	103	15	(	(	PUNCT
dpc-2102	103	16	p	p	X
dpc-2102	103	17	<	<	X
dpc-2102	103	18	0.01	0.01	NUM
dpc-2102	103	19	)	)	PUNCT
dpc-2102	103	20	.	.	PUNCT
dpc-2102	104	1	duration	duration	NOUN
dpc-2102	104	2	of	of	ADP
dpc-2102	104	3	active	active	ADJ
dpc-2102	104	4	disease	disease	NOUN
dpc-2102	104	5	in	in	ADP
dpc-2102	104	6	psa	psa	NOUN
dpc-2102	104	7	patients	patient	NOUN
dpc-2102	104	8	with	with	ADP
dpc-2102	104	9	or	or	CCONJ
dpc-2102	104	10	without	without	ADP
dpc-2102	104	11	systemic	systemic	ADJ
dpc-2102	104	12	treatments	treatment	NOUN
dpc-2102	104	13	was	be	AUX
dpc-2102	104	14	also	also	ADV
dpc-2102	104	15	significantly	significantly	ADV
dpc-2102	104	16	shorter	short	ADJ
dpc-2102	104	17	in	in	ADP
dpc-2102	104	18	lop	lop	NOUN
dpc-2102	104	19	than	than	ADP
dpc-2102	104	20	eop	eop	PROPN
dpc-2102	104	21	respectively	respectively	ADV
dpc-2102	104	22	(	(	PUNCT
dpc-2102	104	23	p	p	X
dpc-2102	104	24	=	=	NOUN
dpc-2102	104	25	0.002	0.002	NUM
dpc-2102	104	26	,	,	PUNCT
dpc-2102	104	27	p	p	X
dpc-2102	104	28	<	<	X
dpc-2102	104	29	0.01	0.01	NUM
dpc-2102	104	30	)	)	PUNCT
dpc-2102	104	31	.	.	PUNCT
dpc-2102	105	1	rsq	rsq	PROPN
dpc-2102	105	2	revealed	reveal	VERB
dpc-2102	105	3	morning	morning	NOUN
dpc-2102	105	4	stiffness	stiffness	NOUN
dpc-2102	105	5	in	in	ADP
dpc-2102	105	6	10.7	10.7	NUM
dpc-2102	105	7	%	%	NOUN
dpc-2102	105	8	(	(	PUNCT
dpc-2102	105	9	n	n	NOUN
dpc-2102	105	10	=	=	SYM
dpc-2102	105	11	13	13	NUM
dpc-2102	105	12	)	)	PUNCT
dpc-2102	105	13	of	of	ADP
dpc-2102	105	14	eop	eop	PROPN
dpc-2102	105	15	and	and	CCONJ
dpc-2102	105	16	5.1	5.1	NUM
dpc-2102	105	17	%	%	NOUN
dpc-2102	105	18	(	(	PUNCT
dpc-2102	105	19	n	n	NOUN
dpc-2102	105	20	=	=	SYM
dpc-2102	105	21	2	2	NUM
dpc-2102	105	22	)	)	PUNCT
dpc-2102	105	23	of	of	ADP
dpc-2102	105	24	lop	lop	PROPN
dpc-2102	105	25	.	.	PUNCT
dpc-2102	106	1	muscle	muscle	NOUN
dpc-2102	106	2	-	-	PUNCT
dpc-2102	106	3	joint	joint	ADJ
dpc-2102	106	4	complaints	complaint	NOUN
dpc-2102	106	5	was	be	AUX
dpc-2102	106	6	observed	observe	VERB
dpc-2102	106	7	in	in	ADP
dpc-2102	106	8	9.1	9.1	NUM
dpc-2102	106	9	%	%	NOUN
dpc-2102	106	10	(	(	PUNCT
dpc-2102	106	11	n	n	NOUN
dpc-2102	106	12	=	=	SYM
dpc-2102	106	13	11	11	NUM
dpc-2102	106	14	)	)	PUNCT
dpc-2102	106	15	and	and	CCONJ
dpc-2102	106	16	10.3	10.3	NUM
dpc-2102	106	17	%	%	NOUN
dpc-2102	106	18	(	(	PUNCT
dpc-2102	106	19	n	n	NOUN
dpc-2102	106	20	=	=	SYM
dpc-2102	106	21	4	4	NUM
dpc-2102	106	22	)	)	PUNCT
dpc-2102	106	23	,	,	PUNCT
dpc-2102	106	24	small	small	ADJ
dpc-2102	106	25	joints	joint	NOUN
dpc-2102	106	26	complaints	complaint	NOUN
dpc-2102	106	27	were	be	AUX
dpc-2102	106	28	found	find	VERB
dpc-2102	106	29	in	in	ADP
dpc-2102	106	30	9.1	9.1	NUM
dpc-2102	106	31	%	%	NOUN
dpc-2102	106	32	(	(	PUNCT
dpc-2102	106	33	n	n	NOUN
dpc-2102	106	34	=	=	SYM
dpc-2102	106	35	11	11	NUM
dpc-2102	106	36	)	)	PUNCT
dpc-2102	106	37	and	and	CCONJ
dpc-2102	106	38	5.1	5.1	NUM
dpc-2102	106	39	%	%	NOUN
dpc-2102	106	40	(	(	PUNCT
dpc-2102	106	41	n	n	NOUN
dpc-2102	106	42	=	=	SYM
dpc-2102	106	43	2	2	NUM
dpc-2102	106	44	)	)	PUNCT
dpc-2102	106	45	,	,	PUNCT
dpc-2102	106	46	enthesis	enthesis	NOUN
dpc-2102	106	47	complaints	complaint	NOUN
dpc-2102	106	48	were	be	AUX
dpc-2102	106	49	found	find	VERB
dpc-2102	106	50	in	in	ADP
dpc-2102	106	51	14	14	NUM
dpc-2102	106	52	%	%	NOUN
dpc-2102	106	53	(	(	PUNCT
dpc-2102	106	54	n	n	NOUN
dpc-2102	106	55	=	=	SYM
dpc-2102	106	56	17	17	NUM
dpc-2102	106	57	)	)	PUNCT
dpc-2102	106	58	and	and	CCONJ
dpc-2102	106	59	12.8	12.8	NUM
dpc-2102	106	60	%	%	NOUN
dpc-2102	106	61	(	(	PUNCT
dpc-2102	106	62	n	n	NOUN
dpc-2102	106	63	=	=	SYM
dpc-2102	106	64	5	5	NUM
dpc-2102	106	65	)	)	PUNCT
dpc-2102	106	66	and	and	CCONJ
dpc-2102	106	67	axial	axial	ADJ
dpc-2102	106	68	complaints	complaint	NOUN
dpc-2102	106	69	were	be	AUX
dpc-2102	106	70	noted	note	VERB
dpc-2102	106	71	in	in	ADP
dpc-2102	106	72	14.9	14.9	NUM
dpc-2102	106	73	%	%	NOUN
dpc-2102	106	74	(	(	PUNCT
dpc-2102	106	75	n	n	NOUN
dpc-2102	106	76	=	=	SYM
dpc-2102	106	77	18	18	NUM
dpc-2102	106	78	)	)	PUNCT
dpc-2102	106	79	and	and	CCONJ
dpc-2102	106	80	20.5	20.5	NUM
dpc-2102	106	81	%	%	NOUN
dpc-2102	106	82	(	(	PUNCT
dpc-2102	106	83	n	n	NOUN
dpc-2102	106	84	=	=	SYM
dpc-2102	106	85	8)	8)	NUM
dpc-2102	106	86	of	of	ADP
dpc-2102	106	87	eop	eop	PROPN
dpc-2102	106	88	and	and	CCONJ
dpc-2102	106	89	lop	lop	PROPN
dpc-2102	106	90	patients	patient	NOUN
dpc-2102	106	91	respectively	respectively	ADV
dpc-2102	106	92	.	.	PUNCT
dpc-2102	107	1	none	none	NOUN
dpc-2102	107	2	of	of	ADP
dpc-2102	107	3	the	the	DET
dpc-2102	107	4	patients	patient	NOUN
dpc-2102	107	5	referred	refer	VERB
dpc-2102	107	6	to	to	ADP
dpc-2102	107	7	rheumatologic	rheumatologic	NOUN
dpc-2102	107	8	consultations	consultation	NOUN
dpc-2102	107	9	were	be	AUX
dpc-2102	107	10	diagnosed	diagnose	VERB
dpc-2102	107	11	with	with	ADP
dpc-2102	107	12	psa	psa	PROPN
dpc-2102	107	13	.	.	PUNCT
dpc-2102	108	1	concurrent	concurrent	ADJ
dpc-2102	108	2	systemic	systemic	ADJ
dpc-2102	108	3	inflammatory	inflammatory	ADJ
dpc-2102	108	4	comorbidities	comorbiditie	NOUN
dpc-2102	108	5	in	in	ADP
dpc-2102	108	6	eop	eop	PROPN
dpc-2102	108	7	and	and	CCONJ
dpc-2102	108	8	lop	lop	PROPN
dpc-2102	108	9	prevalence	prevalence	NOUN
dpc-2102	108	10	and	and	CCONJ
dpc-2102	108	11	age	age	NOUN
dpc-2102	108	12	at	at	ADP
dpc-2102	108	13	onset	onset	NOUN
dpc-2102	108	14	of	of	ADP
dpc-2102	108	15	systemic	systemic	ADJ
dpc-2102	108	16	inflammatory	inflammatory	ADJ
dpc-2102	108	17	comorbidities	comorbiditie	NOUN
dpc-2102	108	18	in	in	ADP
dpc-2102	108	19	eop	eop	PROPN
dpc-2102	108	20	and	and	CCONJ
dpc-2102	108	21	lop	lop	PROPN
dpc-2102	108	22	are	be	AUX
dpc-2102	108	23	shown	show	VERB
dpc-2102	108	24	in	in	ADP
dpc-2102	108	25	table	table	NOUN
dpc-2102	108	26	7	7	NUM
dpc-2102	108	27	.	.	PUNCT
dpc-2102	109	1	cvd	cvd	PROPN
dpc-2102	109	2	,	,	PUNCT
dpc-2102	109	3	ht	ht	PROPN
dpc-2102	109	4	,	,	PUNCT
dpc-2102	109	5	dm	dm	PROPN
dpc-2102	109	6	and	and	CCONJ
dpc-2102	109	7	ms	ms	PROPN
dpc-2102	109	8	were	be	AUX
dpc-2102	109	9	found	find	VERB
dpc-2102	109	10	significantly	significantly	ADV
dpc-2102	109	11	more	more	ADV
dpc-2102	109	12	frequent	frequent	ADJ
dpc-2102	109	13	in	in	ADP
dpc-2102	109	14	lop	lop	NOUN
dpc-2102	109	15	compared	compare	VERB
dpc-2102	109	16	to	to	ADP
dpc-2102	109	17	eop	eop	PROPN
dpc-2102	109	18	(	(	PUNCT
dpc-2102	109	19	p	p	X
dpc-2102	109	20	=	=	PROPN
dpc-2102	109	21	0.045	0.045	NUM
dpc-2102	109	22	,	,	PUNCT
dpc-2102	109	23	p	p	NOUN
dpc-2102	109	24	=	=	NOUN
dpc-2102	109	25	0.001	0.001	NUM
dpc-2102	109	26	,	,	PUNCT
dpc-2102	109	27	p	p	X
dpc-2102	109	28	<	<	X
dpc-2102	109	29	0.01	0.01	NUM
dpc-2102	109	30	,	,	PUNCT
dpc-2102	109	31	p	p	X
dpc-2102	109	32	=	=	NOUN
dpc-2102	109	33	0.022	0.022	NUM
dpc-2102	109	34	)	)	PUNCT
dpc-2102	109	35	.	.	PUNCT
dpc-2102	110	1	in	in	ADP
dpc-2102	110	2	order	order	NOUN
dpc-2102	110	3	to	to	PART
dpc-2102	110	4	evaluate	evaluate	VERB
dpc-2102	110	5	the	the	DET
dpc-2102	110	6	effect	effect	NOUN
dpc-2102	110	7	of	of	ADP
dpc-2102	110	8	psoriasis	psoriasis	NOUN
dpc-2102	110	9	subtype	subtype	NOUN
dpc-2102	110	10	to	to	ADP
dpc-2102	110	11	the	the	DET
dpc-2102	110	12	development	development	NOUN
dpc-2102	110	13	of	of	ADP
dpc-2102	110	14	concurrent	concurrent	ADJ
dpc-2102	110	15	systemic	systemic	ADJ
dpc-2102	110	16	inflammatory	inflammatory	ADJ
dpc-2102	110	17	comorbidities	comorbiditie	NOUN
dpc-2102	110	18	,	,	PUNCT
dpc-2102	110	19	multivariate	multivariate	NOUN
dpc-2102	110	20	regression	regression	NOUN
dpc-2102	110	21	analysis	analysis	NOUN
dpc-2102	110	22	was	be	AUX
dpc-2102	110	23	performed	perform	VERB
dpc-2102	110	24	;	;	PUNCT
dpc-2102	110	25	age	age	NOUN
dpc-2102	110	26	,	,	PUNCT
dpc-2102	110	27	gender	gender	NOUN
dpc-2102	110	28	,	,	PUNCT
dpc-2102	110	29	severity	severity	NOUN
dpc-2102	110	30	parameters	parameter	NOUN
dpc-2102	110	31	of	of	ADP
dpc-2102	110	32	disease	disease	NOUN
dpc-2102	110	33	,	,	PUNCT
dpc-2102	110	34	alcohol	alcohol	NOUN
dpc-2102	110	35	consumption	consumption	NOUN
dpc-2102	110	36	,	,	PUNCT
dpc-2102	110	37	smoking	smoking	NOUN
dpc-2102	110	38	habits	habit	NOUN
dpc-2102	110	39	and	and	CCONJ
dpc-2102	110	40	other	other	ADJ
dpc-2102	110	41	concurrent	concurrent	ADJ
dpc-2102	110	42	systemic	systemic	ADJ
dpc-2102	110	43	comorbidities	comorbiditie	NOUN
dpc-2102	110	44	were	be	AUX
dpc-2102	110	45	taken	take	VERB
dpc-2102	110	46	into	into	ADP
dpc-2102	110	47	account	account	NOUN
dpc-2102	110	48	(	(	PUNCT
dpc-2102	110	49	table	table	NOUN
dpc-2102	110	50	8)	8)	NUM
dpc-2102	110	51	.	.	PUNCT
dpc-2102	111	1	based	base	VERB
dpc-2102	111	2	on	on	ADP
dpc-2102	111	3	this	this	DET
dpc-2102	111	4	analysis	analysis	NOUN
dpc-2102	111	5	,	,	PUNCT
dpc-2102	111	6	lop	lop	PROPN
dpc-2102	111	7	was	be	AUX
dpc-2102	111	8	found	find	VERB
dpc-2102	111	9	as	as	ADP
dpc-2102	111	10	an	an	DET
dpc-2102	111	11	independent	independent	ADJ
dpc-2102	111	12	risk	risk	NOUN
dpc-2102	111	13	factor	factor	NOUN
dpc-2102	111	14	for	for	ADP
dpc-2102	111	15	cvd	cvd	PROPN
dpc-2102	111	16	and	and	CCONJ
dpc-2102	111	17	dm	dm	PROPN
dpc-2102	111	18	(	(	PUNCT
dpc-2102	111	19	p	p	X
dpc-2102	111	20	<	<	X
dpc-2102	111	21	0.01	0.01	NUM
dpc-2102	111	22	,	,	PUNCT
dpc-2102	111	23	r2	r2	NOUN
dpc-2102	111	24	:	:	PUNCT
dpc-2102	111	25	0.036	0.036	NUM
dpc-2102	111	26	;	;	PUNCT
dpc-2102	111	27	p	p	X
dpc-2102	111	28	<	<	X
dpc-2102	111	29	0.01	0.01	NUM
dpc-2102	111	30	,	,	PUNCT
dpc-2102	111	31	r2	r2	NOUN
dpc-2102	111	32	:	:	PUNCT
dpc-2102	111	33	0.077	0.077	NUM
dpc-2102	111	34	)	)	PUNCT
dpc-2102	111	35	.	.	PUNCT
dpc-2102	112	1	risk	risk	NOUN
dpc-2102	112	2	of	of	ADP
dpc-2102	112	3	cvd	cvd	PROPN
dpc-2102	112	4	,	,	PUNCT
dpc-2102	112	5	dm	dm	PROPN
dpc-2102	112	6	,	,	PUNCT
dpc-2102	112	7	ht	ht	PROPN
dpc-2102	112	8	and	and	CCONJ
dpc-2102	112	9	ms	ms	PROPN
dpc-2102	112	10	were	be	AUX
dpc-2102	112	11	increased	increase	VERB
dpc-2102	112	12	accordingly	accordingly	ADV
dpc-2102	112	13	with	with	ADP
dpc-2102	112	14	decades	decade	NOUN
dpc-2102	112	15	of	of	ADP
dpc-2102	112	16	psoriasis	psoriasis	NOUN
dpc-2102	112	17	onset	onset	NOUN
dpc-2102	112	18	(	(	PUNCT
dpc-2102	112	19	p	p	X
dpc-2102	112	20	=	=	NOUN
dpc-2102	112	21	0.036	0.036	NUM
dpc-2102	112	22	,	,	PUNCT
dpc-2102	112	23	p	p	X
dpc-2102	112	24	=	=	NOUN
dpc-2102	112	25	0.007	0.007	NUM
dpc-2102	112	26	,	,	PUNCT
dpc-2102	112	27	p	p	NOUN
dpc-2102	112	28	=	=	NOUN
dpc-2102	112	29	0.001	0.001	NUM
dpc-2102	112	30	,	,	PUNCT
dpc-2102	112	31	p	p	X
dpc-2102	112	32	=	=	NOUN
dpc-2102	112	33	0.003	0.003	NUM
dpc-2102	112	34	)	)	PUNCT
dpc-2102	112	35	.	.	PUNCT
dpc-2102	113	1	nash	nash	PROPN
dpc-2102	113	2	,	,	PUNCT
dpc-2102	113	3	dlp	dlp	NOUN
dpc-2102	113	4	and	and	CCONJ
dpc-2102	113	5	ob	ob	NOUN
dpc-2102	113	6	development	development	NOUN
dpc-2102	113	7	risk	risk	NOUN
dpc-2102	113	8	was	be	AUX
dpc-2102	113	9	not	not	PART
dpc-2102	113	10	found	find	VERB
dpc-2102	113	11	to	to	PART
dpc-2102	113	12	be	be	AUX
dpc-2102	113	13	showing	show	VERB
dpc-2102	113	14	this	this	DET
dpc-2102	113	15	relationship	relationship	NOUN
dpc-2102	113	16	with	with	ADP
dpc-2102	113	17	psoriasis	psoriasis	NOUN
dpc-2102	113	18	onset	onset	NOUN
dpc-2102	113	19	(	(	PUNCT
dpc-2102	113	20	p	p	X
dpc-2102	113	21	=	=	NOUN
dpc-2102	113	22	0.194	0.194	NUM
dpc-2102	113	23	,	,	PUNCT
dpc-2102	113	24	p	p	X
dpc-2102	113	25	=	=	NOUN
dpc-2102	113	26	0.158	0.158	NUM
dpc-2102	113	27	,	,	PUNCT
dpc-2102	113	28	p	p	X
dpc-2102	113	29	=	=	NOUN
dpc-2102	113	30	0.644	0.644	NUM
dpc-2102	113	31	)	)	PUNCT
dpc-2102	113	32	.	.	PUNCT
dpc-2102	114	1	conclusions	conclusion	NOUN
dpc-2102	114	2	as	as	SCONJ
dpc-2102	114	3	it	it	PRON
dpc-2102	114	4	was	be	AUX
dpc-2102	114	5	aimed	aim	VERB
dpc-2102	114	6	,	,	PUNCT
dpc-2102	114	7	comparison	comparison	NOUN
dpc-2102	114	8	of	of	ADP
dpc-2102	114	9	disease	disease	NOUN
dpc-2102	114	10	characteristics	characteristic	NOUN
dpc-2102	114	11	and	and	CCONJ
dpc-2102	114	12	concurrent	concurrent	ADJ
dpc-2102	114	13	inflammatory	inflammatory	ADJ
dpc-2102	114	14	comorbidities	comorbiditie	NOUN
dpc-2102	114	15	enabled	enable	VERB
dpc-2102	114	16	us	we	PRON
dpc-2102	114	17	to	to	PART
dpc-2102	114	18	spot	spot	VERB
dpc-2102	114	19	the	the	DET
dpc-2102	114	20	peculiar	peculiar	ADJ
dpc-2102	114	21	differences	difference	NOUN
dpc-2102	114	22	in	in	ADP
dpc-2102	114	23	eop	eop	PROPN
dpc-2102	114	24	and	and	CCONJ
dpc-2102	114	25	lop	lop	PROPN
dpc-2102	114	26	;	;	PUNCT
dpc-2102	114	27	we	we	PRON
dpc-2102	114	28	were	be	AUX
dpc-2102	114	29	also	also	ADV
dpc-2102	114	30	able	able	ADJ
dpc-2102	114	31	table	table	NOUN
dpc-2102	114	32	4	4	NUM
dpc-2102	114	33	.	.	PUNCT
dpc-2102	114	34	laboratory	laboratory	NOUN
dpc-2102	114	35	findings	finding	NOUN
dpc-2102	114	36	in	in	ADP
dpc-2102	114	37	eop	eop	PROPN
dpc-2102	114	38	and	and	CCONJ
dpc-2102	114	39	lop	lop	PROPN
dpc-2102	114	40	variables	variable	NOUN
dpc-2102	114	41	total	total	ADJ
dpc-2102	114	42	patients	patient	NOUN
dpc-2102	114	43	(	(	PUNCT
dpc-2102	114	44	n	n	NOUN
dpc-2102	114	45	=	=	SYM
dpc-2102	114	46	160	160	NUM
dpc-2102	114	47	)	)	PUNCT
dpc-2102	114	48	eop	eop	PROPN
dpc-2102	114	49	(	(	PUNCT
dpc-2102	114	50	n	n	NOUN
dpc-2102	114	51	=	=	SYM
dpc-2102	114	52	121	121	NUM
dpc-2102	114	53	)	)	PUNCT
dpc-2102	114	54	lop	lop	NOUN
dpc-2102	114	55	(	(	PUNCT
dpc-2102	114	56	n	n	NOUN
dpc-2102	114	57	=	=	SYM
dpc-2102	114	58	39	39	NUM
dpc-2102	114	59	)	)	PUNCT
dpc-2102	114	60	p	p	NOUN
dpc-2102	114	61	hemoglobin	hemoglobin	NOUN
dpc-2102	114	62	,	,	PUNCT
dpc-2102	114	63	gr	gr	PROPN
dpc-2102	114	64	/	/	SYM
dpc-2102	114	65	dl	dl	PROPN
dpc-2102	114	66	14.71	14.71	NUM
dpc-2102	114	67	±	±	NUM
dpc-2102	114	68	1.46	1.46	NUM
dpc-2102	114	69	14.85	14.85	NUM
dpc-2102	114	70	±	±	NUM
dpc-2102	114	71	1.43	1.43	NUM
dpc-2102	114	72	14.28	14.28	NUM
dpc-2102	114	73	±	±	NUM
dpc-2102	114	74	1.48	1.48	NUM
dpc-2102	114	75	mean±sd	mean±sd	PROPN
dpc-2102	114	76	(	(	PUNCT
dpc-2102	114	77	range	range	NOUN
dpc-2102	114	78	)	)	PUNCT
dpc-2102	114	79	(	(	PUNCT
dpc-2102	114	80	9.6	9.6	NUM
dpc-2102	114	81	-	-	SYM
dpc-2102	114	82	17.6	17.6	NUM
dpc-2102	114	83	)	)	PUNCT
dpc-2102	114	84	(	(	PUNCT
dpc-2102	114	85	9.6	9.6	NUM
dpc-2102	114	86	-	-	SYM
dpc-2102	114	87	17.6	17.6	NUM
dpc-2102	114	88	)	)	PUNCT
dpc-2102	114	89	(	(	PUNCT
dpc-2102	114	90	11.0	11.0	NUM
dpc-2102	114	91	-	-	SYM
dpc-2102	114	92	17.2	17.2	NUM
dpc-2102	114	93	)	)	PUNCT
dpc-2102	114	94	0.035	0.035	NUM
dpc-2102	114	95	wbc	wbc	PROPN
dpc-2102	114	96	,	,	PUNCT
dpc-2102	114	97	x103/µl	x103/µl	PROPN
dpc-2102	114	98	7069	7069	NUM
dpc-2102	114	99	±	±	NUM
dpc-2102	114	100	1716.37	1716.37	NUM
dpc-2102	114	101	6973	6973	NUM
dpc-2102	114	102	±1701.75	±1701.75	VERB
dpc-2102	114	103	7364	7364	NUM
dpc-2102	114	104	±	±	NOUN
dpc-2102	114	105	1750.11	1750.11	NUM
dpc-2102	114	106	mean±sd	mean±sd	PROPN
dpc-2102	114	107	(	(	PUNCT
dpc-2102	114	108	range	range	NOUN
dpc-2102	114	109	)	)	PUNCT
dpc-2102	114	110	(	(	PUNCT
dpc-2102	114	111	3800	3800	NUM
dpc-2102	114	112	-	-	SYM
dpc-2102	114	113	13400	13400	NUM
dpc-2102	114	114	)	)	PUNCT
dpc-2102	114	115	(	(	PUNCT
dpc-2102	114	116	3900	3900	NUM
dpc-2102	114	117	-	-	SYM
dpc-2102	114	118	11800	11800	NUM
dpc-2102	114	119	)	)	PUNCT
dpc-2102	114	120	(	(	PUNCT
dpc-2102	114	121	3800	3800	NUM
dpc-2102	114	122	-	-	SYM
dpc-2102	114	123	13400	13400	NUM
dpc-2102	114	124	)	)	PUNCT
dpc-2102	114	125	0.222	0.222	NUM
dpc-2102	114	126	platelets	platelet	NOUN
dpc-2102	114	127	,	,	PUNCT
dpc-2102	114	128	x103/µl	x103/µl	PROPN
dpc-2102	114	129	230597±60028.87	230597±60028.87	NUM
dpc-2102	114	130	227699	227699	NUM
dpc-2102	114	131	±58982.59	±58982.59	NUM
dpc-2102	114	132	239589	239589	NUM
dpc-2102	114	133	±	±	NUM
dpc-2102	114	134	63101.30	63101.30	NUM
dpc-2102	114	135	mean±sd	mean±sd	ADP
dpc-2102	114	136	(	(	PUNCT
dpc-2102	114	137	range	range	NOUN
dpc-2102	114	138	)	)	PUNCT
dpc-2102	114	139	(	(	PUNCT
dpc-2102	114	140	24600	24600	NUM
dpc-2102	114	141	-	-	SYM
dpc-2102	114	142	424000	424000	NUM
dpc-2102	114	143	)	)	PUNCT
dpc-2102	114	144	(	(	PUNCT
dpc-2102	114	145	24600	24600	NUM
dpc-2102	114	146	-	-	SYM
dpc-2102	114	147	381000	381000	NUM
dpc-2102	114	148	)	)	PUNCT
dpc-2102	114	149	(	(	PUNCT
dpc-2102	114	150	137000	137000	NUM
dpc-2102	114	151	-	-	SYM
dpc-2102	114	152	424000	424000	NUM
dpc-2102	114	153	)	)	PUNCT
dpc-2102	114	154	0.283	0.283	NUM
dpc-2102	114	155	rdw	rdw	ADJ
dpc-2102	114	156	,	,	PUNCT
dpc-2102	114	157	%	%	NOUN
dpc-2102	114	158	13.99±1.64	13.99±1.64	NUM
dpc-2102	114	159	13.84	13.84	NUM
dpc-2102	114	160	±	±	NUM
dpc-2102	114	161	1.33	1.33	NUM
dpc-2102	114	162	14.46	14.46	NUM
dpc-2102	114	163	±	±	NUM
dpc-2102	114	164	2.34	2.34	NUM
dpc-2102	114	165	mean±sd	mean±sd	PROPN
dpc-2102	114	166	(	(	PUNCT
dpc-2102	114	167	range	range	NOUN
dpc-2102	114	168	)	)	PUNCT
dpc-2102	114	169	(	(	PUNCT
dpc-2102	114	170	12	12	NUM
dpc-2102	114	171	-	-	SYM
dpc-2102	114	172	27	27	NUM
dpc-2102	114	173	)	)	PUNCT
dpc-2102	114	174	(	(	PUNCT
dpc-2102	114	175	12	12	NUM
dpc-2102	114	176	-	-	SYM
dpc-2102	114	177	20.1	20.1	NUM
dpc-2102	114	178	)	)	PUNCT
dpc-2102	114	179	(	(	PUNCT
dpc-2102	114	180	12.5	12.5	NUM
dpc-2102	114	181	-	-	SYM
dpc-2102	114	182	27.1	27.1	NUM
dpc-2102	114	183	)	)	PUNCT
dpc-2102	114	184	0.017	0.017	NUM
dpc-2102	114	185	fasting	fast	VERB
dpc-2102	114	186	blood	blood	NOUN
dpc-2102	114	187	glucose	glucose	NOUN
dpc-2102	114	188	,	,	PUNCT
dpc-2102	114	189	mg	mg	PROPN
dpc-2102	114	190	/	/	SYM
dpc-2102	114	191	dl	dl	PROPN
dpc-2102	114	192	97.75	97.75	NUM
dpc-2102	114	193	±	±	NUM
dpc-2102	114	194	25.77	25.77	NUM
dpc-2102	114	195	94.84	94.84	NUM
dpc-2102	114	196	±	±	NUM
dpc-2102	114	197	22.37	22.37	NUM
dpc-2102	114	198	106.65	106.65	NUM
dpc-2102	114	199	±	±	NUM
dpc-2102	114	200	32.92	32.92	NUM
dpc-2102	114	201	mean±sd	mean±sd	PROPN
dpc-2102	114	202	(	(	PUNCT
dpc-2102	114	203	range	range	NOUN
dpc-2102	114	204	)	)	PUNCT
dpc-2102	114	205	(	(	PUNCT
dpc-2102	114	206	68	68	NUM
dpc-2102	114	207	-	-	SYM
dpc-2102	114	208	260	260	NUM
dpc-2102	114	209	)	)	PUNCT
dpc-2102	114	210	(	(	PUNCT
dpc-2102	114	211	68	68	NUM
dpc-2102	114	212	-	-	SYM
dpc-2102	114	213	203	203	NUM
dpc-2102	114	214	)	)	PUNCT
dpc-2102	114	215	(	(	PUNCT
dpc-2102	114	216	77	77	NUM
dpc-2102	114	217	-	-	SYM
dpc-2102	114	218	260	260	NUM
dpc-2102	114	219	)	)	PUNCT
dpc-2102	114	220	0.002	0.002	NUM
dpc-2102	114	221	crp	crp	NOUN
dpc-2102	114	222	,	,	PUNCT
dpc-2102	114	223	mg	mg	PROPN
dpc-2102	114	224	/	/	SYM
dpc-2102	114	225	l	l	NOUN
dpc-2102	114	226	0.52	0.52	NUM
dpc-2102	114	227	±	±	NUM
dpc-2102	114	228	0.81	0.81	NUM
dpc-2102	114	229	0.45	0.45	NUM
dpc-2102	114	230	±	±	NUM
dpc-2102	114	231	0.59	0.59	NUM
dpc-2102	114	232	0.76	0.76	NUM
dpc-2102	114	233	±	±	NUM
dpc-2102	114	234	1.28	1.28	NUM
dpc-2102	114	235	mean±sd	mean±sd	PROPN
dpc-2102	114	236	(	(	PUNCT
dpc-2102	114	237	range	range	NOUN
dpc-2102	114	238	)	)	PUNCT
dpc-2102	114	239	(	(	PUNCT
dpc-2102	114	240	0.02	0.02	NUM
dpc-2102	114	241	-	-	SYM
dpc-2102	114	242	7.90	7.90	NUM
dpc-2102	114	243	)	)	PUNCT
dpc-2102	114	244	(	(	PUNCT
dpc-2102	114	245	0.02	0.02	NUM
dpc-2102	114	246	-	-	SYM
dpc-2102	114	247	5.59	5.59	NUM
dpc-2102	114	248	)	)	PUNCT
dpc-2102	114	249	(	(	PUNCT
dpc-2102	114	250	0.15	0.15	NUM
dpc-2102	114	251	-	-	SYM
dpc-2102	114	252	7.99	7.99	NUM
dpc-2102	114	253	)	)	PUNCT
dpc-2102	114	254	0.006	0.006	NUM
dpc-2102	114	255	esr	esr	NOUN
dpc-2102	114	256	,	,	PUNCT
dpc-2102	114	257	mm	mm	PROPN
dpc-2102	114	258	/	/	SYM
dpc-2102	114	259	hour	hour	NOUN
dpc-2102	114	260	11.61	11.61	NUM
dpc-2102	114	261	±	±	NUM
dpc-2102	114	262	9.52	9.52	NUM
dpc-2102	114	263	10.30	10.30	NUM
dpc-2102	114	264	±	±	NUM
dpc-2102	114	265	8.58	8.58	NUM
dpc-2102	114	266	16.56	16.56	NUM
dpc-2102	114	267	±	±	NUM
dpc-2102	114	268	11.30	11.30	NUM
dpc-2102	114	269	mean±sd	mean±sd	PROPN
dpc-2102	114	270	(	(	PUNCT
dpc-2102	114	271	range	range	NOUN
dpc-2102	114	272	)	)	PUNCT
dpc-2102	114	273	(	(	PUNCT
dpc-2102	114	274	2	2	NUM
dpc-2102	114	275	-	-	SYM
dpc-2102	114	276	54	54	NUM
dpc-2102	114	277	)	)	PUNCT
dpc-2102	114	278	(	(	PUNCT
dpc-2102	114	279	2	2	NUM
dpc-2102	114	280	-	-	SYM
dpc-2102	114	281	37	37	NUM
dpc-2102	114	282	)	)	PUNCT
dpc-2102	114	283	(	(	PUNCT
dpc-2102	114	284	2	2	NUM
dpc-2102	114	285	-	-	SYM
dpc-2102	114	286	54	54	NUM
dpc-2102	114	287	)	)	PUNCT
dpc-2102	114	288	0.001	0.001	NUM
dpc-2102	114	289	crp	crp	NOUN
dpc-2102	114	290	=	=	SYM
dpc-2102	114	291	c	c	X
dpc-2102	114	292	-	-	PUNCT
dpc-2102	114	293	reactive	reactive	ADJ
dpc-2102	114	294	protein	protein	NOUN
dpc-2102	114	295	;	;	PUNCT
dpc-2102	114	296	eop	eop	PROPN
dpc-2102	114	297	=	=	PROPN
dpc-2102	114	298	early	early	ADJ
dpc-2102	114	299	onset	onset	VERB
dpc-2102	114	300	psoriasis	psoriasis	NOUN
dpc-2102	114	301	;	;	PUNCT
dpc-2102	114	302	esr	esr	PROPN
dpc-2102	114	303	=	=	PUNCT
dpc-2102	114	304	erythrocyte	erythrocyte	PROPN
dpc-2102	114	305	sedimentation	sedimentation	NOUN
dpc-2102	114	306	rate	rate	NOUN
dpc-2102	114	307	;	;	PUNCT
dpc-2102	114	308	lop	lop	NOUN
dpc-2102	114	309	=	=	PUNCT
dpc-2102	114	310	late	late	ADJ
dpc-2102	114	311	onset	onset	NOUN
dpc-2102	114	312	psoriasis	psoriasis	NOUN
dpc-2102	114	313	;	;	PUNCT
dpc-2102	114	314	mcv	mcv	PROPN
dpc-2102	114	315	=	=	SYM
dpc-2102	114	316	mean	mean	ADJ
dpc-2102	114	317	corpuscular	corpuscular	NOUN
dpc-2102	114	318	volume	volume	NOUN
dpc-2102	114	319	;	;	PUNCT
dpc-2102	114	320	mpv	mpv	PROPN
dpc-2102	114	321	=	=	NOUN
dpc-2102	114	322	mean	mean	VERB
dpc-2102	114	323	platelet	platelet	NOUN
dpc-2102	114	324	volume	volume	NOUN
dpc-2102	114	325	;	;	PUNCT
dpc-2102	114	326	nlr	nlr	PROPN
dpc-2102	114	327	=	=	PUNCT
dpc-2102	114	328	neutrophil	neutrophil	ADJ
dpc-2102	114	329	lymphocyte	lymphocyte	ADJ
dpc-2102	114	330	ratio	ratio	NOUN
dpc-2102	114	331	;	;	PUNCT
dpc-2102	114	332	rdw	rdw	ADJ
dpc-2102	114	333	=	=	NOUN
dpc-2102	114	334	red	red	ADJ
dpc-2102	114	335	cell	cell	NOUN
dpc-2102	114	336	distribution	distribution	NOUN
dpc-2102	114	337	width	width	NOUN
dpc-2102	114	338	;	;	PUNCT
dpc-2102	114	339	sd	sd	NOUN
dpc-2102	114	340	=	=	SYM
dpc-2102	114	341	standard	standard	ADJ
dpc-2102	114	342	deviation	deviation	NOUN
dpc-2102	114	343	;	;	PUNCT
dpc-2102	114	344	wbc	wbc	PROPN
dpc-2102	114	345	=	=	SYM
dpc-2102	114	346	white	white	ADJ
dpc-2102	114	347	blood	blood	NOUN
dpc-2102	114	348	cells	cell	NOUN
dpc-2102	114	349	.	.	PUNCT
dpc-2102	115	1	6	6	NUM
dpc-2102	115	2	original	original	ADJ
dpc-2102	115	3	article	article	NOUN
dpc-2102	115	4	|	|	ADV
dpc-2102	115	5	dermatol	dermatol	ADJ
dpc-2102	115	6	pract	pract	NOUN
dpc-2102	115	7	concept	concept	NOUN
dpc-2102	115	8	.	.	PUNCT
dpc-2102	116	1	2022;12(3):e2022144	2022;12(3):e2022144	NUM
dpc-2102	116	2	table	table	NOUN
dpc-2102	116	3	6	6	NUM
dpc-2102	116	4	.	.	PUNCT
dpc-2102	117	1	psa	psa	PROPN
dpc-2102	117	2	characteristics	characteristic	NOUN
dpc-2102	117	3	in	in	ADP
dpc-2102	117	4	eop	eop	PROPN
dpc-2102	117	5	and	and	CCONJ
dpc-2102	117	6	lop	lop	PROPN
dpc-2102	117	7	variables	variable	NOUN
dpc-2102	117	8	total	total	ADJ
dpc-2102	117	9	patients	patient	NOUN
dpc-2102	117	10	(	(	PUNCT
dpc-2102	117	11	n	n	NOUN
dpc-2102	117	12	=	=	SYM
dpc-2102	117	13	160	160	NUM
dpc-2102	117	14	)	)	PUNCT
dpc-2102	117	15	eop	eop	PROPN
dpc-2102	117	16	(	(	PUNCT
dpc-2102	117	17	n	n	NOUN
dpc-2102	117	18	=	=	SYM
dpc-2102	117	19	121	121	NUM
dpc-2102	117	20	)	)	PUNCT
dpc-2102	117	21	lop	lop	NOUN
dpc-2102	117	22	(	(	PUNCT
dpc-2102	117	23	n	n	NOUN
dpc-2102	117	24	=	=	SYM
dpc-2102	117	25	39	39	NUM
dpc-2102	117	26	)	)	PUNCT
dpc-2102	117	27	p	p	NOUN
dpc-2102	117	28	psa	psa	NOUN
dpc-2102	117	29	,	,	PUNCT
dpc-2102	117	30	n	n	CCONJ
dpc-2102	117	31	(	(	PUNCT
dpc-2102	117	32	%	%	INTJ
dpc-2102	117	33	)	)	PUNCT
dpc-2102	117	34	41	41	NUM
dpc-2102	117	35	(	(	PUNCT
dpc-2102	117	36	25.6	25.6	NUM
dpc-2102	117	37	)	)	PUNCT
dpc-2102	117	38	33	33	NUM
dpc-2102	117	39	(	(	PUNCT
dpc-2102	117	40	27.3	27.3	NUM
dpc-2102	117	41	)	)	PUNCT
dpc-2102	117	42	8	8	NUM
dpc-2102	117	43	(	(	PUNCT
dpc-2102	117	44	20.5	20.5	NUM
dpc-2102	117	45	)	)	PUNCT
dpc-2102	117	46	0.057	0.057	NUM
dpc-2102	117	47	age	age	NOUN
dpc-2102	117	48	at	at	ADP
dpc-2102	117	49	psa	psa	NOUN
dpc-2102	117	50	onset	onset	NOUN
dpc-2102	117	51	,	,	PUNCT
dpc-2102	117	52	years	year	NOUN
dpc-2102	117	53	38.98	38.98	NUM
dpc-2102	117	54	±	±	NUM
dpc-2102	117	55	11.64	11.64	NUM
dpc-2102	117	56	37.0	37.0	NUM
dpc-2102	117	57	±	±	NUM
dpc-2102	117	58	11.49	11.49	NUM
dpc-2102	117	59	47.13	47.13	NUM
dpc-2102	117	60	±	±	NUM
dpc-2102	117	61	8.77	8.77	NUM
dpc-2102	117	62	mean±sd	mean±sd	PROPN
dpc-2102	117	63	(	(	PUNCT
dpc-2102	117	64	range	range	NOUN
dpc-2102	117	65	)	)	PUNCT
dpc-2102	117	66	(	(	PUNCT
dpc-2102	117	67	10	10	NUM
dpc-2102	117	68	-	-	SYM
dpc-2102	117	69	71	71	NUM
dpc-2102	117	70	)	)	PUNCT
dpc-2102	117	71	(	(	PUNCT
dpc-2102	117	72	10	10	NUM
dpc-2102	117	73	-	-	SYM
dpc-2102	117	74	63	63	NUM
dpc-2102	117	75	)	)	PUNCT
dpc-2102	117	76	(	(	PUNCT
dpc-2102	117	77	37	37	NUM
dpc-2102	117	78	-	-	SYM
dpc-2102	117	79	71	71	NUM
dpc-2102	117	80	)	)	PUNCT
dpc-2102	117	81	0.025	0.025	NUM
dpc-2102	117	82	duration	duration	NOUN
dpc-2102	117	83	between	between	ADP
dpc-2102	117	84	ps	ps	PROPN
dpc-2102	117	85	and	and	CCONJ
dpc-2102	117	86	psa	psa	NOUN
dpc-2102	117	87	,	,	PUNCT
dpc-2102	117	88	years	year	NOUN
dpc-2102	117	89	12.80	12.80	NUM
dpc-2102	117	90	±	±	NUM
dpc-2102	117	91	11.46	11.46	NUM
dpc-2102	117	92	15.72	15.72	NUM
dpc-2102	117	93	±	±	NUM
dpc-2102	117	94	10.36	10.36	NUM
dpc-2102	117	95	0.75	0.75	NUM
dpc-2102	117	96	±	±	NUM
dpc-2102	117	97	7.36	7.36	NUM
dpc-2102	117	98	-a	-a	X
dpc-2102	117	99	,	,	PUNCT
dpc-2102	117	100	<	<	X
dpc-2102	117	101	0,01b	0,01b	ADJ
dpc-2102	117	102	mean±sd	mean±sd	PROPN
dpc-2102	117	103	(	(	PUNCT
dpc-2102	117	104	range	range	NOUN
dpc-2102	117	105	)	)	PUNCT
dpc-2102	117	106	(	(	PUNCT
dpc-2102	117	107	15	15	NUM
dpc-2102	117	108	-	-	SYM
dpc-2102	117	109	34	34	NUM
dpc-2102	117	110	)	)	PUNCT
dpc-2102	117	111	(	(	PUNCT
dpc-2102	117	112	1	1	NUM
dpc-2102	117	113	-	-	SYM
dpc-2102	117	114	34	34	NUM
dpc-2102	117	115	)	)	PUNCT
dpc-2102	117	116	(	(	PUNCT
dpc-2102	117	117	1	1	NUM
dpc-2102	117	118	-	-	SYM
dpc-2102	117	119	15	15	NUM
dpc-2102	117	120	)	)	PUNCT
dpc-2102	117	121	active	active	ADJ
dpc-2102	117	122	ps	ps	NOUN
dpc-2102	117	123	duration	duration	NOUN
dpc-2102	117	124	in	in	ADP
dpc-2102	117	125	psa	psa	NOUN
dpc-2102	117	126	patients	patient	NOUN
dpc-2102	117	127	with	with	ADP
dpc-2102	117	128	rx	rx	NOUN
dpc-2102	117	129	,	,	PUNCT
dpc-2102	117	130	months	month	NOUN
dpc-2102	117	131	28.34	28.34	NUM
dpc-2102	117	132	 	 	SPACE
dpc-2102	117	133	±	±	NOUN
dpc-2102	117	134	9.2	9.2	NUM
dpc-2102	117	135	34	34	NUM
dpc-2102	117	136	 	 	SPACE
dpc-2102	117	137	±	±	NUM
dpc-2102	117	138	20.1	20.1	NUM
dpc-2102	117	139	6	6	NUM
dpc-2102	117	140	 	 	SPACE
dpc-2102	117	141	±	±	NOUN
dpc-2102	117	142	8.3	8.3	NUM
dpc-2102	117	143	0.761	0.761	NUM
dpc-2102	117	144	a	a	DET
dpc-2102	117	145	,	,	PUNCT
dpc-2102	117	146	0.002	0.002	NUM
dpc-2102	117	147	b	b	NOUN
dpc-2102	117	148	mean±sd	mean±sd	ADP
dpc-2102	117	149	active	active	ADJ
dpc-2102	117	150	ps	ps	NOUN
dpc-2102	117	151	duration	duration	NOUN
dpc-2102	117	152	in	in	ADP
dpc-2102	117	153	psa	psa	NOUN
dpc-2102	117	154	patients	patient	NOUN
dpc-2102	117	155	without	without	ADP
dpc-2102	117	156	rx	rx	ADP
dpc-2102	117	157	,	,	PUNCT
dpc-2102	117	158	months	month	NOUN
dpc-2102	117	159	27.98	27.98	NUM
dpc-2102	117	160	 	 	SPACE
dpc-2102	117	161	±	±	NUM
dpc-2102	117	162	10.3	10.3	NUM
dpc-2102	117	163	33	33	NUM
dpc-2102	117	164	±	±	NUM
dpc-2102	117	165	15.1	15.1	NUM
dpc-2102	117	166	9	9	NUM
dpc-2102	117	167	 	 	SPACE
dpc-2102	117	168	±	±	NUM
dpc-2102	117	169	18.1	18.1	NUM
dpc-2102	117	170	0.803	0.803	NUM
dpc-2102	117	171	a	a	PRON
dpc-2102	117	172	,	,	PUNCT
dpc-2102	117	173	<	<	X
dpc-2102	117	174	0.0	0.0	NUM
dpc-2102	117	175	b	b	NOUN
dpc-2102	117	176	mean±sd	mean±sd	ADP
dpc-2102	117	177	eop	eop	PROPN
dpc-2102	117	178	=	=	PROPN
dpc-2102	117	179	early	early	ADJ
dpc-2102	117	180	onset	onset	VERB
dpc-2102	117	181	psoriasis	psoriasis	NOUN
dpc-2102	117	182	;	;	PUNCT
dpc-2102	117	183	lop	lop	NOUN
dpc-2102	117	184	=	=	PUNCT
dpc-2102	117	185	late	late	ADJ
dpc-2102	117	186	onset	onset	NOUN
dpc-2102	117	187	psoriasis	psoriasis	NOUN
dpc-2102	117	188	;	;	PUNCT
dpc-2102	117	189	ps	ps	NOUN
dpc-2102	117	190	=	=	SYM
dpc-2102	117	191	psoriasis	psoriasis	NOUN
dpc-2102	117	192	;	;	PUNCT
dpc-2102	117	193	psa	psa	VERB
dpc-2102	117	194	=	=	SYM
dpc-2102	117	195	psoriatic	psoriatic	ADJ
dpc-2102	117	196	arthritis	arthritis	NOUN
dpc-2102	117	197	;	;	PUNCT
dpc-2102	117	198	rx	rx	VERB
dpc-2102	117	199	=	=	VERB
dpc-2102	117	200	systemic	systemic	ADJ
dpc-2102	117	201	treatment	treatment	NOUN
dpc-2102	117	202	;	;	PUNCT
dpc-2102	117	203	sd	sd	NOUN
dpc-2102	117	204	=	=	SYM
dpc-2102	117	205	standard	standard	ADJ
dpc-2102	117	206	deviation	deviation	NOUN
dpc-2102	117	207	.	.	PUNCT
dpc-2102	118	1	pa	pa	NOUN
dpc-2102	118	2	:	:	PUNCT
dpc-2102	118	3	patients	patient	NOUN
dpc-2102	118	4	with	with	ADP
dpc-2102	118	5	psoriasis	psoriasis	NOUN
dpc-2102	118	6	;	;	PUNCT
dpc-2102	118	7	pb	pb	ADP
dpc-2102	118	8	:	:	PUNCT
dpc-2102	118	9	between	between	ADP
dpc-2102	118	10	eop	eop	PROPN
dpc-2102	118	11	and	and	CCONJ
dpc-2102	118	12	lop	lop	PROPN
dpc-2102	118	13	table	table	NOUN
dpc-2102	118	14	5	5	NUM
dpc-2102	118	15	.	.	PUNCT
dpc-2102	119	1	psoriatic	psoriatic	ADJ
dpc-2102	119	2	nail	nail	NOUN
dpc-2102	119	3	involvement	involvement	NOUN
dpc-2102	119	4	in	in	ADP
dpc-2102	119	5	eop	eop	PROPN
dpc-2102	119	6	and	and	CCONJ
dpc-2102	119	7	lop	lop	PROPN
dpc-2102	119	8	variables	variable	NOUN
dpc-2102	119	9	total	total	ADJ
dpc-2102	119	10	patients	patient	NOUN
dpc-2102	119	11	(	(	PUNCT
dpc-2102	119	12	n	n	NOUN
dpc-2102	119	13	=	=	SYM
dpc-2102	119	14	160	160	NUM
dpc-2102	119	15	)	)	PUNCT
dpc-2102	119	16	eop	eop	PROPN
dpc-2102	119	17	(	(	PUNCT
dpc-2102	119	18	n	n	NOUN
dpc-2102	119	19	=	=	SYM
dpc-2102	119	20	121	121	NUM
dpc-2102	119	21	)	)	PUNCT
dpc-2102	119	22	lop	lop	NOUN
dpc-2102	119	23	(	(	PUNCT
dpc-2102	119	24	n	n	NOUN
dpc-2102	119	25	=	=	SYM
dpc-2102	119	26	39	39	NUM
dpc-2102	119	27	)	)	PUNCT
dpc-2102	119	28	p	p	NOUN
dpc-2102	119	29	nail	nail	NOUN
dpc-2102	119	30	involvement	involvement	NOUN
dpc-2102	119	31	,	,	PUNCT
dpc-2102	119	32	n	n	CCONJ
dpc-2102	119	33	(	(	PUNCT
dpc-2102	119	34	%	%	INTJ
dpc-2102	119	35	)	)	PUNCT
dpc-2102	119	36	87	87	NUM
dpc-2102	119	37	(	(	PUNCT
dpc-2102	119	38	54.3	54.3	NUM
dpc-2102	119	39	)	)	PUNCT
dpc-2102	119	40	68	68	NUM
dpc-2102	119	41	(	(	PUNCT
dpc-2102	119	42	56.1	56.1	NUM
dpc-2102	119	43	)	)	PUNCT
dpc-2102	119	44	19	19	NUM
dpc-2102	119	45	(	(	PUNCT
dpc-2102	119	46	48.7	48.7	NUM
dpc-2102	119	47	)	)	PUNCT
dpc-2102	119	48	0.415	0.415	NUM
dpc-2102	119	49	age	age	NOUN
dpc-2102	119	50	at	at	ADP
dpc-2102	119	51	nail	nail	NOUN
dpc-2102	119	52	involvement	involvement	NOUN
dpc-2102	119	53	onset	onset	NOUN
dpc-2102	119	54	,	,	PUNCT
dpc-2102	119	55	years	year	NOUN
dpc-2102	119	56	34.29	34.29	NUM
dpc-2102	119	57	±	±	NUM
dpc-2102	119	58	12.93	12.93	NUM
dpc-2102	119	59	29.51	29.51	NUM
dpc-2102	119	60	±	±	NUM
dpc-2102	119	61	10.23	10.23	NUM
dpc-2102	119	62	49.85	49.85	NUM
dpc-2102	119	63	±	±	NUM
dpc-2102	119	64	7.33	7.33	NUM
dpc-2102	119	65	mean±sd	mean±sd	PROPN
dpc-2102	119	66	(	(	PUNCT
dpc-2102	119	67	range	range	NOUN
dpc-2102	119	68	)	)	PUNCT
dpc-2102	119	69	(	(	PUNCT
dpc-2102	119	70	10	10	NUM
dpc-2102	119	71	-	-	SYM
dpc-2102	119	72	70	70	NUM
dpc-2102	119	73	)	)	PUNCT
dpc-2102	119	74	(	(	PUNCT
dpc-2102	119	75	10	10	NUM
dpc-2102	119	76	-	-	SYM
dpc-2102	119	77	62	62	NUM
dpc-2102	119	78	)	)	PUNCT
dpc-2102	119	79	(	(	PUNCT
dpc-2102	119	80	37	37	NUM
dpc-2102	119	81	-	-	SYM
dpc-2102	119	82	70	70	NUM
dpc-2102	119	83	)	)	PUNCT
dpc-2102	119	84	<	<	X
dpc-2102	119	85	0.01	0.01	NUM
dpc-2102	119	86	disease	disease	NOUN
dpc-2102	119	87	duration	duration	NOUN
dpc-2102	119	88	between	between	ADP
dpc-2102	119	89	ps	ps	PROPN
dpc-2102	119	90	and	and	CCONJ
dpc-2102	119	91	nail	nail	NOUN
dpc-2102	119	92	involvement	involvement	NOUN
dpc-2102	119	93	,	,	PUNCT
dpc-2102	119	94	years	year	NOUN
dpc-2102	119	95	7.4	7.4	NUM
dpc-2102	119	96	±	±	NUM
dpc-2102	119	97	8.1	8.1	NUM
dpc-2102	119	98	9.06	9.06	NUM
dpc-2102	119	99	±	±	NUM
dpc-2102	119	100	8.5	8.5	NUM
dpc-2102	119	101	2.1	2.1	NUM
dpc-2102	119	102	±	±	NUM
dpc-2102	119	103	3.0	3.0	NUM
dpc-2102	119	104	a	a	NOUN
dpc-2102	119	105	,	,	PUNCT
dpc-2102	119	106	<	<	X
dpc-2102	119	107	0.01b	0.01b	PROPN
dpc-2102	119	108	mean±sd	mean±sd	ADP
dpc-2102	119	109	(	(	PUNCT
dpc-2102	119	110	range	range	NOUN
dpc-2102	119	111	)	)	PUNCT
dpc-2102	119	112	(	(	PUNCT
dpc-2102	119	113	4	4	NUM
dpc-2102	119	114	-	-	SYM
dpc-2102	119	115	37	37	NUM
dpc-2102	119	116	)	)	PUNCT
dpc-2102	119	117	(	(	PUNCT
dpc-2102	119	118	0	0	NUM
dpc-2102	119	119	-	-	SYM
dpc-2102	119	120	37	37	NUM
dpc-2102	119	121	)	)	PUNCT
dpc-2102	119	122	(	(	PUNCT
dpc-2102	119	123	4	4	NUM
dpc-2102	119	124	-	-	SYM
dpc-2102	119	125	9	9	NUM
dpc-2102	119	126	)	)	PUNCT
dpc-2102	119	127	concurrent	concurrent	ADJ
dpc-2102	119	128	nail	nail	NOUN
dpc-2102	119	129	involvement	involvement	NOUN
dpc-2102	119	130	and	and	CCONJ
dpc-2102	119	131	psa	psa	NOUN
dpc-2102	119	132	,	,	PUNCT
dpc-2102	119	133	n	n	CCONJ
dpc-2102	119	134	(	(	PUNCT
dpc-2102	119	135	%	%	INTJ
dpc-2102	119	136	)	)	PUNCT
dpc-2102	119	137	28	28	NUM
dpc-2102	119	138	(	(	PUNCT
dpc-2102	119	139	17.5	17.5	NUM
dpc-2102	119	140	)	)	SYM
dpc-2102	119	141	8	8	NUM
dpc-2102	119	142	(	(	PUNCT
dpc-2102	119	143	6.6	6.6	NUM
dpc-2102	119	144	)	)	SYM
dpc-2102	119	145	5	5	NUM
dpc-2102	119	146	(	(	PUNCT
dpc-2102	119	147	12.8	12.8	NUM
dpc-2102	119	148	)	)	PUNCT
dpc-2102	119	149	0.072	0.072	NUM
dpc-2102	119	150	a	a	PRON
dpc-2102	119	151	,	,	PUNCT
dpc-2102	119	152	0.041	0.041	NUM
dpc-2102	119	153	b	b	NUM
dpc-2102	119	154	active	active	ADJ
dpc-2102	119	155	disease	disease	NOUN
dpc-2102	119	156	duration	duration	NOUN
dpc-2102	119	157	in	in	ADP
dpc-2102	119	158	patients	patient	NOUN
dpc-2102	119	159	with	with	ADP
dpc-2102	119	160	nail	nail	NOUN
dpc-2102	119	161	involvement	involvement	NOUN
dpc-2102	119	162	and	and	CCONJ
dpc-2102	119	163	rx	rx	VERB
dpc-2102	119	164	,	,	PUNCT
dpc-2102	119	165	months	month	NOUN
dpc-2102	119	166	30.63	30.63	NUM
dpc-2102	119	167	±	±	NUM
dpc-2102	119	168	9.1	9.1	NUM
dpc-2102	119	169	35	35	NUM
dpc-2102	119	170	±	±	NUM
dpc-2102	119	171	48.32	48.32	NUM
dpc-2102	119	172	16	16	NUM
dpc-2102	119	173	±	±	NUM
dpc-2102	119	174	19.3	19.3	NUM
dpc-2102	119	175	0.639	0.639	NUM
dpc-2102	119	176	a	a	DET
dpc-2102	119	177	,	,	PUNCT
dpc-2102	119	178	<	<	X
dpc-2102	119	179	0.01	0.01	NUM
dpc-2102	119	180	b	b	NOUN
dpc-2102	119	181	mean±sd	mean±sd	ADP
dpc-2102	119	182	active	active	ADJ
dpc-2102	119	183	disease	disease	NOUN
dpc-2102	119	184	duration	duration	NOUN
dpc-2102	119	185	in	in	ADP
dpc-2102	119	186	patients	patient	NOUN
dpc-2102	119	187	with	with	ADP
dpc-2102	119	188	nail	nail	NOUN
dpc-2102	119	189	involvement	involvement	NOUN
dpc-2102	119	190	without	without	ADP
dpc-2102	119	191	rx	rx	NOUN
dpc-2102	119	192	,	,	PUNCT
dpc-2102	119	193	months	month	NOUN
dpc-2102	119	194	30.22	30.22	NUM
dpc-2102	119	195	 	 	SPACE
dpc-2102	119	196	±	±	PROPN
dpc-2102	119	197	9.8	9.8	NUM
dpc-2102	119	198	34	34	NUM
dpc-2102	119	199	 	 	SPACE
dpc-2102	119	200	±	±	NUM
dpc-2102	119	201	50.1	50.1	NUM
dpc-2102	119	202	17	17	NUM
dpc-2102	119	203	 	 	SPACE
dpc-2102	119	204	±	±	NUM
dpc-2102	119	205	18.2	18.2	NUM
dpc-2102	119	206	0.027a	0.027a	NOUN
dpc-2102	119	207	,	,	PUNCT
dpc-2102	119	208	<	<	X
dpc-2102	119	209	0.01	0.01	NUM
dpc-2102	119	210	b	b	PROPN
dpc-2102	119	211	mean±sd	mean±sd	ADP
dpc-2102	119	212	eop	eop	PROPN
dpc-2102	119	213	=	=	PROPN
dpc-2102	119	214	early	early	ADJ
dpc-2102	119	215	onset	onset	VERB
dpc-2102	119	216	psoriasis	psoriasis	NOUN
dpc-2102	119	217	;	;	PUNCT
dpc-2102	119	218	lop	lop	NOUN
dpc-2102	119	219	=	=	PUNCT
dpc-2102	119	220	late	late	ADJ
dpc-2102	119	221	onset	onset	NOUN
dpc-2102	119	222	psoriasis	psoriasis	NOUN
dpc-2102	119	223	;	;	PUNCT
dpc-2102	119	224	ps	ps	NOUN
dpc-2102	119	225	=	=	SYM
dpc-2102	119	226	psoriasis	psoriasis	NOUN
dpc-2102	119	227	;	;	PUNCT
dpc-2102	119	228	psa	psa	VERB
dpc-2102	119	229	=	=	SYM
dpc-2102	119	230	psoriatic	psoriatic	ADJ
dpc-2102	119	231	arthritis	arthritis	NOUN
dpc-2102	119	232	;	;	PUNCT
dpc-2102	119	233	rx	rx	VERB
dpc-2102	119	234	=	=	VERB
dpc-2102	119	235	systemic	systemic	ADJ
dpc-2102	119	236	treatment	treatment	NOUN
dpc-2102	119	237	;	;	PUNCT
dpc-2102	119	238	sd	sd	NOUN
dpc-2102	119	239	=	=	SYM
dpc-2102	119	240	standard	standard	ADJ
dpc-2102	119	241	deviation	deviation	NOUN
dpc-2102	119	242	.	.	PUNCT
dpc-2102	120	1	p	p	X
dpc-2102	120	2	a	a	PRON
dpc-2102	120	3	:	:	PUNCT
dpc-2102	120	4	patients	patient	NOUN
dpc-2102	120	5	with	with	ADP
dpc-2102	120	6	psoriasis	psoriasis	NOUN
dpc-2102	120	7	;	;	PUNCT
dpc-2102	120	8	pb	pb	ADP
dpc-2102	120	9	:	:	PUNCT
dpc-2102	120	10	between	between	ADP
dpc-2102	120	11	eop	eop	PROPN
dpc-2102	120	12	and	and	CCONJ
dpc-2102	120	13	lop	lop	NOUN
dpc-2102	120	14	to	to	PART
dpc-2102	120	15	evaluate	evaluate	VERB
dpc-2102	120	16	the	the	DET
dpc-2102	120	17	sole	sole	ADJ
dpc-2102	120	18	contribution	contribution	NOUN
dpc-2102	120	19	of	of	ADP
dpc-2102	120	20	psoriasis	psoriasis	NOUN
dpc-2102	120	21	subtype	subtype	NOUN
dpc-2102	120	22	(	(	PUNCT
dpc-2102	120	23	lop	lop	NOUN
dpc-2102	120	24	)	)	PUNCT
dpc-2102	120	25	to	to	ADP
dpc-2102	120	26	the	the	DET
dpc-2102	120	27	developmental	developmental	ADJ
dpc-2102	120	28	risk	risk	NOUN
dpc-2102	120	29	of	of	ADP
dpc-2102	120	30	certain	certain	ADJ
dpc-2102	120	31	comorbidities	comorbiditie	NOUN
dpc-2102	120	32	determined	determine	VERB
dpc-2102	120	33	as	as	ADP
dpc-2102	120	34	cvd	cvd	PROPN
dpc-2102	120	35	and	and	CCONJ
dpc-2102	120	36	dm	dm	PROPN
dpc-2102	120	37	.	.	PUNCT
dpc-2102	120	38	psoriasis	psoriasis	NOUN
dpc-2102	120	39	is	be	AUX
dpc-2102	120	40	proven	prove	VERB
dpc-2102	120	41	to	to	PART
dpc-2102	120	42	cause	cause	VERB
dpc-2102	120	43	serious	serious	ADJ
dpc-2102	120	44	systemic	systemic	ADJ
dpc-2102	120	45	inflammation	inflammation	NOUN
dpc-2102	120	46	however	however	ADV
dpc-2102	120	47	the	the	DET
dpc-2102	120	48	exact	exact	ADJ
dpc-2102	120	49	tools	tool	NOUN
dpc-2102	120	50	to	to	PART
dpc-2102	120	51	monitor	monitor	VERB
dpc-2102	120	52	the	the	DET
dpc-2102	120	53	inflammatory	inflammatory	ADJ
dpc-2102	120	54	burden	burden	NOUN
dpc-2102	120	55	is	be	AUX
dpc-2102	120	56	yet	yet	ADV
dpc-2102	120	57	to	to	PART
dpc-2102	120	58	be	be	AUX
dpc-2102	120	59	discovered	discover	VERB
dpc-2102	120	60	.	.	PUNCT
dpc-2102	121	1	reports	report	NOUN
dpc-2102	121	2	in	in	ADP
dpc-2102	121	3	literature	literature	NOUN
dpc-2102	121	4	concerning	concern	VERB
dpc-2102	121	5	the	the	DET
dpc-2102	121	6	severity	severity	NOUN
dpc-2102	121	7	of	of	ADP
dpc-2102	121	8	psoriasis	psoriasis	NOUN
dpc-2102	121	9	subtypes	subtype	NOUN
dpc-2102	121	10	comparing	compare	VERB
dpc-2102	121	11	eop	eop	PROPN
dpc-2102	121	12	and	and	CCONJ
dpc-2102	121	13	lop	lop	NOUN
dpc-2102	121	14	are	be	AUX
dpc-2102	121	15	few	few	ADJ
dpc-2102	121	16	and	and	CCONJ
dpc-2102	121	17	contradictory	contradictory	ADJ
dpc-2102	121	18	.	.	PUNCT
dpc-2102	122	1	in	in	ADP
dpc-2102	122	2	these	these	DET
dpc-2102	122	3	data	datum	NOUN
dpc-2102	122	4	,	,	PUNCT
dpc-2102	122	5	authors	author	NOUN
dpc-2102	122	6	mostly	mostly	ADV
dpc-2102	122	7	used	use	VERB
dpc-2102	122	8	pasi	pasi	NOUN
dpc-2102	122	9	score	score	NOUN
dpc-2102	122	10	,	,	PUNCT
dpc-2102	122	11	bsa	bsa	NOUN
dpc-2102	122	12	and	and	CCONJ
dpc-2102	122	13	duration	duration	NOUN
dpc-2102	122	14	of	of	ADP
dpc-2102	122	15	systemic	systemic	ADJ
dpc-2102	122	16	treatment	treatment	NOUN
dpc-2102	122	17	to	to	PART
dpc-2102	122	18	evaluate	evaluate	VERB
dpc-2102	122	19	severity	severity	NOUN
dpc-2102	122	20	of	of	ADP
dpc-2102	122	21	psoriasis	psoriasis	NOUN
dpc-2102	122	22	.	.	PUNCT
dpc-2102	123	1	although	although	SCONJ
dpc-2102	123	2	some	some	DET
dpc-2102	123	3	researches	research	NOUN
dpc-2102	123	4	did	do	AUX
dpc-2102	123	5	not	not	PART
dpc-2102	123	6	find	find	VERB
dpc-2102	123	7	significant	significant	ADJ
dpc-2102	123	8	difference	difference	NOUN
dpc-2102	123	9	in	in	ADP
dpc-2102	123	10	the	the	DET
dpc-2102	123	11	severity	severity	NOUN
dpc-2102	123	12	of	of	ADP
dpc-2102	123	13	psoriasis	psoriasis	NOUN
dpc-2102	123	14	between	between	ADP
dpc-2102	123	15	eop	eop	PROPN
dpc-2102	123	16	and	and	CCONJ
dpc-2102	123	17	lop	lop	PROPN
dpc-2102	123	18	,	,	PUNCT
dpc-2102	123	19	others	other	NOUN
dpc-2102	123	20	found	find	VERB
dpc-2102	123	21	eop	eop	PROPN
dpc-2102	123	22	to	to	PART
dpc-2102	123	23	be	be	AUX
dpc-2102	123	24	more	more	ADV
dpc-2102	123	25	severe	severe	ADJ
dpc-2102	123	26	than	than	ADP
dpc-2102	123	27	lop	lop	NOUN
dpc-2102	123	28	[	[	X
dpc-2102	123	29	1,3,4,7,17	1,3,4,7,17	NOUN
dpc-2102	123	30	]	]	PUNCT
dpc-2102	123	31	.	.	PUNCT
dpc-2102	124	1	in	in	ADP
dpc-2102	124	2	this	this	DET
dpc-2102	124	3	study	study	NOUN
dpc-2102	124	4	,	,	PUNCT
dpc-2102	124	5	evaluation	evaluation	NOUN
dpc-2102	124	6	of	of	ADP
dpc-2102	124	7	psoriatic	psoriatic	ADJ
dpc-2102	124	8	inflammation	inflammation	NOUN
dpc-2102	124	9	was	be	AUX
dpc-2102	124	10	assessed	assess	VERB
dpc-2102	124	11	by	by	ADP
dpc-2102	124	12	severity	severity	NOUN
dpc-2102	124	13	parameters	parameter	NOUN
dpc-2102	124	14	along	along	ADP
dpc-2102	124	15	with	with	ADP
dpc-2102	124	16	calculations	calculation	NOUN
dpc-2102	124	17	made	make	VERB
dpc-2102	124	18	for	for	ADP
dpc-2102	124	19	active	active	ADJ
dpc-2102	124	20	disease	disease	NOUN
dpc-2102	124	21	duration	duration	NOUN
dpc-2102	124	22	and	and	CCONJ
dpc-2102	124	23	duration	duration	NOUN
dpc-2102	124	24	of	of	ADP
dpc-2102	124	25	time	time	NOUN
dpc-2102	124	26	between	between	ADP
dpc-2102	124	27	onset	onset	NOUN
dpc-2102	124	28	of	of	ADP
dpc-2102	124	29	psoriasis	psoriasis	NOUN
dpc-2102	124	30	and	and	CCONJ
dpc-2102	124	31	concurrent	concurrent	ADJ
dpc-2102	124	32	inflammatory	inflammatory	ADJ
dpc-2102	124	33	comorbidities	comorbiditie	NOUN
dpc-2102	124	34	.	.	PUNCT
dpc-2102	125	1	although	although	SCONJ
dpc-2102	125	2	traditional	traditional	ADJ
dpc-2102	125	3	markers	marker	NOUN
dpc-2102	125	4	of	of	ADP
dpc-2102	125	5	psoriasis	psoriasis	NOUN
dpc-2102	125	6	severity	severity	NOUN
dpc-2102	125	7	such	such	ADJ
dpc-2102	125	8	as	as	ADP
dpc-2102	125	9	pasi	pasi	NOUN
dpc-2102	125	10	scores	score	NOUN
dpc-2102	125	11	and	and	CCONJ
dpc-2102	125	12	bsa	bsa	PROPN
dpc-2102	125	13	did	do	AUX
dpc-2102	125	14	not	not	PART
dpc-2102	125	15	show	show	VERB
dpc-2102	125	16	any	any	DET
dpc-2102	125	17	difference	difference	NOUN
dpc-2102	125	18	between	between	ADP
dpc-2102	125	19	eop	eop	PROPN
dpc-2102	125	20	and	and	CCONJ
dpc-2102	125	21	lop	lop	PROPN
dpc-2102	125	22	,	,	PUNCT
dpc-2102	125	23	we	we	PRON
dpc-2102	125	24	found	find	VERB
dpc-2102	125	25	that	that	SCONJ
dpc-2102	125	26	lop	lop	PROPN
dpc-2102	125	27	was	be	AUX
dpc-2102	125	28	associated	associate	VERB
dpc-2102	125	29	with	with	ADP
dpc-2102	125	30	rapid	rapid	ADJ
dpc-2102	125	31	development	development	NOUN
dpc-2102	125	32	of	of	ADP
dpc-2102	125	33	psoriatic	psoriatic	ADJ
dpc-2102	125	34	nail	nail	NOUN
dpc-2102	125	35	involvement	involvement	NOUN
dpc-2102	125	36	and	and	CCONJ
dpc-2102	125	37	psa	psa	VERB
dpc-2102	125	38	in	in	ADP
dpc-2102	125	39	statistically	statistically	ADV
dpc-2102	125	40	significantly	significantly	ADV
dpc-2102	125	41	shorter	short	ADJ
dpc-2102	125	42	periods	period	NOUN
dpc-2102	125	43	of	of	ADP
dpc-2102	125	44	time	time	NOUN
dpc-2102	125	45	despite	despite	SCONJ
dpc-2102	125	46	shorter	short	ADJ
dpc-2102	125	47	active	active	ADJ
dpc-2102	125	48	disease	disease	NOUN
dpc-2102	125	49	durations	duration	NOUN
dpc-2102	125	50	with	with	ADP
dpc-2102	125	51	and	and	CCONJ
dpc-2102	125	52	without	without	ADP
dpc-2102	125	53	treatment	treatment	NOUN
dpc-2102	125	54	.	.	PUNCT
dpc-2102	126	1	lop	lop	PROPN
dpc-2102	126	2	was	be	AUX
dpc-2102	126	3	also	also	ADV
dpc-2102	126	4	found	find	VERB
dpc-2102	126	5	to	to	PART
dpc-2102	126	6	associate	associate	VERB
dpc-2102	126	7	with	with	ADP
dpc-2102	126	8	higher	high	ADJ
dpc-2102	126	9	levels	level	NOUN
dpc-2102	126	10	of	of	ADP
dpc-2102	126	11	inflammatory	inflammatory	ADJ
dpc-2102	126	12	serum	serum	NOUN
dpc-2102	126	13	markers	marker	NOUN
dpc-2102	126	14	like	like	ADP
dpc-2102	126	15	crp	crp	PROPN
dpc-2102	126	16	,	,	PUNCT
dpc-2102	126	17	esr	esr	PROPN
dpc-2102	126	18	and	and	CCONJ
dpc-2102	126	19	rdw	rdw	PROPN
dpc-2102	126	20	.	.	PUNCT
dpc-2102	127	1	as	as	ADP
dpc-2102	127	2	a	a	DET
dpc-2102	127	3	whole	whole	NOUN
dpc-2102	127	4	,	,	PUNCT
dpc-2102	127	5	our	our	PRON
dpc-2102	127	6	results	result	NOUN
dpc-2102	127	7	strongly	strongly	ADV
dpc-2102	127	8	support	support	VERB
dpc-2102	127	9	that	that	SCONJ
dpc-2102	127	10	lop	lop	NOUN
dpc-2102	127	11	poses	pose	VERB
dpc-2102	127	12	heavier	heavier	ADV
dpc-2102	127	13	and	and	CCONJ
dpc-2102	127	14	rapid	rapid	ADJ
dpc-2102	127	15	inflammatory	inflammatory	ADJ
dpc-2102	127	16	burden	burden	NOUN
dpc-2102	127	17	.	.	PUNCT
dpc-2102	128	1	accordingly	accordingly	ADV
dpc-2102	128	2	,	,	PUNCT
dpc-2102	128	3	we	we	PRON
dpc-2102	128	4	prioritize	prioritize	VERB
dpc-2102	128	5	the	the	DET
dpc-2102	128	6	determination	determination	NOUN
dpc-2102	128	7	of	of	ADP
dpc-2102	128	8	the	the	DET
dpc-2102	128	9	disease	disease	NOUN
dpc-2102	128	10	subtype	subtype	NOUN
dpc-2102	128	11	as	as	ADP
dpc-2102	128	12	eop	eop	PROPN
dpc-2102	128	13	or	or	CCONJ
dpc-2102	128	14	lop	lop	PROPN
dpc-2102	128	15	and	and	CCONJ
dpc-2102	128	16	suggest	suggest	VERB
dpc-2102	128	17	exploring	explore	VERB
dpc-2102	128	18	the	the	DET
dpc-2102	128	19	duration	duration	NOUN
dpc-2102	128	20	of	of	ADP
dpc-2102	128	21	time	time	NOUN
dpc-2102	128	22	between	between	ADP
dpc-2102	128	23	original	original	ADJ
dpc-2102	128	24	article	article	NOUN
dpc-2102	128	25	|	|	ADV
dpc-2102	128	26	dermatol	dermatol	ADJ
dpc-2102	128	27	pract	pract	NOUN
dpc-2102	128	28	concept	concept	NOUN
dpc-2102	128	29	.	.	PUNCT
dpc-2102	129	1	2022;12(3):e2022144	2022;12(3):e2022144	NUM
dpc-2102	129	2	7	7	NUM
dpc-2102	129	3	table	table	NOUN
dpc-2102	129	4	7	7	NUM
dpc-2102	129	5	.	.	PUNCT
dpc-2102	129	6	prevalence	prevalence	NOUN
dpc-2102	129	7	and	and	CCONJ
dpc-2102	129	8	age	age	NOUN
dpc-2102	129	9	at	at	ADP
dpc-2102	129	10	onset	onset	NOUN
dpc-2102	129	11	of	of	ADP
dpc-2102	129	12	psoriatic	psoriatic	ADJ
dpc-2102	129	13	comorbidities	comorbiditie	NOUN
dpc-2102	129	14	in	in	ADP
dpc-2102	129	15	eop	eop	PROPN
dpc-2102	129	16	and	and	CCONJ
dpc-2102	129	17	lop	lop	PROPN
dpc-2102	129	18	variables	variable	NOUN
dpc-2102	129	19	total	total	ADJ
dpc-2102	129	20	patients	patient	NOUN
dpc-2102	129	21	(	(	PUNCT
dpc-2102	129	22	n	n	NOUN
dpc-2102	129	23	=	=	SYM
dpc-2102	129	24	160	160	NUM
dpc-2102	129	25	)	)	PUNCT
dpc-2102	129	26	eop	eop	PROPN
dpc-2102	129	27	(	(	PUNCT
dpc-2102	129	28	n	n	NOUN
dpc-2102	129	29	=	=	SYM
dpc-2102	129	30	121	121	NUM
dpc-2102	129	31	)	)	PUNCT
dpc-2102	129	32	lop	lop	NOUN
dpc-2102	129	33	(	(	PUNCT
dpc-2102	129	34	n	n	NOUN
dpc-2102	129	35	=	=	SYM
dpc-2102	129	36	39	39	NUM
dpc-2102	129	37	)	)	PUNCT
dpc-2102	129	38	p	p	PROPN
dpc-2102	129	39	cvd	cvd	PROPN
dpc-2102	129	40	,	,	PUNCT
dpc-2102	129	41	n	n	PROPN
dpc-2102	129	42	(	(	PUNCT
dpc-2102	129	43	%	%	INTJ
dpc-2102	129	44	)	)	PUNCT
dpc-2102	129	45	4	4	NUM
dpc-2102	129	46	(	(	PUNCT
dpc-2102	129	47	2.5	2.5	NUM
dpc-2102	129	48	)	)	SYM
dpc-2102	129	49	1	1	NUM
dpc-2102	129	50	(	(	PUNCT
dpc-2102	129	51	0.8	0.8	NUM
dpc-2102	129	52	)	)	PUNCT
dpc-2102	129	53	3	3	NUM
dpc-2102	129	54	(	(	PUNCT
dpc-2102	129	55	7.7	7.7	NUM
dpc-2102	129	56	)	)	PUNCT
dpc-2102	129	57	0.045	0.045	NUM
dpc-2102	129	58	age	age	NOUN
dpc-2102	129	59	at	at	ADP
dpc-2102	129	60	cvd	cvd	PROPN
dpc-2102	129	61	onset	onset	PROPN
dpc-2102	129	62	,	,	PUNCT
dpc-2102	129	63	years	year	NOUN
dpc-2102	129	64	50.75	50.75	NUM
dpc-2102	129	65	±	±	NUM
dpc-2102	129	66	2.36	2.36	NUM
dpc-2102	129	67	51	51	NUM
dpc-2102	129	68	50.67	50.67	NUM
dpc-2102	129	69	±	±	NUM
dpc-2102	129	70	1.67	1.67	NUM
dpc-2102	129	71	0.929	0.929	NUM
dpc-2102	129	72	mean±sd	mean±sd	PROPN
dpc-2102	129	73	(	(	PUNCT
dpc-2102	129	74	range	range	NOUN
dpc-2102	129	75	)	)	PUNCT
dpc-2102	129	76	(	(	PUNCT
dpc-2102	129	77	49	49	NUM
dpc-2102	129	78	-	-	SYM
dpc-2102	129	79	54	54	NUM
dpc-2102	129	80	)	)	PUNCT
dpc-2102	129	81	51	51	NUM
dpc-2102	129	82	(	(	PUNCT
dpc-2102	129	83	49	49	NUM
dpc-2102	129	84	-54	-54	NUM
dpc-2102	129	85	)	)	PUNCT
dpc-2102	129	86	ht	ht	PROPN
dpc-2102	129	87	,	,	PUNCT
dpc-2102	129	88	n	n	PROPN
dpc-2102	129	89	(	(	PUNCT
dpc-2102	129	90	%	%	INTJ
dpc-2102	129	91	)	)	PUNCT
dpc-2102	129	92	32	32	NUM
dpc-2102	129	93	(	(	PUNCT
dpc-2102	129	94	20	20	NUM
dpc-2102	129	95	)	)	PUNCT
dpc-2102	129	96	17	17	NUM
dpc-2102	129	97	(	(	PUNCT
dpc-2102	129	98	14	14	NUM
dpc-2102	129	99	)	)	SYM
dpc-2102	129	100	15	15	NUM
dpc-2102	129	101	(	(	PUNCT
dpc-2102	129	102	38.5	38.5	NUM
dpc-2102	129	103	)	)	PUNCT
dpc-2102	129	104	0.001	0.001	NUM
dpc-2102	129	105	age	age	NOUN
dpc-2102	129	106	at	at	ADP
dpc-2102	129	107	ht	ht	PROPN
dpc-2102	129	108	onset	onset	NOUN
dpc-2102	129	109	,	,	PUNCT
dpc-2102	129	110	years	year	NOUN
dpc-2102	129	111	44.28	44.28	NUM
dpc-2102	129	112	±	±	NUM
dpc-2102	129	113	8.23	8.23	NUM
dpc-2102	129	114	41.53	41.53	NUM
dpc-2102	129	115	±	±	NUM
dpc-2102	129	116	5.37	5.37	NUM
dpc-2102	129	117	47.40	47.40	NUM
dpc-2102	129	118	±	±	NUM
dpc-2102	129	119	9.87	9.87	NUM
dpc-2102	129	120	mean±sd	mean±sd	PROPN
dpc-2102	129	121	(	(	PUNCT
dpc-2102	129	122	range	range	NOUN
dpc-2102	129	123	)	)	PUNCT
dpc-2102	129	124	(	(	PUNCT
dpc-2102	129	125	33	33	NUM
dpc-2102	129	126	-	-	SYM
dpc-2102	129	127	70	70	NUM
dpc-2102	129	128	)	)	PUNCT
dpc-2102	129	129	(	(	PUNCT
dpc-2102	129	130	33	33	NUM
dpc-2102	129	131	-	-	SYM
dpc-2102	129	132	53	53	NUM
dpc-2102	129	133	)	)	PUNCT
dpc-2102	129	134	(	(	PUNCT
dpc-2102	129	135	39	39	NUM
dpc-2102	129	136	-	-	SYM
dpc-2102	129	137	70	70	NUM
dpc-2102	129	138	)	)	PUNCT
dpc-2102	129	139	0.165	0.165	NUM
dpc-2102	129	140	dm	dm	PROPN
dpc-2102	129	141	,	,	PUNCT
dpc-2102	129	142	n	n	CCONJ
dpc-2102	129	143	(	(	PUNCT
dpc-2102	129	144	%	%	INTJ
dpc-2102	129	145	)	)	PUNCT
dpc-2102	129	146	25	25	NUM
dpc-2102	129	147	(	(	PUNCT
dpc-2102	129	148	15.6	15.6	NUM
dpc-2102	129	149	)	)	PUNCT
dpc-2102	129	150	12	12	NUM
dpc-2102	129	151	(	(	PUNCT
dpc-2102	129	152	9.9	9.9	NUM
dpc-2102	129	153	)	)	PUNCT
dpc-2102	129	154	13	13	NUM
dpc-2102	129	155	(	(	PUNCT
dpc-2102	129	156	33.3	33.3	NUM
dpc-2102	129	157	)	)	PUNCT
dpc-2102	129	158	<	<	X
dpc-2102	129	159	0.01	0.01	NUM
dpc-2102	129	160	age	age	NOUN
dpc-2102	129	161	at	at	ADP
dpc-2102	129	162	dm	dm	PROPN
dpc-2102	129	163	onset	onset	NOUN
dpc-2102	129	164	,	,	PUNCT
dpc-2102	129	165	years	year	NOUN
dpc-2102	129	166	42.68	42.68	NUM
dpc-2102	129	167	±	±	NUM
dpc-2102	129	168	9.79	9.79	NUM
dpc-2102	129	169	37.75	37.75	NUM
dpc-2102	129	170	±	±	NUM
dpc-2102	129	171	7.70	7.70	NUM
dpc-2102	129	172	47.23	47.23	NUM
dpc-2102	129	173	±	±	NUM
dpc-2102	129	174	9.53	9.53	NUM
dpc-2102	129	175	0.004	0.004	NUM
dpc-2102	129	176	mean±sd	mean±sd	PROPN
dpc-2102	129	177	(	(	PUNCT
dpc-2102	129	178	range	range	NOUN
dpc-2102	129	179	)	)	PUNCT
dpc-2102	129	180	(	(	PUNCT
dpc-2102	129	181	28	28	NUM
dpc-2102	129	182	-	-	SYM
dpc-2102	129	183	65	65	NUM
dpc-2102	129	184	)	)	PUNCT
dpc-2102	129	185	(	(	PUNCT
dpc-2102	129	186	28	28	NUM
dpc-2102	129	187	-	-	SYM
dpc-2102	129	188	57	57	NUM
dpc-2102	129	189	)	)	PUNCT
dpc-2102	129	190	(	(	PUNCT
dpc-2102	129	191	38	38	NUM
dpc-2102	129	192	-	-	SYM
dpc-2102	129	193	65	65	NUM
dpc-2102	129	194	)	)	PUNCT
dpc-2102	129	195	nash	nash	NOUN
dpc-2102	129	196	,	,	PUNCT
dpc-2102	129	197	n	n	CCONJ
dpc-2102	129	198	(	(	PUNCT
dpc-2102	129	199	%	%	INTJ
dpc-2102	129	200	)	)	PUNCT
dpc-2102	129	201	29	29	NUM
dpc-2102	129	202	(	(	PUNCT
dpc-2102	129	203	18.1	18.1	NUM
dpc-2102	129	204	)	)	SYM
dpc-2102	129	205	22	22	NUM
dpc-2102	129	206	(	(	PUNCT
dpc-2102	129	207	18.2	18.2	NUM
dpc-2102	129	208	)	)	PUNCT
dpc-2102	129	209	7	7	NUM
dpc-2102	129	210	(	(	PUNCT
dpc-2102	129	211	17.9	17.9	NUM
dpc-2102	129	212	)	)	PUNCT
dpc-2102	129	213	0.974	0.974	NUM
dpc-2102	129	214	age	age	NOUN
dpc-2102	129	215	at	at	ADP
dpc-2102	129	216	nash	nash	PROPN
dpc-2102	129	217	onset	onset	NOUN
dpc-2102	129	218	,	,	PUNCT
dpc-2102	129	219	years	year	NOUN
dpc-2102	129	220	39.21	39.21	NUM
dpc-2102	129	221	±	±	NUM
dpc-2102	129	222	8.20	8.20	NUM
dpc-2102	129	223	37.48	37.48	NUM
dpc-2102	129	224	±	±	NUM
dpc-2102	129	225	8.34	8.34	NUM
dpc-2102	129	226	44.43	44.43	NUM
dpc-2102	129	227	±	±	NUM
dpc-2102	129	228	5.38	5.38	NUM
dpc-2102	129	229	0.045	0.045	NUM
dpc-2102	129	230	mean±sd	mean±sd	PROPN
dpc-2102	129	231	(	(	PUNCT
dpc-2102	129	232	range	range	NOUN
dpc-2102	129	233	)	)	PUNCT
dpc-2102	129	234	(	(	PUNCT
dpc-2102	129	235	20	20	NUM
dpc-2102	129	236	-	-	SYM
dpc-2102	129	237	59	59	NUM
dpc-2102	129	238	)	)	PUNCT
dpc-2102	129	239	(	(	PUNCT
dpc-2102	129	240	20	20	NUM
dpc-2102	129	241	-	-	SYM
dpc-2102	129	242	59	59	NUM
dpc-2102	129	243	)	)	PUNCT
dpc-2102	129	244	(	(	PUNCT
dpc-2102	129	245	38	38	NUM
dpc-2102	129	246	-	-	SYM
dpc-2102	129	247	53	53	NUM
dpc-2102	129	248	)	)	PUNCT
dpc-2102	129	249	dlp	dlp	NOUN
dpc-2102	129	250	,	,	PUNCT
dpc-2102	129	251	n	n	CCONJ
dpc-2102	129	252	(	(	PUNCT
dpc-2102	129	253	%	%	INTJ
dpc-2102	129	254	)	)	PUNCT
dpc-2102	129	255	99	99	NUM
dpc-2102	129	256	(	(	PUNCT
dpc-2102	129	257	61.9	61.9	NUM
dpc-2102	129	258	)	)	PUNCT
dpc-2102	129	259	72	72	NUM
dpc-2102	129	260	(	(	PUNCT
dpc-2102	129	261	59.5	59.5	NUM
dpc-2102	129	262	)	)	PUNCT
dpc-2102	129	263	27	27	NUM
dpc-2102	129	264	(	(	PUNCT
dpc-2102	129	265	69.2	69.2	NUM
dpc-2102	129	266	)	)	PUNCT
dpc-2102	129	267	0.392	0.392	NUM
dpc-2102	129	268	ms	ms	PROPN
dpc-2102	129	269	,	,	PUNCT
dpc-2102	129	270	n	n	PROPN
dpc-2102	129	271	(	(	PUNCT
dpc-2102	129	272	%	%	INTJ
dpc-2102	129	273	)	)	PUNCT
dpc-2102	129	274	47	47	NUM
dpc-2102	129	275	(	(	PUNCT
dpc-2102	129	276	29.6	29.6	NUM
dpc-2102	129	277	)	)	SYM
dpc-2102	129	278	30	30	NUM
dpc-2102	129	279	(	(	PUNCT
dpc-2102	129	280	24.8	24.8	NUM
dpc-2102	129	281	)	)	PUNCT
dpc-2102	129	282	17	17	NUM
dpc-2102	129	283	(	(	PUNCT
dpc-2102	129	284	44.7	44.7	NUM
dpc-2102	129	285	)	)	PUNCT
dpc-2102	129	286	0.022	0.022	NUM
dpc-2102	129	287	ob	ob	PROPN
dpc-2102	129	288	,	,	PUNCT
dpc-2102	129	289	n	n	PROPN
dpc-2102	129	290	(	(	PUNCT
dpc-2102	129	291	%	%	INTJ
dpc-2102	129	292	)	)	PUNCT
dpc-2102	129	293	46	46	NUM
dpc-2102	129	294	(	(	PUNCT
dpc-2102	129	295	28.7	28.7	NUM
dpc-2102	129	296	)	)	PUNCT
dpc-2102	129	297	36	36	NUM
dpc-2102	129	298	(	(	PUNCT
dpc-2102	129	299	29.8	29.8	NUM
dpc-2102	129	300	)	)	PUNCT
dpc-2102	129	301	10	10	NUM
dpc-2102	129	302	(	(	PUNCT
dpc-2102	129	303	25.6	25.6	NUM
dpc-2102	129	304	)	)	PUNCT
dpc-2102	129	305	0.622	0.622	NUM
dpc-2102	129	306	cvd	cvd	NOUN
dpc-2102	129	307	=	=	PUNCT
dpc-2102	129	308	cardiovascular	cardiovascular	ADJ
dpc-2102	129	309	disease	disease	NOUN
dpc-2102	129	310	;	;	PUNCT
dpc-2102	129	311	dlp	dlp	NOUN
dpc-2102	129	312	=	=	SYM
dpc-2102	129	313	dyslipidemia	dyslipidemia	NOUN
dpc-2102	129	314	;	;	PUNCT
dpc-2102	129	315	dm	dm	PROPN
dpc-2102	129	316	=	=	PUNCT
dpc-2102	129	317	diabetes	diabete	NOUN
dpc-2102	129	318	mellitus	mellitus	NOUN
dpc-2102	129	319	;	;	PUNCT
dpc-2102	129	320	eop	eop	PROPN
dpc-2102	129	321	:	:	PUNCT
dpc-2102	129	322	early	early	ADJ
dpc-2102	129	323	onset	onset	VERB
dpc-2102	129	324	psoriasis	psoriasis	NOUN
dpc-2102	129	325	;	;	PUNCT
dpc-2102	129	326	ht	ht	PROPN
dpc-2102	129	327	=	=	PUNCT
dpc-2102	129	328	hypertension	hypertension	NOUN
dpc-2102	129	329	;	;	PUNCT
dpc-2102	129	330	lop	lop	NOUN
dpc-2102	129	331	=	=	PUNCT
dpc-2102	129	332	late	late	ADJ
dpc-2102	129	333	onset	onset	NOUN
dpc-2102	129	334	psoriasis	psoriasis	NOUN
dpc-2102	129	335	;	;	PUNCT
dpc-2102	129	336	ms	ms	PROPN
dpc-2102	129	337	=	=	PROPN
dpc-2102	129	338	metabolic	metabolic	NOUN
dpc-2102	129	339	syndrome	syndrome	NOUN
dpc-2102	129	340	;	;	PUNCT
dpc-2102	129	341	nash	nash	NOUN
dpc-2102	129	342	=	=	PUNCT
dpc-2102	129	343	non	non	ADJ
dpc-2102	129	344	-	-	ADJ
dpc-2102	129	345	alcoholic	alcoholic	ADJ
dpc-2102	129	346	steatohepatitis	steatohepatitis	NOUN
dpc-2102	129	347	;	;	PUNCT
dpc-2102	129	348	ob	ob	ADP
dpc-2102	129	349	=	=	NOUN
dpc-2102	129	350	obesity	obesity	NOUN
dpc-2102	129	351	;	;	PUNCT
dpc-2102	129	352	sd	sd	NOUN
dpc-2102	129	353	=	=	SYM
dpc-2102	129	354	standard	standard	ADJ
dpc-2102	129	355	deviation	deviation	NOUN
dpc-2102	129	356	.	.	PUNCT
dpc-2102	130	1	table	table	NOUN
dpc-2102	130	2	8	8	NUM
dpc-2102	130	3	.	.	PUNCT
dpc-2102	131	1	multivariate	multivariate	NOUN
dpc-2102	131	2	regression	regression	NOUN
dpc-2102	131	3	analysis	analysis	NOUN
dpc-2102	131	4	of	of	ADP
dpc-2102	131	5	impact	impact	NOUN
dpc-2102	131	6	of	of	ADP
dpc-2102	131	7	psoriasis	psoriasis	NOUN
dpc-2102	131	8	subtype	subtype	NOUN
dpc-2102	131	9	on	on	ADP
dpc-2102	131	10	concurrent	concurrent	ADJ
dpc-2102	131	11	systemic	systemic	ADJ
dpc-2102	131	12	inflammatory	inflammatory	ADJ
dpc-2102	131	13	comorbidities	comorbiditie	NOUN
dpc-2102	131	14	ht	ht	INTJ
dpc-2102	131	15	dm	dm	PROPN
dpc-2102	131	16	ibd	ibd	PROPN
dpc-2102	131	17	nash	nash	PROPN
dpc-2102	131	18	cvd	cvd	PROPN
dpc-2102	131	19	dlp	dlp	VERB
dpc-2102	131	20	ms	ms	PROPN
dpc-2102	131	21	ob	ob	ADP
dpc-2102	131	22	rx	rx	VERB
dpc-2102	131	23	duration	duration	NOUN
dpc-2102	131	24	disease	disease	NOUN
dpc-2102	131	25	duration	duration	NOUN
dpc-2102	131	26	ht	ht	PROPN
dpc-2102	131	27	0.158	0.158	NUM
dpc-2102	131	28	-0.249	-0.249	PUNCT
dpc-2102	131	29	0.225	0.225	NUM
dpc-2102	131	30	0.177	0.177	NUM
dpc-2102	131	31	dm	dm	NUM
dpc-2102	131	32	0.167	0.167	NUM
dpc-2102	131	33	0.235	0.235	NUM
dpc-2102	131	34	ibd	ibd	NOUN
dpc-2102	131	35	0.217	0.217	NUM
dpc-2102	131	36	nash	nash	NOUN
dpc-2102	131	37	0.219	0.219	NUM
dpc-2102	131	38	0.249	0.249	NUM
dpc-2102	131	39	cvd	cvd	PROPN
dpc-2102	131	40	dlp	dlp	VERB
dpc-2102	131	41	-0.231	-0.231	NUM
dpc-2102	131	42	0.557	0.557	NUM
dpc-2102	131	43	-0.194	-0.194	NOUN
dpc-2102	131	44	ms	ms	NOUN
dpc-2102	131	45	0.402	0.402	NUM
dpc-2102	131	46	0.309	0.309	NUM
dpc-2102	131	47	0.632	0.632	NUM
dpc-2102	131	48	ob	ob	SYM
dpc-2102	131	49	0.220	0.220	NUM
dpc-2102	131	50	pasi	pasi	X
dpc-2102	131	51	bsa	bsa	PROPN
dpc-2102	131	52	ps	ps	PROPN
dpc-2102	131	53	subtype	subtype	VERB
dpc-2102	131	54	0.168	0.168	NUM
dpc-2102	131	55	0.248	0.248	NUM
dpc-2102	131	56	-0.747	-0.747	PUNCT
dpc-2102	131	57	gender	gender	NOUN
dpc-2102	131	58	-0.265	-0.265	X
dpc-2102	131	59	-0.163	-0.163	NOUN
dpc-2102	131	60	0.182	0.182	NOUN
dpc-2102	131	61	0.101	0.101	NUM
dpc-2102	131	62	duration	duration	NOUN
dpc-2102	131	63	of	of	ADP
dpc-2102	131	64	rx	rx	VERB
dpc-2102	131	65	0.236	0.236	NUM
dpc-2102	131	66	0.250	0.250	NUM
dpc-2102	131	67	age	age	NOUN
dpc-2102	131	68	0.403	0.403	NUM
dpc-2102	131	69	0.224	0.224	NUM
dpc-2102	131	70	 	 	SPACE
dpc-2102	131	71	1.009	1.009	NUM
dpc-2102	131	72	0.663	0.663	NUM
dpc-2102	131	73	disease	disease	NOUN
dpc-2102	131	74	duration	duration	NOUN
dpc-2102	131	75	 	 	SPACE
dpc-2102	131	76	-0.516	-0.516	VERB
dpc-2102	131	77	duration	duration	NOUN
dpc-2102	131	78	of	of	ADP
dpc-2102	131	79	active	active	ADJ
dpc-2102	131	80	disease	disease	NOUN
dpc-2102	131	81	without	without	ADP
dpc-2102	131	82	rx	rx	PROPN
dpc-2102	131	83	.	.	PUNCT
dpc-2102	131	84	 	 	SPACE
dpc-2102	131	85	0.156	0.156	NUM
dpc-2102	131	86	duration	duration	NOUN
dpc-2102	131	87	of	of	ADP
dpc-2102	131	88	active	active	ADJ
dpc-2102	131	89	disease	disease	NOUN
dpc-2102	131	90	with	with	ADP
dpc-2102	131	91	rx	rx	VERB
dpc-2102	131	92	0.123	0.123	NUM
dpc-2102	131	93	0.188	0.188	NUM
dpc-2102	131	94	smoking	smoking	NOUN
dpc-2102	131	95	r2	r2	NOUN
dpc-2102	131	96	value	value	NOUN
dpc-2102	131	97	0.288	0.288	NUM
dpc-2102	131	98	0.237	0.237	NUM
dpc-2102	131	99	0.056	0.056	NUM
dpc-2102	131	100	0.200	0.200	NUM
dpc-2102	131	101	0.133	0.133	NUM
dpc-2102	131	102	0.451	0.451	NUM
dpc-2102	131	103	0.538	0.538	NUM
dpc-2102	131	104	0.115	0.115	NUM
dpc-2102	131	105	0.325	0.325	NUM
dpc-2102	131	106	0.620	0.620	NUM
dpc-2102	131	107	p	p	NOUN
dpc-2102	131	108	value	value	NOUN
dpc-2102	131	109	0.000	0.000	NUM
dpc-2102	131	110	0.000	0.000	NUM
dpc-2102	131	111	0.003	0.003	NUM
dpc-2102	131	112	0.000	0.000	NUM
dpc-2102	131	113	0.000	0.000	NUM
dpc-2102	131	114	0.000	0.000	NUM
dpc-2102	131	115	0.000	0.000	NUM
dpc-2102	131	116	0.000	0.000	NUM
dpc-2102	131	117	0.000	0.000	NUM
dpc-2102	131	118	0.000	0.000	NUM
dpc-2102	131	119	bsa	bsa	PROPN
dpc-2102	131	120	=	=	PROPN
dpc-2102	131	121	body	body	PROPN
dpc-2102	131	122	surface	surface	NOUN
dpc-2102	131	123	area	area	NOUN
dpc-2102	131	124	;	;	PUNCT
dpc-2102	131	125	cvd	cvd	PROPN
dpc-2102	131	126	=	=	PROPN
dpc-2102	131	127	cardiovascular	cardiovascular	ADJ
dpc-2102	131	128	disease	disease	NOUN
dpc-2102	131	129	;	;	PUNCT
dpc-2102	131	130	dlp	dlp	NOUN
dpc-2102	131	131	=	=	SYM
dpc-2102	131	132	dyslipidemia	dyslipidemia	NOUN
dpc-2102	131	133	;	;	PUNCT
dpc-2102	131	134	dm	dm	PROPN
dpc-2102	131	135	=	=	PUNCT
dpc-2102	131	136	diabetes	diabete	NOUN
dpc-2102	131	137	mellitus	mellitus	NOUN
dpc-2102	131	138	;	;	PUNCT
dpc-2102	131	139	ht	ht	PROPN
dpc-2102	131	140	=	=	PUNCT
dpc-2102	131	141	hypertension	hypertension	NOUN
dpc-2102	131	142	;	;	PUNCT
dpc-2102	131	143	ibd	ibd	NOUN
dpc-2102	131	144	=	=	SYM
dpc-2102	131	145	inflammatory	inflammatory	ADJ
dpc-2102	131	146	bowel	bowel	NOUN
dpc-2102	131	147	disease	disease	NOUN
dpc-2102	131	148	;	;	PUNCT
dpc-2102	131	149	ms	ms	PROPN
dpc-2102	131	150	=	=	PROPN
dpc-2102	131	151	metabolic	metabolic	NOUN
dpc-2102	131	152	syndrome	syndrome	NOUN
dpc-2102	131	153	;	;	PUNCT
dpc-2102	131	154	nash	nash	PROPN
dpc-2102	131	155	=	=	PUNCT
dpc-2102	131	156	nonalcoholic	nonalcoholic	PROPN
dpc-2102	131	157	steatohepatitis	steatohepatitis	NOUN
dpc-2102	131	158	;	;	PUNCT
dpc-2102	131	159	ob	ob	ADP
dpc-2102	131	160	=	=	NOUN
dpc-2102	131	161	obesity	obesity	NOUN
dpc-2102	131	162	;	;	PUNCT
dpc-2102	131	163	pasi	pasi	NOUN
dpc-2102	131	164	=	=	SYM
dpc-2102	131	165	psoriasis	psoriasis	NOUN
dpc-2102	131	166	area	area	NOUN
dpc-2102	131	167	and	and	CCONJ
dpc-2102	131	168	severity	severity	NOUN
dpc-2102	131	169	index	index	NOUN
dpc-2102	131	170	;	;	PUNCT
dpc-2102	131	171	ps	ps	NOUN
dpc-2102	131	172	=	=	SYM
dpc-2102	131	173	psoriasis	psoriasis	NOUN
dpc-2102	131	174	;	;	PUNCT
dpc-2102	131	175	rx	rx	VERB
dpc-2102	131	176	=	=	PUNCT
dpc-2102	131	177	systemic	systemic	ADJ
dpc-2102	131	178	treatment	treatment	NOUN
dpc-2102	131	179	.	.	PUNCT
dpc-2102	132	1	8	8	NUM
dpc-2102	132	2	original	original	ADJ
dpc-2102	132	3	article	article	NOUN
dpc-2102	132	4	|	|	ADV
dpc-2102	132	5	dermatol	dermatol	ADJ
dpc-2102	132	6	pract	pract	NOUN
dpc-2102	132	7	concept	concept	NOUN
dpc-2102	132	8	.	.	PUNCT
dpc-2102	133	1	2022;12(3):e2022144	2022;12(3):e2022144	NUM
dpc-2102	133	2	onset	onset	NOUN
dpc-2102	133	3	of	of	ADP
dpc-2102	133	4	psoriatic	psoriatic	ADJ
dpc-2102	133	5	involvements	involvement	NOUN
dpc-2102	133	6	and	and	CCONJ
dpc-2102	133	7	comorbidities	comorbiditie	NOUN
dpc-2102	133	8	(	(	PUNCT
dpc-2102	133	9	psoriatic	psoriatic	ADJ
dpc-2102	133	10	nail	nail	NOUN
dpc-2102	133	11	,	,	PUNCT
dpc-2102	133	12	psa	psa	NOUN
dpc-2102	133	13	,	,	PUNCT
dpc-2102	133	14	cvd	cvd	PROPN
dpc-2102	133	15	,	,	PUNCT
dpc-2102	133	16	dm	dm	PROPN
dpc-2102	133	17	,	,	PUNCT
dpc-2102	133	18	ht	ht	PROPN
dpc-2102	133	19	,	,	PUNCT
dpc-2102	133	20	ms	ms	PROPN
dpc-2102	133	21	)	)	PUNCT
dpc-2102	133	22	and	and	CCONJ
dpc-2102	133	23	active	active	ADJ
dpc-2102	133	24	disease	disease	NOUN
dpc-2102	133	25	duration	duration	NOUN
dpc-2102	133	26	for	for	ADP
dpc-2102	133	27	evaluating	evaluate	VERB
dpc-2102	133	28	inflammation	inflammation	NOUN
dpc-2102	133	29	and	and	CCONJ
dpc-2102	133	30	its	its	PRON
dpc-2102	133	31	consequences	consequence	NOUN
dpc-2102	133	32	in	in	ADP
dpc-2102	133	33	psoriasis	psoriasis	NOUN
dpc-2102	133	34	.	.	PUNCT
dpc-2102	134	1	we	we	PRON
dpc-2102	134	2	believe	believe	VERB
dpc-2102	134	3	that	that	SCONJ
dpc-2102	134	4	the	the	DET
dpc-2102	134	5	alltogether	alltogether	ADJ
dpc-2102	134	6	analysis	analysis	NOUN
dpc-2102	134	7	of	of	ADP
dpc-2102	134	8	these	these	DET
dpc-2102	134	9	parameters	parameter	NOUN
dpc-2102	134	10	with	with	ADP
dpc-2102	134	11	the	the	DET
dpc-2102	134	12	traditional	traditional	ADJ
dpc-2102	134	13	clinical	clinical	ADJ
dpc-2102	134	14	severity	severity	NOUN
dpc-2102	134	15	scores	score	NOUN
dpc-2102	134	16	may	may	AUX
dpc-2102	134	17	create	create	VERB
dpc-2102	134	18	a	a	DET
dpc-2102	134	19	new	new	ADJ
dpc-2102	134	20	concept	concept	NOUN
dpc-2102	134	21	of	of	ADP
dpc-2102	134	22	approach	approach	NOUN
dpc-2102	134	23	for	for	ADP
dpc-2102	134	24	psoriasis	psoriasis	NOUN
dpc-2102	134	25	follow	follow	NOUN
dpc-2102	134	26	-	-	PUNCT
dpc-2102	134	27	up	up	NOUN
dpc-2102	134	28	.	.	PUNCT
dpc-2102	135	1	nail	nail	NOUN
dpc-2102	135	2	involvement	involvement	NOUN
dpc-2102	135	3	is	be	AUX
dpc-2102	135	4	observed	observe	VERB
dpc-2102	135	5	in	in	ADP
dpc-2102	135	6	13%-50	13%-50	NUM
dpc-2102	135	7	%	%	NOUN
dpc-2102	135	8	of	of	ADP
dpc-2102	135	9	psoriasis	psoriasis	NOUN
dpc-2102	135	10	patients	patient	NOUN
dpc-2102	135	11	and	and	CCONJ
dpc-2102	135	12	this	this	DET
dpc-2102	135	13	rate	rate	NOUN
dpc-2102	135	14	increases	increase	VERB
dpc-2102	135	15	to	to	ADP
dpc-2102	135	16	80%-90	80%-90	NUM
dpc-2102	135	17	%	%	NOUN
dpc-2102	135	18	by	by	ADP
dpc-2102	135	19	age	age	NOUN
dpc-2102	136	1	[	[	X
dpc-2102	136	2	18	18	NUM
dpc-2102	136	3	]	]	PUNCT
dpc-2102	136	4	.	.	PUNCT
dpc-2102	137	1	reports	report	NOUN
dpc-2102	137	2	on	on	ADP
dpc-2102	137	3	nail	nail	NOUN
dpc-2102	137	4	involvement	involvement	NOUN
dpc-2102	137	5	in	in	ADP
dpc-2102	137	6	eop	eop	PROPN
dpc-2102	137	7	and	and	CCONJ
dpc-2102	137	8	lop	lop	PROPN
dpc-2102	137	9	differ	differ	VERB
dpc-2102	137	10	;	;	PUNCT
dpc-2102	137	11	some	some	PRON
dpc-2102	137	12	report	report	VERB
dpc-2102	137	13	more	more	ADV
dpc-2102	137	14	frequent	frequent	ADJ
dpc-2102	137	15	nail	nail	NOUN
dpc-2102	137	16	involvement	involvement	NOUN
dpc-2102	137	17	in	in	ADP
dpc-2102	137	18	eop	eop	PROPN
dpc-2102	137	19	,	,	PUNCT
dpc-2102	137	20	others	other	NOUN
dpc-2102	137	21	found	find	VERB
dpc-2102	137	22	that	that	SCONJ
dpc-2102	137	23	lop	lop	NOUN
dpc-2102	137	24	more	more	ADV
dpc-2102	137	25	frequently	frequently	ADV
dpc-2102	137	26	affect	affect	VERB
dpc-2102	137	27	nails	nail	NOUN
dpc-2102	138	1	[	[	X
dpc-2102	138	2	3,5,10,17	3,5,10,17	NOUN
dpc-2102	138	3	]	]	PUNCT
dpc-2102	138	4	.	.	PUNCT
dpc-2102	139	1	there	there	PRON
dpc-2102	139	2	are	be	VERB
dpc-2102	139	3	also	also	ADV
dpc-2102	139	4	studies	study	NOUN
dpc-2102	139	5	showing	show	VERB
dpc-2102	139	6	no	no	DET
dpc-2102	139	7	difference	difference	NOUN
dpc-2102	139	8	in	in	ADP
dpc-2102	139	9	nail	nail	NOUN
dpc-2102	139	10	involvement	involvement	NOUN
dpc-2102	139	11	between	between	ADP
dpc-2102	139	12	eop	eop	PROPN
dpc-2102	139	13	and	and	CCONJ
dpc-2102	139	14	lop	lop	NOUN
dpc-2102	140	1	[	[	X
dpc-2102	140	2	1,4,7	1,4,7	NUM
dpc-2102	140	3	]	]	PUNCT
dpc-2102	140	4	.	.	PUNCT
dpc-2102	141	1	we	we	PRON
dpc-2102	141	2	did	do	AUX
dpc-2102	141	3	not	not	PART
dpc-2102	141	4	observe	observe	VERB
dpc-2102	141	5	statistically	statistically	ADV
dpc-2102	141	6	significant	significant	ADJ
dpc-2102	141	7	difference	difference	NOUN
dpc-2102	141	8	in	in	ADP
dpc-2102	141	9	both	both	DET
dpc-2102	141	10	nail	nail	NOUN
dpc-2102	141	11	involvement	involvement	NOUN
dpc-2102	141	12	and	and	CCONJ
dpc-2102	141	13	type	type	NOUN
dpc-2102	141	14	of	of	ADP
dpc-2102	141	15	nail	nail	NOUN
dpc-2102	141	16	involvement	involvement	NOUN
dpc-2102	141	17	,	,	PUNCT
dpc-2102	141	18	neither	neither	ADV
dpc-2102	141	19	.	.	PUNCT
dpc-2102	142	1	but	but	CCONJ
dpc-2102	142	2	interestingly	interestingly	ADV
dpc-2102	142	3	,	,	PUNCT
dpc-2102	142	4	nails	nail	NOUN
dpc-2102	142	5	were	be	AUX
dpc-2102	142	6	found	find	VERB
dpc-2102	142	7	to	to	PART
dpc-2102	142	8	be	be	AUX
dpc-2102	142	9	affected	affect	VERB
dpc-2102	142	10	in	in	ADP
dpc-2102	142	11	significantly	significantly	ADV
dpc-2102	142	12	shorter	short	ADJ
dpc-2102	142	13	duration	duration	NOUN
dpc-2102	142	14	in	in	ADP
dpc-2102	142	15	lop	lop	NOUN
dpc-2102	142	16	in	in	ADP
dpc-2102	142	17	comparison	comparison	NOUN
dpc-2102	142	18	with	with	ADP
dpc-2102	142	19	eop	eop	PROPN
dpc-2102	142	20	.	.	PROPN
dpc-2102	142	21	similar	similar	ADJ
dpc-2102	142	22	to	to	ADP
dpc-2102	142	23	the	the	DET
dpc-2102	142	24	findings	finding	NOUN
dpc-2102	142	25	observed	observe	VERB
dpc-2102	142	26	in	in	ADP
dpc-2102	142	27	psoriatic	psoriatic	ADJ
dpc-2102	142	28	nail	nail	NOUN
dpc-2102	142	29	involvement	involvement	NOUN
dpc-2102	142	30	,	,	PUNCT
dpc-2102	142	31	psa	psa	PROPN
dpc-2102	142	32	was	be	AUX
dpc-2102	142	33	found	find	VERB
dpc-2102	142	34	to	to	PART
dpc-2102	142	35	develop	develop	VERB
dpc-2102	142	36	in	in	ADP
dpc-2102	142	37	significant	significant	ADJ
dpc-2102	142	38	shorter	short	ADJ
dpc-2102	142	39	periods	period	NOUN
dpc-2102	142	40	of	of	ADP
dpc-2102	142	41	time	time	NOUN
dpc-2102	142	42	in	in	ADP
dpc-2102	142	43	eop	eop	PROPN
dpc-2102	142	44	.	.	PUNCT
dpc-2102	143	1	generally	generally	ADV
dpc-2102	143	2	,	,	PUNCT
dpc-2102	143	3	psa	psa	VERB
dpc-2102	143	4	is	be	AUX
dpc-2102	143	5	observed	observe	VERB
dpc-2102	143	6	in	in	ADP
dpc-2102	143	7	5	5	NUM
dpc-2102	143	8	-	-	SYM
dpc-2102	143	9	30	30	NUM
dpc-2102	143	10	%	%	NOUN
dpc-2102	143	11	of	of	ADP
dpc-2102	143	12	patients	patient	NOUN
dpc-2102	143	13	with	with	ADP
dpc-2102	143	14	psoriasis	psoriasis	NOUN
dpc-2102	143	15	[	[	X
dpc-2102	143	16	19	19	NUM
dpc-2102	143	17	]	]	PUNCT
dpc-2102	143	18	.	.	PUNCT
dpc-2102	144	1	most	most	ADJ
dpc-2102	144	2	researches	research	NOUN
dpc-2102	144	3	did	do	AUX
dpc-2102	144	4	not	not	PART
dpc-2102	144	5	find	find	VERB
dpc-2102	144	6	difference	difference	NOUN
dpc-2102	144	7	in	in	ADP
dpc-2102	144	8	concurrent	concurrent	ADJ
dpc-2102	144	9	psa	psa	NOUN
dpc-2102	144	10	between	between	ADP
dpc-2102	144	11	eop	eop	PROPN
dpc-2102	144	12	and	and	CCONJ
dpc-2102	144	13	lop	lop	NOUN
dpc-2102	145	1	[	[	X
dpc-2102	145	2	3,4,7	3,4,7	NUM
dpc-2102	145	3	]	]	PUNCT
dpc-2102	145	4	.	.	PUNCT
dpc-2102	146	1	heredi	heredi	PROPN
dpc-2102	146	2	et	et	PROPN
dpc-2102	146	3	al	al	PROPN
dpc-2102	146	4	have	have	AUX
dpc-2102	146	5	demonstrated	demonstrate	VERB
dpc-2102	146	6	that	that	SCONJ
dpc-2102	146	7	the	the	DET
dpc-2102	146	8	psa	psa	NOUN
dpc-2102	146	9	was	be	AUX
dpc-2102	146	10	more	more	ADV
dpc-2102	146	11	frequent	frequent	ADJ
dpc-2102	146	12	in	in	ADP
dpc-2102	146	13	eop	eop	PROPN
dpc-2102	146	14	and	and	CCONJ
dpc-2102	146	15	risk	risk	NOUN
dpc-2102	146	16	of	of	ADP
dpc-2102	146	17	development	development	NOUN
dpc-2102	146	18	of	of	ADP
dpc-2102	146	19	psa	psa	NOUN
dpc-2102	146	20	decreases	decrease	NOUN
dpc-2102	146	21	by	by	ADP
dpc-2102	146	22	increasing	increase	VERB
dpc-2102	146	23	age	age	NOUN
dpc-2102	146	24	and	and	CCONJ
dpc-2102	146	25	this	this	DET
dpc-2102	146	26	risk	risk	NOUN
dpc-2102	146	27	completely	completely	ADV
dpc-2102	146	28	disappears	disappear	VERB
dpc-2102	146	29	after	after	ADP
dpc-2102	146	30	age	age	NOUN
dpc-2102	146	31	75	75	NUM
dpc-2102	147	1	[	[	X
dpc-2102	147	2	1	1	NUM
dpc-2102	147	3	]	]	PUNCT
dpc-2102	147	4	.	.	PUNCT
dpc-2102	148	1	in	in	ADP
dpc-2102	148	2	this	this	DET
dpc-2102	148	3	study	study	NOUN
dpc-2102	148	4	,	,	PUNCT
dpc-2102	148	5	there	there	PRON
dpc-2102	148	6	was	be	VERB
dpc-2102	148	7	no	no	DET
dpc-2102	148	8	difference	difference	NOUN
dpc-2102	148	9	between	between	ADP
dpc-2102	148	10	eop	eop	PROPN
dpc-2102	148	11	and	and	CCONJ
dpc-2102	148	12	lop	lop	VERB
dpc-2102	148	13	for	for	ADP
dpc-2102	148	14	associating	associate	VERB
dpc-2102	148	15	psa	psa	NOUN
dpc-2102	148	16	prevalence	prevalence	NOUN
dpc-2102	148	17	.	.	PUNCT
dpc-2102	149	1	rsq	rsq	PROPN
dpc-2102	149	2	responses	response	NOUN
dpc-2102	149	3	were	be	AUX
dpc-2102	149	4	also	also	ADV
dpc-2102	149	5	similar	similar	ADJ
dpc-2102	149	6	in	in	ADP
dpc-2102	149	7	two	two	NUM
dpc-2102	149	8	disease	disease	NOUN
dpc-2102	149	9	subtypes	subtype	NOUN
dpc-2102	149	10	.	.	PUNCT
dpc-2102	150	1	as	as	SCONJ
dpc-2102	150	2	it	it	PRON
dpc-2102	150	3	leads	lead	VERB
dpc-2102	150	4	to	to	PART
dpc-2102	150	5	psa	psa	VERB
dpc-2102	150	6	faster	fast	ADV
dpc-2102	150	7	than	than	ADP
dpc-2102	150	8	eop	eop	PROPN
dpc-2102	150	9	,	,	PUNCT
dpc-2102	150	10	lop	lop	PROPN
dpc-2102	150	11	can	can	AUX
dpc-2102	150	12	be	be	AUX
dpc-2102	150	13	accepted	accept	VERB
dpc-2102	150	14	to	to	PART
dpc-2102	150	15	generate	generate	VERB
dpc-2102	150	16	a	a	DET
dpc-2102	150	17	rapid	rapid	ADJ
dpc-2102	150	18	inflammatory	inflammatory	ADJ
dpc-2102	150	19	course	course	NOUN
dpc-2102	150	20	and	and	CCONJ
dpc-2102	150	21	cause	cause	VERB
dpc-2102	150	22	damage	damage	NOUN
dpc-2102	150	23	target	target	NOUN
dpc-2102	150	24	organs	organ	NOUN
dpc-2102	150	25	such	such	ADJ
dpc-2102	150	26	as	as	ADP
dpc-2102	150	27	nails	nail	NOUN
dpc-2102	150	28	,	,	PUNCT
dpc-2102	150	29	ligaments	ligament	NOUN
dpc-2102	150	30	,	,	PUNCT
dpc-2102	150	31	tendons	tendon	NOUN
dpc-2102	150	32	and	and	CCONJ
dpc-2102	150	33	joints	joint	NOUN
dpc-2102	150	34	.	.	PUNCT
dpc-2102	151	1	increased	increase	VERB
dpc-2102	151	2	frequencies	frequency	NOUN
dpc-2102	151	3	of	of	ADP
dpc-2102	151	4	systemic	systemic	ADJ
dpc-2102	151	5	comorbidities	comorbiditie	NOUN
dpc-2102	151	6	such	such	ADJ
dpc-2102	151	7	as	as	ADP
dpc-2102	151	8	cvd	cvd	PROPN
dpc-2102	151	9	,	,	PUNCT
dpc-2102	151	10	dm	dm	PROPN
dpc-2102	151	11	,	,	PUNCT
dpc-2102	151	12	ht	ht	PROPN
dpc-2102	151	13	and	and	CCONJ
dpc-2102	151	14	ms	ms	PROPN
dpc-2102	151	15	in	in	ADP
dpc-2102	151	16	lop	lop	NOUN
dpc-2102	151	17	compared	compare	VERB
dpc-2102	151	18	to	to	ADP
dpc-2102	151	19	eop	eop	PROPN
dpc-2102	151	20	were	be	AUX
dpc-2102	151	21	detected	detect	VERB
dpc-2102	151	22	in	in	ADP
dpc-2102	151	23	this	this	DET
dpc-2102	151	24	study	study	NOUN
dpc-2102	151	25	.	.	PUNCT
dpc-2102	152	1	bmi	bmi	PROPN
dpc-2102	152	2	,	,	PUNCT
dpc-2102	152	3	systolic	systolic	ADJ
dpc-2102	152	4	and	and	CCONJ
dpc-2102	152	5	diastolic	diastolic	ADJ
dpc-2102	152	6	blood	blood	NOUN
dpc-2102	152	7	pressure	pressure	NOUN
dpc-2102	152	8	values	value	NOUN
dpc-2102	152	9	,	,	PUNCT
dpc-2102	152	10	fasting	fast	VERB
dpc-2102	152	11	blood	blood	NOUN
dpc-2102	152	12	glucose	glucose	NOUN
dpc-2102	152	13	,	,	PUNCT
dpc-2102	152	14	bun	bun	PROPN
dpc-2102	152	15	,	,	PUNCT
dpc-2102	152	16	crp	crp	PROPN
dpc-2102	152	17	,	,	PUNCT
dpc-2102	152	18	esr	esr	PROPN
dpc-2102	152	19	,	,	PUNCT
dpc-2102	152	20	rdw	rdw	ADJ
dpc-2102	152	21	levels	level	NOUN
dpc-2102	152	22	were	be	AUX
dpc-2102	152	23	also	also	ADV
dpc-2102	152	24	higher	high	ADJ
dpc-2102	152	25	in	in	ADP
dpc-2102	152	26	lop	lop	NOUN
dpc-2102	152	27	.	.	PUNCT
dpc-2102	153	1	these	these	DET
dpc-2102	153	2	findings	finding	NOUN
dpc-2102	153	3	suggest	suggest	VERB
dpc-2102	153	4	that	that	SCONJ
dpc-2102	153	5	concomitant	concomitant	ADJ
dpc-2102	153	6	inflammatory	inflammatory	ADJ
dpc-2102	153	7	comorbidities	comorbiditie	NOUN
dpc-2102	153	8	may	may	AUX
dpc-2102	153	9	increase	increase	VERB
dpc-2102	153	10	the	the	DET
dpc-2102	153	11	amount	amount	NOUN
dpc-2102	153	12	and	and	CCONJ
dpc-2102	153	13	speed	speed	NOUN
dpc-2102	153	14	of	of	ADP
dpc-2102	153	15	psoriatic	psoriatic	ADJ
dpc-2102	153	16	inflammation	inflammation	NOUN
dpc-2102	153	17	.	.	PUNCT
dpc-2102	154	1	to	to	ADP
dpc-2102	154	2	our	our	PRON
dpc-2102	154	3	knowledge	knowledge	NOUN
dpc-2102	154	4	there	there	PRON
dpc-2102	154	5	are	be	VERB
dpc-2102	154	6	no	no	DET
dpc-2102	154	7	reports	report	NOUN
dpc-2102	154	8	comparing	compare	VERB
dpc-2102	154	9	the	the	DET
dpc-2102	154	10	laboratory	laboratory	NOUN
dpc-2102	154	11	indicatives	indicative	NOUN
dpc-2102	154	12	of	of	ADP
dpc-2102	154	13	systemic	systemic	ADJ
dpc-2102	154	14	inflammation	inflammation	NOUN
dpc-2102	154	15	in	in	ADP
dpc-2102	154	16	eop	eop	PROPN
dpc-2102	154	17	and	and	CCONJ
dpc-2102	154	18	lop	lop	PROPN
dpc-2102	154	19	,	,	PUNCT
dpc-2102	154	20	but	but	CCONJ
dpc-2102	154	21	these	these	DET
dpc-2102	154	22	parameters	parameter	NOUN
dpc-2102	154	23	have	have	AUX
dpc-2102	154	24	been	be	AUX
dpc-2102	154	25	shown	show	VERB
dpc-2102	154	26	to	to	PART
dpc-2102	154	27	be	be	AUX
dpc-2102	154	28	higher	high	ADJ
dpc-2102	154	29	in	in	ADP
dpc-2102	154	30	psoriasis	psoriasis	NOUN
dpc-2102	154	31	patients	patient	NOUN
dpc-2102	154	32	in	in	ADP
dpc-2102	154	33	comparison	comparison	NOUN
dpc-2102	154	34	to	to	ADP
dpc-2102	154	35	general	general	ADJ
dpc-2102	154	36	population	population	NOUN
dpc-2102	155	1	[	[	X
dpc-2102	155	2	20,21	20,21	NUM
dpc-2102	155	3	]	]	PUNCT
dpc-2102	155	4	.	.	PUNCT
dpc-2102	156	1	rdw	rdw	PROPN
dpc-2102	156	2	and	and	CCONJ
dpc-2102	156	3	crp	crp	PROPN
dpc-2102	156	4	levels	level	NOUN
dpc-2102	156	5	have	have	AUX
dpc-2102	156	6	also	also	ADV
dpc-2102	156	7	been	be	AUX
dpc-2102	156	8	suggested	suggest	VERB
dpc-2102	156	9	as	as	ADP
dpc-2102	156	10	reliable	reliable	ADJ
dpc-2102	156	11	markers	marker	NOUN
dpc-2102	156	12	of	of	ADP
dpc-2102	156	13	inflammation	inflammation	NOUN
dpc-2102	156	14	in	in	ADP
dpc-2102	156	15	psoriasis	psoriasis	NOUN
dpc-2102	156	16	[	[	X
dpc-2102	156	17	20,21	20,21	NUM
dpc-2102	156	18	]	]	PUNCT
dpc-2102	156	19	.	.	PUNCT
dpc-2102	157	1	besides	besides	SCONJ
dpc-2102	157	2	,	,	PUNCT
dpc-2102	157	3	elevated	elevated	ADJ
dpc-2102	157	4	levels	level	NOUN
dpc-2102	157	5	of	of	ADP
dpc-2102	157	6	crp	crp	PROPN
dpc-2102	157	7	have	have	AUX
dpc-2102	157	8	been	be	AUX
dpc-2102	157	9	shown	show	VERB
dpc-2102	157	10	to	to	PART
dpc-2102	157	11	be	be	AUX
dpc-2102	157	12	an	an	DET
dpc-2102	157	13	independent	independent	ADJ
dpc-2102	157	14	risk	risk	NOUN
dpc-2102	157	15	factor	factor	NOUN
dpc-2102	157	16	for	for	ADP
dpc-2102	157	17	development	development	NOUN
dpc-2102	157	18	of	of	ADP
dpc-2102	157	19	cvd	cvd	PROPN
dpc-2102	157	20	in	in	ADP
dpc-2102	157	21	psoriasis	psoriasis	NOUN
dpc-2102	157	22	and	and	CCONJ
dpc-2102	157	23	may	may	AUX
dpc-2102	157	24	be	be	AUX
dpc-2102	157	25	associated	associate	VERB
dpc-2102	157	26	with	with	ADP
dpc-2102	157	27	increased	increase	VERB
dpc-2102	157	28	risk	risk	NOUN
dpc-2102	157	29	of	of	ADP
dpc-2102	157	30	ms	ms	NOUN
dpc-2102	157	31	[	[	X
dpc-2102	157	32	21	21	NUM
dpc-2102	157	33	]	]	PUNCT
dpc-2102	157	34	.	.	PUNCT
dpc-2102	158	1	however	however	ADV
dpc-2102	158	2	,	,	PUNCT
dpc-2102	158	3	there	there	PRON
dpc-2102	158	4	is	be	VERB
dpc-2102	158	5	again	again	ADV
dpc-2102	158	6	few	few	ADJ
dpc-2102	158	7	data	datum	NOUN
dpc-2102	158	8	of	of	ADP
dpc-2102	158	9	psoriasis	psoriasis	NOUN
dpc-2102	158	10	subtype	subtype	NOUN
dpc-2102	158	11	and	and	CCONJ
dpc-2102	158	12	its	its	PRON
dpc-2102	158	13	contribution	contribution	NOUN
dpc-2102	158	14	to	to	ADP
dpc-2102	158	15	these	these	DET
dpc-2102	158	16	concurrent	concurrent	ADJ
dpc-2102	158	17	comorbidities	comorbiditie	NOUN
dpc-2102	158	18	.	.	PUNCT
dpc-2102	159	1	heredi	heredi	PROPN
dpc-2102	159	2	et	et	PROPN
dpc-2102	159	3	al	al	PROPN
dpc-2102	159	4	did	do	AUX
dpc-2102	159	5	not	not	PART
dpc-2102	159	6	found	find	VERB
dpc-2102	159	7	difference	difference	NOUN
dpc-2102	159	8	in	in	ADP
dpc-2102	159	9	the	the	DET
dpc-2102	159	10	risk	risk	NOUN
dpc-2102	159	11	of	of	ADP
dpc-2102	159	12	development	development	NOUN
dpc-2102	159	13	of	of	ADP
dpc-2102	159	14	cvd	cvd	PROPN
dpc-2102	159	15	between	between	ADP
dpc-2102	159	16	eop	eop	PROPN
dpc-2102	159	17	and	and	CCONJ
dpc-2102	159	18	lop	lop	NOUN
dpc-2102	160	1	[	[	X
dpc-2102	160	2	1	1	NUM
dpc-2102	160	3	]	]	PUNCT
dpc-2102	160	4	.	.	PUNCT
dpc-2102	161	1	despite	despite	SCONJ
dpc-2102	161	2	our	our	PRON
dpc-2102	161	3	low	low	ADJ
dpc-2102	161	4	number	number	NOUN
dpc-2102	161	5	of	of	ADP
dpc-2102	161	6	cases	case	NOUN
dpc-2102	161	7	in	in	ADP
dpc-2102	161	8	the	the	DET
dpc-2102	161	9	study	study	NOUN
dpc-2102	161	10	,	,	PUNCT
dpc-2102	161	11	lop	lop	PROPN
dpc-2102	161	12	was	be	AUX
dpc-2102	161	13	able	able	ADJ
dpc-2102	161	14	to	to	PART
dpc-2102	161	15	be	be	AUX
dpc-2102	161	16	shown	show	VERB
dpc-2102	161	17	as	as	ADP
dpc-2102	161	18	an	an	DET
dpc-2102	161	19	independent	independent	ADJ
dpc-2102	161	20	risk	risk	NOUN
dpc-2102	161	21	factor	factor	NOUN
dpc-2102	161	22	for	for	ADP
dpc-2102	161	23	cvd	cvd	PROPN
dpc-2102	161	24	and	and	CCONJ
dpc-2102	161	25	dm	dm	PROPN
dpc-2102	161	26	.	.	PUNCT
dpc-2102	162	1	this	this	DET
dpc-2102	162	2	risk	risk	NOUN
dpc-2102	162	3	must	must	AUX
dpc-2102	162	4	be	be	AUX
dpc-2102	162	5	kept	keep	VERB
dpc-2102	162	6	in	in	ADP
dpc-2102	162	7	mind	mind	NOUN
dpc-2102	162	8	in	in	ADP
dpc-2102	162	9	lop	lop	NOUN
dpc-2102	162	10	and	and	CCONJ
dpc-2102	162	11	on	on	ADP
dpc-2102	162	12	time	time	NOUN
dpc-2102	162	13	referral	referral	NOUN
dpc-2102	162	14	and	and	CCONJ
dpc-2102	162	15	adequate	adequate	ADJ
dpc-2102	162	16	anti	anti	ADJ
dpc-2102	162	17	-	-	ADJ
dpc-2102	162	18	psoriatic	psoriatic	ADJ
dpc-2102	162	19	treatment	treatment	NOUN
dpc-2102	162	20	choice	choice	NOUN
dpc-2102	162	21	is	be	AUX
dpc-2102	162	22	mandatory	mandatory	ADJ
dpc-2102	162	23	and	and	CCONJ
dpc-2102	162	24	is	be	AUX
dpc-2102	162	25	lately	lately	ADV
dpc-2102	162	26	recommended	recommend	VERB
dpc-2102	162	27	in	in	ADP
dpc-2102	162	28	psoriasis	psoriasis	NOUN
dpc-2102	162	29	guidelines	guideline	NOUN
dpc-2102	162	30	[	[	X
dpc-2102	162	31	22	22	NUM
dpc-2102	162	32	]	]	PUNCT
dpc-2102	162	33	.	.	PUNCT
dpc-2102	163	1	eop	eop	PROPN
dpc-2102	163	2	and	and	CCONJ
dpc-2102	163	3	lop	lop	PROPN
dpc-2102	163	4	are	be	AUX
dpc-2102	163	5	two	two	NUM
dpc-2102	163	6	different	different	ADJ
dpc-2102	163	7	types	type	NOUN
dpc-2102	163	8	of	of	ADP
dpc-2102	163	9	psoriasis	psoriasis	NOUN
dpc-2102	163	10	with	with	ADP
dpc-2102	163	11	different	different	ADJ
dpc-2102	163	12	etiologies	etiology	NOUN
dpc-2102	163	13	,	,	PUNCT
dpc-2102	163	14	clinical	clinical	ADJ
dpc-2102	163	15	characteristics	characteristic	NOUN
dpc-2102	163	16	,	,	PUNCT
dpc-2102	163	17	laboratory	laboratory	NOUN
dpc-2102	163	18	indicatives	indicative	NOUN
dpc-2102	163	19	and	and	CCONJ
dpc-2102	163	20	concurrent	concurrent	ADJ
dpc-2102	163	21	systemic	systemic	ADJ
dpc-2102	163	22	comorbidities	comorbiditie	NOUN
dpc-2102	163	23	.	.	PUNCT
dpc-2102	164	1	despite	despite	SCONJ
dpc-2102	164	2	similar	similar	ADJ
dpc-2102	164	3	treatment	treatment	NOUN
dpc-2102	164	4	regimens	regimen	NOUN
dpc-2102	164	5	and	and	CCONJ
dpc-2102	164	6	shorter	short	ADJ
dpc-2102	164	7	duration	duration	NOUN
dpc-2102	164	8	of	of	ADP
dpc-2102	164	9	active	active	ADJ
dpc-2102	164	10	disease	disease	NOUN
dpc-2102	164	11	,	,	PUNCT
dpc-2102	164	12	lop	lop	PROPN
dpc-2102	164	13	causes	cause	VERB
dpc-2102	164	14	faster	fast	ADJ
dpc-2102	164	15	nail	nail	NOUN
dpc-2102	164	16	and	and	CCONJ
dpc-2102	164	17	joint	joint	ADJ
dpc-2102	164	18	involvement	involvement	NOUN
dpc-2102	164	19	in	in	ADP
dpc-2102	164	20	a	a	DET
dpc-2102	164	21	shorter	short	ADJ
dpc-2102	164	22	period	period	NOUN
dpc-2102	164	23	of	of	ADP
dpc-2102	164	24	time	time	NOUN
dpc-2102	164	25	and	and	CCONJ
dpc-2102	164	26	is	be	AUX
dpc-2102	164	27	more	more	ADV
dpc-2102	164	28	frequently	frequently	ADV
dpc-2102	164	29	associated	associate	VERB
dpc-2102	164	30	with	with	ADP
dpc-2102	164	31	systemic	systemic	ADJ
dpc-2102	164	32	inflammatory	inflammatory	ADJ
dpc-2102	164	33	comorbidities	comorbiditie	NOUN
dpc-2102	164	34	such	such	ADJ
dpc-2102	164	35	as	as	ADP
dpc-2102	164	36	cvd	cvd	PROPN
dpc-2102	164	37	,	,	PUNCT
dpc-2102	164	38	dm	dm	PROPN
dpc-2102	164	39	,	,	PUNCT
dpc-2102	164	40	ht	ht	PROPN
dpc-2102	164	41	and	and	CCONJ
dpc-2102	164	42	ms	ms	PROPN
dpc-2102	164	43	.	.	PROPN
dpc-2102	164	44	lop	lop	PROPN
dpc-2102	164	45	was	be	AUX
dpc-2102	164	46	also	also	ADV
dpc-2102	164	47	found	find	VERB
dpc-2102	164	48	to	to	PART
dpc-2102	164	49	be	be	AUX
dpc-2102	164	50	independent	independent	ADJ
dpc-2102	164	51	risk	risk	NOUN
dpc-2102	164	52	factor	factor	NOUN
dpc-2102	164	53	for	for	ADP
dpc-2102	164	54	development	development	NOUN
dpc-2102	164	55	of	of	ADP
dpc-2102	164	56	cvd	cvd	PROPN
dpc-2102	164	57	and	and	CCONJ
dpc-2102	164	58	dm	dm	PROPN
dpc-2102	164	59	.	.	PROPN
dpc-2102	165	1	from	from	ADP
dpc-2102	165	2	this	this	DET
dpc-2102	165	3	aspect	aspect	NOUN
dpc-2102	165	4	,	,	PUNCT
dpc-2102	165	5	we	we	PRON
dpc-2102	165	6	prioritize	prioritize	VERB
dpc-2102	165	7	the	the	DET
dpc-2102	165	8	determination	determination	NOUN
dpc-2102	165	9	of	of	ADP
dpc-2102	165	10	the	the	DET
dpc-2102	165	11	disease	disease	NOUN
dpc-2102	165	12	subtype	subtype	NOUN
dpc-2102	165	13	as	as	ADP
dpc-2102	165	14	eop	eop	PROPN
dpc-2102	165	15	or	or	CCONJ
dpc-2102	165	16	lop	lop	PROPN
dpc-2102	165	17	and	and	CCONJ
dpc-2102	165	18	suggest	suggest	VERB
dpc-2102	165	19	lop	lop	NOUN
dpc-2102	165	20	to	to	PART
dpc-2102	165	21	be	be	AUX
dpc-2102	165	22	closely	closely	ADV
dpc-2102	165	23	monitored	monitor	VERB
dpc-2102	165	24	for	for	ADP
dpc-2102	165	25	potential	potential	ADJ
dpc-2102	165	26	development	development	NOUN
dpc-2102	165	27	of	of	ADP
dpc-2102	165	28	end	end	NOUN
dpc-2102	165	29	-	-	PUNCT
dpc-2102	165	30	organ	organ	NOUN
dpc-2102	165	31	inflammatory	inflammatory	ADJ
dpc-2102	165	32	comorbidities	comorbiditie	NOUN
dpc-2102	165	33	.	.	PUNCT
dpc-2102	166	1	lop	lop	NOUN
dpc-2102	166	2	must	must	AUX
dpc-2102	166	3	be	be	AUX
dpc-2102	166	4	considered	consider	VERB
dpc-2102	166	5	as	as	ADP
dpc-2102	166	6	the	the	DET
dpc-2102	166	7	more	more	ADV
dpc-2102	166	8	rapid	rapid	ADJ
dpc-2102	166	9	and	and	CCONJ
dpc-2102	166	10	aggressive	aggressive	ADJ
dpc-2102	166	11	type	type	NOUN
dpc-2102	166	12	of	of	ADP
dpc-2102	166	13	psoriasis	psoriasis	NOUN
dpc-2102	166	14	which	which	PRON
dpc-2102	166	15	provokes	provoke	VERB
dpc-2102	166	16	development	development	NOUN
dpc-2102	166	17	of	of	ADP
dpc-2102	166	18	inflammatory	inflammatory	ADJ
dpc-2102	166	19	comorbidities	comorbiditie	NOUN
dpc-2102	166	20	in	in	ADP
dpc-2102	166	21	shorter	short	ADJ
dpc-2102	166	22	duration	duration	NOUN
dpc-2102	166	23	in	in	ADP
dpc-2102	166	24	comparison	comparison	NOUN
dpc-2102	166	25	to	to	ADP
dpc-2102	166	26	eop	eop	PROPN
dpc-2102	166	27	.	.	PUNCT
dpc-2102	167	1	references	reference	NOUN
dpc-2102	167	2	1	1	NUM
dpc-2102	167	3	.	.	PUNCT
dpc-2102	168	1	herédi	herédi	PROPN
dpc-2102	168	2	e	e	PROPN
dpc-2102	168	3	,	,	PUNCT
dpc-2102	168	4	csordás	csordás	PROPN
dpc-2102	168	5	a	a	PROPN
dpc-2102	168	6	,	,	PUNCT
dpc-2102	168	7	clemens	clemens	PROPN
dpc-2102	168	8	m	m	PROPN
dpc-2102	168	9	,	,	PUNCT
dpc-2102	168	10	et	et	PROPN
dpc-2102	168	11	al	al	PROPN
dpc-2102	168	12	.	.	PUNCT
dpc-2102	169	1	the	the	DET
dpc-2102	169	2	prevalence	prevalence	NOUN
dpc-2102	169	3	of	of	ADP
dpc-2102	169	4	obesity	obesity	NOUN
dpc-2102	169	5	is	be	AUX
dpc-2102	169	6	increased	increase	VERB
dpc-2102	169	7	in	in	ADP
dpc-2102	169	8	patients	patient	NOUN
dpc-2102	169	9	with	with	ADP
dpc-2102	169	10	late	late	ADV
dpc-2102	169	11	compared	compare	VERB
dpc-2102	169	12	with	with	ADP
dpc-2102	169	13	early	early	ADJ
dpc-2102	169	14	onset	onset	VERB
dpc-2102	169	15	psoriasis	psoriasis	NOUN
dpc-2102	169	16	.	.	PUNCT
dpc-2102	170	1	ann	ann	PROPN
dpc-2102	170	2	epidemiol	epidemiol	PROPN
dpc-2102	170	3	.	.	PUNCT
dpc-2102	171	1	2013;23:688–692	2013;23:688–692	X
dpc-2102	171	2	.	.	PUNCT
dpc-2102	172	1	doi	doi	NOUN
dpc-2102	172	2	:	:	PUNCT
dpc-2102	172	3	10.1016/	10.1016/	NUM
dpc-2102	172	4	j.annepidem.2013.08.006	j.annepidem.2013.08.006	NOUN
dpc-2102	172	5	.	.	PUNCT
dpc-2102	173	1	pmid	pmid	NOUN
dpc-2102	173	2	:	:	PUNCT
dpc-2102	173	3	24095656	24095656	NUM
dpc-2102	173	4	.	.	PUNCT
dpc-2102	174	1	2	2	X
dpc-2102	174	2	.	.	X
dpc-2102	174	3	henseler	henseler	PROPN
dpc-2102	174	4	t	t	PROPN
dpc-2102	174	5	,	,	PUNCT
dpc-2102	174	6	christophers	christopher	NOUN
dpc-2102	174	7	e.	e.	PROPN
dpc-2102	174	8	psoriasis	psoriasis	NOUN
dpc-2102	174	9	of	of	ADP
dpc-2102	174	10	early	early	ADJ
dpc-2102	174	11	and	and	CCONJ
dpc-2102	174	12	late	late	ADJ
dpc-2102	174	13	onset	onset	NOUN
dpc-2102	174	14	:	:	PUNCT
dpc-2102	174	15	characterization	characterization	NOUN
dpc-2102	174	16	of	of	ADP
dpc-2102	174	17	two	two	NUM
dpc-2102	174	18	types	type	NOUN
dpc-2102	174	19	of	of	ADP
dpc-2102	174	20	psoriasis	psoriasis	NOUN
dpc-2102	174	21	vulgaris	vulgaris	NOUN
dpc-2102	174	22	.	.	PUNCT
dpc-2102	175	1	j	j	PROPN
dpc-2102	175	2	am	be	AUX
dpc-2102	175	3	acad	acad	ADJ
dpc-2102	175	4	dermatol	dermatol	NOUN
dpc-2102	175	5	.	.	PUNCT
dpc-2102	176	1	1985;13(3):450–456	1985;13(3):450–456	NOUN
dpc-2102	176	2	.	.	PUNCT
dpc-2102	177	1	doi	doi	NOUN
dpc-2102	177	2	:	:	PUNCT
dpc-2102	177	3	10.1016	10.1016	NUM
dpc-2102	177	4	/	/	SYM
dpc-2102	177	5	s01909622(85)70188	s01909622(85)70188	PROPN
dpc-2102	177	6	-	-	PUNCT
dpc-2102	177	7	0	0	NUM
dpc-2102	177	8	.	.	PUNCT
dpc-2102	178	1	pmid	pmid	NOUN
dpc-2102	178	2	:	:	PUNCT
dpc-2102	178	3	4056119	4056119	NUM
dpc-2102	178	4	.	.	PUNCT
dpc-2102	179	1	3	3	X
dpc-2102	179	2	.	.	X
dpc-2102	179	3	ferrándiz	ferrándiz	PROPN
dpc-2102	179	4	c	c	NOUN
dpc-2102	179	5	,	,	PUNCT
dpc-2102	179	6	pujol	pujol	PROPN
dpc-2102	179	7	rm	rm	PROPN
dpc-2102	179	8	,	,	PUNCT
dpc-2102	179	9	garcía	garcía	ADJ
dpc-2102	179	10	-	-	PUNCT
dpc-2102	179	11	patos	patos	NOUN
dpc-2102	179	12	v	v	NOUN
dpc-2102	179	13	,	,	PUNCT
dpc-2102	179	14	et	et	PROPN
dpc-2102	179	15	al	al	PROPN
dpc-2102	179	16	.	.	PUNCT
dpc-2102	179	17	psoriasis	psoriasis	NOUN
dpc-2102	179	18	of	of	ADP
dpc-2102	179	19	early	early	ADJ
dpc-2102	179	20	and	and	CCONJ
dpc-2102	179	21	late	late	ADJ
dpc-2102	179	22	onset	onset	NOUN
dpc-2102	179	23	:	:	PUNCT
dpc-2102	179	24	a	a	DET
dpc-2102	179	25	clinical	clinical	ADJ
dpc-2102	179	26	and	and	CCONJ
dpc-2102	179	27	epidemiologic	epidemiologic	ADJ
dpc-2102	179	28	study	study	NOUN
dpc-2102	179	29	from	from	ADP
dpc-2102	179	30	spain	spain	PROPN
dpc-2102	179	31	.	.	PUNCT
dpc-2102	180	1	j	j	PROPN
dpc-2102	180	2	am	be	AUX
dpc-2102	180	3	acad	acad	ADJ
dpc-2102	180	4	dermatol	dermatol	NOUN
dpc-2102	180	5	.	.	PUNCT
dpc-2102	181	1	2002;46(6):867–873	2002;46(6):867–873	X
dpc-2102	181	2	.	.	X
dpc-2102	181	3	doi	doi	NOUN
dpc-2102	181	4	:	:	PUNCT
dpc-2102	181	5	10.1067	10.1067	NUM
dpc-2102	181	6	/mjd.2002.120470	/mjd.2002.120470	PUNCT
dpc-2102	181	7	.	.	PUNCT
dpc-2102	182	1	pmid	pmid	NOUN
dpc-2102	182	2	:	:	PUNCT
dpc-2102	182	3	12063483	12063483	NUM
dpc-2102	182	4	.	.	PUNCT
dpc-2102	183	1	4	4	X
dpc-2102	183	2	.	.	X
dpc-2102	183	3	ejaz	ejaz	PROPN
dpc-2102	183	4	a	a	PROPN
dpc-2102	183	5	,	,	PUNCT
dpc-2102	183	6	raza	raza	PROPN
dpc-2102	183	7	n	n	CCONJ
dpc-2102	183	8	,	,	PUNCT
dpc-2102	183	9	iftikhar	iftikhar	PROPN
dpc-2102	183	10	n	n	CCONJ
dpc-2102	183	11	,	,	PUNCT
dpc-2102	183	12	et	et	PROPN
dpc-2102	183	13	al	al	PROPN
dpc-2102	183	14	.	.	PROPN
dpc-2102	183	15	presentation	presentation	NOUN
dpc-2102	183	16	of	of	ADP
dpc-2102	183	17	early	early	ADJ
dpc-2102	183	18	onset	onset	VERB
dpc-2102	183	19	psoriasis	psoriasis	NOUN
dpc-2102	183	20	in	in	ADP
dpc-2102	183	21	comparison	comparison	NOUN
dpc-2102	183	22	with	with	ADP
dpc-2102	183	23	late	late	ADJ
dpc-2102	183	24	onset	onset	NOUN
dpc-2102	183	25	psoriasis	psoriasis	NOUN
dpc-2102	183	26	:	:	PUNCT
dpc-2102	183	27	a	a	DET
dpc-2102	183	28	clinical	clinical	ADJ
dpc-2102	183	29	study	study	NOUN
dpc-2102	183	30	from	from	ADP
dpc-2102	183	31	pakistan	pakistan	PROPN
dpc-2102	183	32	.	.	PUNCT
dpc-2102	184	1	indian	indian	PROPN
dpc-2102	184	2	j	j	PROPN
dpc-2102	184	3	dermatol	dermatol	PROPN
dpc-2102	184	4	venereol	venereol	ADJ
dpc-2102	184	5	leprol	leprol	NOUN
dpc-2102	184	6	.	.	PUNCT
dpc-2102	185	1	2009;75	2009;75	NUM
dpc-2102	185	2	:	:	PUNCT
dpc-2102	185	3	36–40	36–40	NUM
dpc-2102	185	4	.	.	PUNCT
dpc-2102	186	1	doi	doi	NOUN
dpc-2102	186	2	:	:	PUNCT
dpc-2102	186	3	10.4103/0378	10.4103/0378	NUM
dpc-2102	186	4	-	-	PUNCT
dpc-2102	186	5	6323.45218	6323.45218	NOUN
dpc-2102	186	6	.	.	PROPN
dpc-2102	187	1	5	5	NUM
dpc-2102	187	2	.	.	X
dpc-2102	187	3	mallbris	mallbris	PROPN
dpc-2102	187	4	l	l	PROPN
dpc-2102	187	5	,	,	PUNCT
dpc-2102	187	6	larsson	larsson	PROPN
dpc-2102	187	7	p	p	PROPN
dpc-2102	187	8	,	,	PUNCT
dpc-2102	187	9	bergqvist	bergqvist	NOUN
dpc-2102	187	10	s	s	PROPN
dpc-2102	187	11	,	,	PUNCT
dpc-2102	187	12	et	et	PROPN
dpc-2102	187	13	al	al	PROPN
dpc-2102	187	14	.	.	PUNCT
dpc-2102	187	15	psoriasis	psoriasis	NOUN
dpc-2102	187	16	phenotype	phenotype	NOUN
dpc-2102	187	17	at	at	ADP
dpc-2102	187	18	disease	disease	NOUN
dpc-2102	187	19	onset	onset	VERB
dpc-2102	187	20	:	:	PUNCT
dpc-2102	187	21	clinical	clinical	ADJ
dpc-2102	187	22	characterization	characterization	NOUN
dpc-2102	187	23	of	of	ADP
dpc-2102	187	24	400	400	NUM
dpc-2102	187	25	adult	adult	NOUN
dpc-2102	187	26	cases	case	NOUN
dpc-2102	187	27	.	.	PUNCT
dpc-2102	188	1	j	j	PROPN
dpc-2102	188	2	invest	invest	VERB
dpc-2102	188	3	dermatol	dermatol	NOUN
dpc-2102	188	4	.	.	PUNCT
dpc-2102	189	1	2005;124(1):499–504	2005;124(1):499–504	NUM
dpc-2102	189	2	.	.	PUNCT
dpc-2102	190	1	doi	doi	NOUN
dpc-2102	190	2	:	:	PUNCT
dpc-2102	190	3	10.1111	10.1111	NUM
dpc-2102	190	4	/	/	SYM
dpc-2102	190	5	j.0022202x.2004.23611.x	j.0022202x.2004.23611.x	NOUN
dpc-2102	190	6	.	.	PUNCT
dpc-2102	191	1	pmid	pmid	NOUN
dpc-2102	191	2	:	:	PUNCT
dpc-2102	191	3	19172029	19172029	NUM
dpc-2102	191	4	.	.	PUNCT
dpc-2102	192	1	6	6	X
dpc-2102	192	2	.	.	X
dpc-2102	192	3	youn	youn	PROPN
dpc-2102	192	4	j	j	PROPN
dpc-2102	192	5	,	,	PUNCT
dpc-2102	192	6	park	park	NOUN
dpc-2102	192	7	b	b	PROPN
dpc-2102	192	8	,	,	PUNCT
dpc-2102	192	9	park	park	NOUN
dpc-2102	192	10	s	s	PROPN
dpc-2102	192	11	,	,	PUNCT
dpc-2102	192	12	et	et	PROPN
dpc-2102	192	13	al	al	PROPN
dpc-2102	192	14	.	.	PUNCT
dpc-2102	192	15	characterization	characterization	NOUN
dpc-2102	192	16	of	of	ADP
dpc-2102	192	17	early	early	ADJ
dpc-2102	192	18	and	and	CCONJ
dpc-2102	192	19	late	late	ADJ
dpc-2102	192	20	onset	onset	VERB
dpc-2102	192	21	psoriasis	psoriasis	NOUN
dpc-2102	192	22	in	in	ADP
dpc-2102	192	23	the	the	DET
dpc-2102	192	24	korean	korean	ADJ
dpc-2102	192	25	population	population	NOUN
dpc-2102	192	26	.	.	PUNCT
dpc-2102	193	1	j	j	PROPN
dpc-2102	193	2	dermatol	dermatol	NOUN
dpc-2102	193	3	.	.	PUNCT
dpc-2102	194	1	1999;26(10):647–652	1999;26(10):647–652	NUM
dpc-2102	194	2	.	.	PUNCT
dpc-2102	195	1	doi	doi	NOUN
dpc-2102	195	2	:	:	PUNCT
dpc-2102	195	3	10.1111	10.1111	NUM
dpc-2102	195	4	/	/	SYM
dpc-2102	195	5	j.1346	j.1346	VERB
dpc-2102	195	6	-	-	PUNCT
dpc-2102	195	7	8138.1999	8138.1999	NOUN
dpc-2102	195	8	.	.	PUNCT
dpc-2102	196	1	tb02066.x	tb02066.x	NOUN
dpc-2102	196	2	.	.	PUNCT
dpc-2102	197	1	pmid	pmid	NOUN
dpc-2102	197	2	:	:	PUNCT
dpc-2102	197	3	10554430	10554430	NUM
dpc-2102	197	4	.	.	PUNCT
dpc-2102	198	1	7	7	X
dpc-2102	198	2	.	.	X
dpc-2102	198	3	chularojanamontri	chularojanamontri	PROPN
dpc-2102	198	4	l	l	PROPN
dpc-2102	198	5	,	,	PUNCT
dpc-2102	198	6	kulthanan	kulthanan	PROPN
dpc-2102	198	7	k	k	PROPN
dpc-2102	198	8	,	,	PUNCT
dpc-2102	198	9	suthipinittharm	suthipinittharm	NOUN
dpc-2102	198	10	p	p	X
dpc-2102	198	11	,	,	PUNCT
dpc-2102	198	12	et	et	PROPN
dpc-2102	198	13	al	al	PROPN
dpc-2102	198	14	.	.	PUNCT
dpc-2102	199	1	clinical	clinical	ADJ
dpc-2102	199	2	differences	difference	NOUN
dpc-2102	199	3	between	between	ADP
dpc-2102	199	4	earlyand	earlyand	NOUN
dpc-2102	199	5	late	late	ADV
dpc-2102	199	6	-	-	PUNCT
dpc-2102	199	7	onset	onset	NOUN
dpc-2102	199	8	psoriasis	psoriasis	NOUN
dpc-2102	199	9	in	in	ADP
dpc-2102	199	10	thai	thai	ADJ
dpc-2102	199	11	patients	patient	NOUN
dpc-2102	199	12	.	.	PUNCT
dpc-2102	200	1	int	int	NOUN
dpc-2102	200	2	j	j	PROPN
dpc-2102	200	3	dermatol	dermatol	NOUN
dpc-2102	200	4	.	.	PUNCT
dpc-2102	201	1	2015;54(3):290–294	2015;54(3):290–294	NUM
dpc-2102	201	2	.	.	PUNCT
dpc-2102	202	1	doi	doi	NOUN
dpc-2102	202	2	:	:	PUNCT
dpc-2102	202	3	10.1111	10.1111	NUM
dpc-2102	202	4	/	/	SYM
dpc-2102	202	5	ijd.12515	ijd.12515	NOUN
dpc-2102	202	6	.	.	PUNCT
dpc-2102	203	1	pmid	pmid	NOUN
dpc-2102	203	2	:	:	PUNCT
dpc-2102	203	3	25069524	25069524	NUM
dpc-2102	203	4	.	.	PUNCT
dpc-2102	204	1	8	8	X
dpc-2102	204	2	.	.	PUNCT
dpc-2102	204	3	fan	fan	PROPN
dpc-2102	204	4	x	x	PROPN
dpc-2102	204	5	,	,	PUNCT
dpc-2102	204	6	yang	yang	PROPN
dpc-2102	204	7	s	s	PROPN
dpc-2102	204	8	,	,	PUNCT
dpc-2102	204	9	sun	sun	PROPN
dpc-2102	204	10	ld	ld	PROPN
dpc-2102	204	11	,	,	PUNCT
dpc-2102	204	12	et	et	PROPN
dpc-2102	204	13	al	al	PROPN
dpc-2102	204	14	.	.	PROPN
dpc-2102	204	15	comparison	comparison	NOUN
dpc-2102	204	16	of	of	ADP
dpc-2102	204	17	clinical	clinical	ADJ
dpc-2102	204	18	features	feature	NOUN
dpc-2102	204	19	of	of	ADP
dpc-2102	204	20	hla	hla	PROPN
dpc-2102	204	21	-	-	PUNCT
dpc-2102	204	22	cw*0602	cw*0602	NOUN
dpc-2102	204	23	-	-	PUNCT
dpc-2102	204	24	positive	positive	ADJ
dpc-2102	204	25	and	and	CCONJ
dpc-2102	204	26	-negative	-negative	ADJ
dpc-2102	204	27	psoriasis	psoriasis	NOUN
dpc-2102	204	28	patients	patient	NOUN
dpc-2102	204	29	in	in	ADP
dpc-2102	204	30	a	a	DET
dpc-2102	204	31	han	han	PROPN
dpc-2102	204	32	chinese	chinese	ADJ
dpc-2102	204	33	population	population	NOUN
dpc-2102	204	34	.	.	PUNCT
dpc-2102	205	1	acta	acta	PROPN
dpc-2102	205	2	derm	derm	PROPN
dpc-2102	205	3	venereol	venereol	NOUN
dpc-2102	205	4	.	.	PUNCT
dpc-2102	206	1	2007;87(4):335	2007;87(4):335	NUM
dpc-2102	206	2	–	–	PUNCT
dpc-2102	206	3	340	340	NUM
dpc-2102	206	4	.	.	PUNCT
dpc-2102	207	1	doi	doi	NOUN
dpc-2102	207	2	:	:	PUNCT
dpc-2102	207	3	10.2340/00015555	10.2340/00015555	NUM
dpc-2102	207	4	-	-	SYM
dpc-2102	207	5	0253	0253	NUM
dpc-2102	207	6	.	.	PUNCT
dpc-2102	208	1	pmid	pmid	NOUN
dpc-2102	208	2	:	:	PUNCT
dpc-2102	208	3	17598037	17598037	NUM
dpc-2102	208	4	.	.	PUNCT
dpc-2102	209	1	9	9	X
dpc-2102	209	2	.	.	X
dpc-2102	209	3	gudjonsson	gudjonsson	PROPN
dpc-2102	209	4	je	je	PROPN
dpc-2102	209	5	,	,	PUNCT
dpc-2102	209	6	karason	karason	PROPN
dpc-2102	209	7	a	a	PROPN
dpc-2102	209	8	,	,	PUNCT
dpc-2102	209	9	runarsdottir	runarsdottir	X
dpc-2102	209	10	eh	eh	INTJ
dpc-2102	209	11	,	,	PUNCT
dpc-2102	209	12	et	et	PROPN
dpc-2102	209	13	al	al	PROPN
dpc-2102	209	14	.	.	PROPN
dpc-2102	210	1	distinct	distinct	ADJ
dpc-2102	210	2	clinical	clinical	ADJ
dpc-2102	210	3	differences	difference	NOUN
dpc-2102	210	4	between	between	ADP
dpc-2102	210	5	hla	hla	PROPN
dpc-2102	210	6	-	-	PUNCT
dpc-2102	210	7	cw*0602	cw*0602	NOUN
dpc-2102	210	8	positive	positive	ADJ
dpc-2102	210	9	and	and	CCONJ
dpc-2102	210	10	negative	negative	ADJ
dpc-2102	210	11	psoriasis	psoriasis	NOUN
dpc-2102	210	12	patients	patient	NOUN
dpc-2102	210	13	--	--	PUNCT
dpc-2102	210	14	an	an	DET
dpc-2102	210	15	analysis	analysis	NOUN
dpc-2102	210	16	of	of	ADP
dpc-2102	210	17	1019	1019	NUM
dpc-2102	210	18	hla	hla	PROPN
dpc-2102	210	19	-	-	PUNCT
dpc-2102	210	20	cand	cand	PROPN
dpc-2102	210	21	hla	hla	PROPN
dpc-2102	210	22	-	-	PUNCT
dpc-2102	210	23	btyped	btype	VERB
dpc-2102	210	24	patients	patient	NOUN
dpc-2102	210	25	.	.	PUNCT
dpc-2102	211	1	j	j	PROPN
dpc-2102	211	2	invest	invest	VERB
dpc-2102	211	3	dermatol	dermatol	NOUN
dpc-2102	211	4	.	.	PUNCT
dpc-2102	212	1	2006;126(4):740–745	2006;126(4):740–745	NUM
dpc-2102	212	2	.	.	PUNCT
dpc-2102	212	3	doi	doi	NOUN
dpc-2102	212	4	:	:	PUNCT
dpc-2102	212	5	10.1038	10.1038	NUM
dpc-2102	212	6	/	/	SYM
dpc-2102	212	7	sj.jid.5700118	sj.jid.5700118	NOUN
dpc-2102	212	8	.	.	PUNCT
dpc-2102	213	1	pmid	pmid	NOUN
dpc-2102	213	2	:	:	PUNCT
dpc-2102	213	3	16439971	16439971	NUM
dpc-2102	213	4	.	.	PUNCT
dpc-2102	214	1	original	original	ADJ
dpc-2102	214	2	article	article	NOUN
dpc-2102	214	3	|	|	ADV
dpc-2102	214	4	dermatol	dermatol	ADJ
dpc-2102	214	5	pract	pract	NOUN
dpc-2102	214	6	concept	concept	NOUN
dpc-2102	214	7	.	.	PUNCT
dpc-2102	215	1	2022;12(3):e2022144	2022;12(3):e2022144	NUM
dpc-2102	215	2	9	9	NUM
dpc-2102	215	3	10	10	NUM
dpc-2102	215	4	.	.	PUNCT
dpc-2102	216	1	stuart	stuart	PROPN
dpc-2102	216	2	p	p	PROPN
dpc-2102	216	3	,	,	PUNCT
dpc-2102	216	4	malick	malick	PROPN
dpc-2102	216	5	f	f	PROPN
dpc-2102	216	6	,	,	PUNCT
dpc-2102	216	7	nair	nair	PROPN
dpc-2102	216	8	rp	rp	PROPN
dpc-2102	216	9	,	,	PUNCT
dpc-2102	216	10	et	et	PROPN
dpc-2102	216	11	al	al	PROPN
dpc-2102	216	12	.	.	PUNCT
dpc-2102	217	1	analysis	analysis	NOUN
dpc-2102	217	2	of	of	ADP
dpc-2102	217	3	phenotypic	phenotypic	ADJ
dpc-2102	217	4	variation	variation	NOUN
dpc-2102	217	5	in	in	ADP
dpc-2102	217	6	psoriasis	psoriasis	NOUN
dpc-2102	217	7	as	as	ADP
dpc-2102	217	8	a	a	DET
dpc-2102	217	9	function	function	NOUN
dpc-2102	217	10	of	of	ADP
dpc-2102	217	11	age	age	NOUN
dpc-2102	217	12	at	at	ADP
dpc-2102	217	13	onset	onset	NOUN
dpc-2102	217	14	and	and	CCONJ
dpc-2102	217	15	family	family	NOUN
dpc-2102	217	16	history	history	NOUN
dpc-2102	217	17	.	.	PUNCT
dpc-2102	218	1	arch	arch	ADJ
dpc-2102	218	2	dermatol	dermatol	NOUN
dpc-2102	218	3	res	re	NOUN
dpc-2102	218	4	.	.	PUNCT
dpc-2102	219	1	2002;294(5):207–213	2002;294(5):207–213	NUM
dpc-2102	219	2	.	.	PUNCT
dpc-2102	219	3	doi	doi	PROPN
dpc-2102	219	4	:	:	PUNCT
dpc-2102	219	5	10.1007/	10.1007/	NUM
dpc-2102	219	6	s00403	s00403	PROPN
dpc-2102	219	7	-	-	PUNCT
dpc-2102	219	8	002	002	NUM
dpc-2102	219	9	-	-	PUNCT
dpc-2102	219	10	0321	0321	NUM
dpc-2102	219	11	-	-	PUNCT
dpc-2102	219	12	3	3	NUM
dpc-2102	219	13	.	.	PUNCT
dpc-2102	220	1	pmid	pmid	NOUN
dpc-2102	220	2	:	:	PUNCT
dpc-2102	220	3	12115023	12115023	NUM
dpc-2102	220	4	.	.	PUNCT
dpc-2102	221	1	11	11	NUM
dpc-2102	221	2	.	.	X
dpc-2102	222	1	doğan	doğan	PROPN
dpc-2102	222	2	s	s	PROPN
dpc-2102	222	3	,	,	PUNCT
dpc-2102	222	4	atakan	atakan	ADJ
dpc-2102	222	5	n	n	CCONJ
dpc-2102	222	6	,	,	PUNCT
dpc-2102	222	7	koç	koç	PROPN
dpc-2102	222	8	yıldırım	yıldırım	PROPN
dpc-2102	222	9	s	s	PROPN
dpc-2102	222	10	,	,	PUNCT
dpc-2102	222	11	et	et	PROPN
dpc-2102	222	12	al	al	PROPN
dpc-2102	222	13	.	.	PUNCT
dpc-2102	222	14	evaluation	evaluation	NOUN
dpc-2102	222	15	of	of	ADP
dpc-2102	222	16	psoriasis	psoriasis	NOUN
dpc-2102	222	17	patients	patient	NOUN
dpc-2102	222	18	with	with	ADP
dpc-2102	222	19	a	a	DET
dpc-2102	222	20	rheumatologic	rheumatologic	ADJ
dpc-2102	222	21	questionnaire	questionnaire	NOUN
dpc-2102	222	22	efficiently	efficiently	ADV
dpc-2102	222	23	aids	aid	VERB
dpc-2102	222	24	in	in	ADP
dpc-2102	222	25	early	early	ADJ
dpc-2102	222	26	detection	detection	NOUN
dpc-2102	222	27	of	of	ADP
dpc-2102	222	28	psoriatic	psoriatic	ADJ
dpc-2102	222	29	arthritis	arthritis	NOUN
dpc-2102	222	30	.	.	PUNCT
dpc-2102	223	1	turkderm	turkderm	NOUN
dpc-2102	223	2	-	-	PUNCT
dpc-2102	223	3	turk	turk	NOUN
dpc-2102	223	4	arch	arch	ADJ
dpc-2102	223	5	dermatol	dermatol	NOUN
dpc-2102	223	6	venereol	venereol	NOUN
dpc-2102	223	7	.	.	PUNCT
dpc-2102	224	1	2017;51:88–91	2017;51:88–91	NUM
dpc-2102	224	2	.	.	PUNCT
dpc-2102	225	1	doi	doi	NOUN
dpc-2102	225	2	:	:	PUNCT
dpc-2102	225	3	10.4274	10.4274	NUM
dpc-2102	225	4	/	/	SYM
dpc-2102	225	5	turkderm.87405	turkderm.87405	PROPN
dpc-2102	225	6	12	12	NUM
dpc-2102	225	7	.	.	PUNCT
dpc-2102	226	1	james	james	PROPN
dpc-2102	226	2	pa	pa	PROPN
dpc-2102	226	3	,	,	PUNCT
dpc-2102	226	4	oparil	oparil	NOUN
dpc-2102	226	5	s	s	PART
dpc-2102	226	6	,	,	PUNCT
dpc-2102	226	7	carter	carter	PROPN
dpc-2102	226	8	bl	bl	PROPN
dpc-2102	226	9	,	,	PUNCT
dpc-2102	226	10	et	et	PROPN
dpc-2102	226	11	al	al	PROPN
dpc-2102	226	12	.	.	PROPN
dpc-2102	226	13	2014	2014	NUM
dpc-2102	226	14	evidence	evidence	NOUN
dpc-2102	226	15	-	-	PUNCT
dpc-2102	226	16	based	base	VERB
dpc-2102	226	17	guideline	guideline	NOUN
dpc-2102	226	18	for	for	ADP
dpc-2102	226	19	the	the	DET
dpc-2102	226	20	management	management	NOUN
dpc-2102	226	21	of	of	ADP
dpc-2102	226	22	high	high	ADJ
dpc-2102	226	23	blood	blood	NOUN
dpc-2102	226	24	pressure	pressure	NOUN
dpc-2102	226	25	in	in	ADP
dpc-2102	226	26	adults	adult	NOUN
dpc-2102	226	27	:	:	PUNCT
dpc-2102	226	28	report	report	NOUN
dpc-2102	226	29	from	from	ADP
dpc-2102	226	30	the	the	DET
dpc-2102	226	31	panel	panel	NOUN
dpc-2102	226	32	members	member	NOUN
dpc-2102	226	33	appointed	appoint	VERB
dpc-2102	226	34	to	to	ADP
dpc-2102	226	35	the	the	DET
dpc-2102	226	36	eighth	eighth	ADJ
dpc-2102	226	37	joint	joint	ADJ
dpc-2102	226	38	national	national	PROPN
dpc-2102	226	39	committee	committee	PROPN
dpc-2102	226	40	(	(	PUNCT
dpc-2102	226	41	jnc	jnc	PROPN
dpc-2102	226	42	8)	8)	NUM
dpc-2102	226	43	.	.	PUNCT
dpc-2102	226	44	jama	jama	NOUN
dpc-2102	226	45	.	.	PUNCT
dpc-2102	227	1	2014;311(5):507–520	2014;311(5):507–520	NUM
dpc-2102	227	2	.	.	PUNCT
dpc-2102	227	3	doi	doi	PROPN
dpc-2102	227	4	:	:	PUNCT
dpc-2102	227	5	10.1001	10.1001	NUM
dpc-2102	227	6	/	/	SYM
dpc-2102	227	7	jama.2013.284427	jama.2013.284427	NOUN
dpc-2102	227	8	.	.	PUNCT
dpc-2102	228	1	pmid	pmid	NOUN
dpc-2102	228	2	:	:	PUNCT
dpc-2102	228	3	24352797	24352797	NUM
dpc-2102	228	4	.	.	PUNCT
dpc-2102	229	1	13	13	NUM
dpc-2102	229	2	.	.	PUNCT
dpc-2102	229	3	american	american	ADJ
dpc-2102	229	4	diabetes	diabetes	PROPN
dpc-2102	229	5	association	association	NOUN
dpc-2102	229	6	.	.	PUNCT
dpc-2102	230	1	2	2	X
dpc-2102	230	2	.	.	X
dpc-2102	230	3	classification	classification	NOUN
dpc-2102	230	4	and	and	CCONJ
dpc-2102	230	5	diagnosis	diagnosis	NOUN
dpc-2102	230	6	of	of	ADP
dpc-2102	230	7	diabetes	diabetes	NOUN
dpc-2102	230	8	:	:	PUNCT
dpc-2102	230	9	standards	standard	NOUN
dpc-2102	230	10	of	of	ADP
dpc-2102	230	11	medical	medical	ADJ
dpc-2102	230	12	care	care	NOUN
dpc-2102	230	13	in	in	ADP
dpc-2102	230	14	diabetes—2018	diabetes—2018	NOUN
dpc-2102	230	15	.	.	PUNCT
dpc-2102	231	1	diabetes	diabetes	NOUN
dpc-2102	231	2	care	care	NOUN
dpc-2102	231	3	.	.	PUNCT
dpc-2102	232	1	2018	2018	NUM
dpc-2102	232	2	;	;	PUNCT
dpc-2102	232	3	41(suppl	41(suppl	NUM
dpc-2102	232	4	1):s13	1):s13	NUM
dpc-2102	232	5	–	–	PUNCT
dpc-2102	232	6	s27	s27	PROPN
dpc-2102	232	7	.	.	PUNCT
dpc-2102	233	1	doi	doi	PROPN
dpc-2102	233	2	:	:	PUNCT
dpc-2102	233	3	10.2337/	10.2337/	NUM
dpc-2102	233	4	dc18	dc18	PROPN
dpc-2102	233	5	-	-	PUNCT
dpc-2102	233	6	s002	s002	PROPN
dpc-2102	233	7	.	.	PUNCT
dpc-2102	234	1	pmid	pmid	NOUN
dpc-2102	234	2	:	:	PUNCT
dpc-2102	234	3	29222373	29222373	NUM
dpc-2102	234	4	.	.	PUNCT
dpc-2102	235	1	14	14	NUM
dpc-2102	235	2	.	.	PUNCT
dpc-2102	236	1	jellinger	jellinger	PROPN
dpc-2102	236	2	ps	ps	PROPN
dpc-2102	236	3	,	,	PUNCT
dpc-2102	236	4	handelsman	handelsman	PROPN
dpc-2102	236	5	y	y	PROPN
dpc-2102	236	6	,	,	PUNCT
dpc-2102	236	7	rosenblit	rosenblit	PROPN
dpc-2102	236	8	pd	pd	PROPN
dpc-2102	236	9	,	,	PUNCT
dpc-2102	236	10	et	et	PROPN
dpc-2102	236	11	al	al	PROPN
dpc-2102	236	12	.	.	PROPN
dpc-2102	236	13	american	american	PROPN
dpc-2102	236	14	association	association	PROPN
dpc-2102	236	15	of	of	ADP
dpc-2102	236	16	clinical	clinical	ADJ
dpc-2102	236	17	endocrinologists	endocrinologist	NOUN
dpc-2102	236	18	and	and	CCONJ
dpc-2102	236	19	american	american	PROPN
dpc-2102	236	20	college	college	PROPN
dpc-2102	236	21	of	of	ADP
dpc-2102	236	22	endocrinology	endocrinology	NOUN
dpc-2102	236	23	guidelines	guideline	NOUN
dpc-2102	236	24	for	for	ADP
dpc-2102	236	25	management	management	NOUN
dpc-2102	236	26	of	of	ADP
dpc-2102	236	27	dyslipidemia	dyslipidemia	NOUN
dpc-2102	236	28	and	and	CCONJ
dpc-2102	236	29	prevention	prevention	NOUN
dpc-2102	236	30	of	of	ADP
dpc-2102	236	31	cardiovascular	cardiovascular	ADJ
dpc-2102	236	32	disease	disease	NOUN
dpc-2102	236	33	.	.	PUNCT
dpc-2102	237	1	endocr	endocr	PROPN
dpc-2102	237	2	pract	pract	PROPN
dpc-2102	237	3	.	.	PUNCT
dpc-2102	238	1	2017;23(suppl	2017;23(suppl	NOUN
dpc-2102	238	2	2):1–87	2):1–87	NUM
dpc-2102	238	3	.	.	PUNCT
dpc-2102	239	1	doi	doi	NOUN
dpc-2102	239	2	:	:	PUNCT
dpc-2102	239	3	10.4158	10.4158	NUM
dpc-2102	239	4	/	/	SYM
dpc-2102	239	5	ep171764.appgl	ep171764.appgl	PROPN
dpc-2102	239	6	.	.	PUNCT
dpc-2102	240	1	pmid	pmid	NOUN
dpc-2102	240	2	:	:	PUNCT
dpc-2102	240	3	28437620	28437620	NUM
dpc-2102	240	4	.	.	PUNCT
dpc-2102	241	1	15	15	NUM
dpc-2102	241	2	.	.	PUNCT
dpc-2102	242	1	grundy	grundy	PROPN
dpc-2102	242	2	sm	sm	PROPN
dpc-2102	242	3	,	,	PUNCT
dpc-2102	242	4	cleeman	cleeman	PROPN
dpc-2102	242	5	ji	ji	PROPN
dpc-2102	242	6	,	,	PUNCT
dpc-2102	242	7	daniels	daniels	PROPN
dpc-2102	242	8	sr	sr	PROPN
dpc-2102	242	9	,	,	PUNCT
dpc-2102	242	10	et	et	PROPN
dpc-2102	242	11	al	al	PROPN
dpc-2102	242	12	.	.	PUNCT
dpc-2102	242	13	diagnosis	diagnosis	NOUN
dpc-2102	242	14	and	and	CCONJ
dpc-2102	242	15	management	management	NOUN
dpc-2102	242	16	of	of	ADP
dpc-2102	242	17	the	the	DET
dpc-2102	242	18	metabolic	metabolic	NOUN
dpc-2102	242	19	syndrome	syndrome	NOUN
dpc-2102	242	20	:	:	PUNCT
dpc-2102	242	21	an	an	DET
dpc-2102	242	22	american	american	ADJ
dpc-2102	242	23	heart	heart	NOUN
dpc-2102	242	24	association/	association/	NUM
dpc-2102	242	25	national	national	ADJ
dpc-2102	242	26	heart	heart	NOUN
dpc-2102	242	27	,	,	PUNCT
dpc-2102	242	28	lung	lung	NOUN
dpc-2102	242	29	,	,	PUNCT
dpc-2102	242	30	and	and	CCONJ
dpc-2102	242	31	blood	blood	NOUN
dpc-2102	242	32	institute	institute	NOUN
dpc-2102	242	33	scientific	scientific	ADJ
dpc-2102	242	34	statement	statement	NOUN
dpc-2102	242	35	:	:	PUNCT
dpc-2102	242	36	executive	executive	ADJ
dpc-2102	242	37	summary	summary	NOUN
dpc-2102	242	38	.	.	PUNCT
dpc-2102	243	1	crit	crit	PROPN
dpc-2102	243	2	pathw	pathw	PROPN
dpc-2102	243	3	cardiol	cardiol	NOUN
dpc-2102	243	4	.	.	PUNCT
dpc-2102	244	1	2015;4(4):198–203	2015;4(4):198–203	X
dpc-2102	244	2	.	.	X
dpc-2102	244	3	doi	doi	NOUN
dpc-2102	244	4	:	:	PUNCT
dpc-2102	244	5	10.1097/00132577	10.1097/00132577	NUM
dpc-2102	244	6	-	-	PUNCT
dpc-2102	244	7	200512000	200512000	NUM
dpc-2102	244	8	-	-	PUNCT
dpc-2102	244	9	00018	00018	NUM
dpc-2102	244	10	.	.	PUNCT
dpc-2102	245	1	pmid	pmid	NOUN
dpc-2102	245	2	:	:	PUNCT
dpc-2102	245	3	18340209	18340209	NUM
dpc-2102	245	4	.	.	PUNCT
dpc-2102	246	1	16	16	NUM
dpc-2102	246	2	.	.	PUNCT
dpc-2102	247	1	who	who	PRON
dpc-2102	247	2	|	|	ADV
dpc-2102	247	3	obesity	obesity	NOUN
dpc-2102	247	4	.	.	PUNCT
dpc-2102	248	1	available	available	ADJ
dpc-2102	248	2	from	from	ADP
dpc-2102	248	3	:	:	PUNCT
dpc-2102	248	4	https://www.who.int/health	https://www.who.int/health	PROPN
dpc-2102	248	5	topics	topic	NOUN
dpc-2102	248	6	/	/	SYM
dpc-2102	248	7	obesity#tab	obesity#tab	NOUN
dpc-2102	248	8	=	=	NOUN
dpc-2102	248	9	tab_1	tab_1	X
dpc-2102	248	10	.	.	PUNCT
dpc-2102	249	1	accessed	access	VERB
dpc-2102	249	2	on	on	ADP
dpc-2102	249	3	?	?	PUNCT
dpc-2102	250	1	17	17	NUM
dpc-2102	250	2	.	.	PUNCT
dpc-2102	250	3	gudjónsson	gudjónsson	PROPN
dpc-2102	250	4	je	je	PROPN
dpc-2102	250	5	,	,	PUNCT
dpc-2102	250	6	kárason	kárason	PROPN
dpc-2102	250	7	a	a	PRON
dpc-2102	250	8	,	,	PUNCT
dpc-2102	250	9	antonsdóttir	antonsdóttir	VERB
dpc-2102	250	10	aa	aa	PROPN
dpc-2102	250	11	,	,	PUNCT
dpc-2102	250	12	et	et	PROPN
dpc-2102	250	13	al	al	PROPN
dpc-2102	250	14	.	.	PROPN
dpc-2102	250	15	hla	hla	PROPN
dpc-2102	250	16	-	-	PUNCT
dpc-2102	250	17	cw6	cw6	NOUN
dpc-2102	250	18	-	-	PUNCT
dpc-2102	250	19	positive	positive	ADJ
dpc-2102	250	20	and	and	CCONJ
dpc-2102	250	21	hla	hla	ADJ
dpc-2102	250	22	-	-	PUNCT
dpc-2102	250	23	cw6	cw6	NOUN
dpc-2102	250	24	-	-	PUNCT
dpc-2102	250	25	negative	negative	ADJ
dpc-2102	250	26	patients	patient	NOUN
dpc-2102	250	27	with	with	ADP
dpc-2102	250	28	psoriasis	psoriasis	NOUN
dpc-2102	250	29	vulgaris	vulgaris	NOUN
dpc-2102	250	30	have	have	VERB
dpc-2102	250	31	distinct	distinct	ADJ
dpc-2102	250	32	clinical	clinical	ADJ
dpc-2102	250	33	features	feature	NOUN
dpc-2102	250	34	.	.	PUNCT
dpc-2102	251	1	j	j	PROPN
dpc-2102	251	2	invest	invest	VERB
dpc-2102	251	3	dermatol	dermatol	NOUN
dpc-2102	251	4	.	.	PUNCT
dpc-2102	252	1	2002;118(2):362–365	2002;118(2):362–365	X
dpc-2102	252	2	.	.	PUNCT
dpc-2102	253	1	doi	doi	NOUN
dpc-2102	253	2	:	:	PUNCT
dpc-2102	253	3	10.1046	10.1046	NUM
dpc-2102	253	4	/	/	SYM
dpc-2102	253	5	j.0022202x.2001.01656.x	j.0022202x.2001.01656.x	PROPN
dpc-2102	253	6	.	.	PUNCT
dpc-2102	254	1	pmid	pmid	NOUN
dpc-2102	254	2	:	:	PUNCT
dpc-2102	254	3	11841557	11841557	NUM
dpc-2102	254	4	.	.	PUNCT
dpc-2102	255	1	18	18	NUM
dpc-2102	255	2	.	.	X
dpc-2102	255	3	zaias	zaias	NUM
dpc-2102	255	4	n.	n.	NOUN
dpc-2102	255	5	psoriasis	psoriasis	NOUN
dpc-2102	255	6	of	of	ADP
dpc-2102	255	7	the	the	DET
dpc-2102	255	8	nail	nail	NOUN
dpc-2102	255	9	.	.	PUNCT
dpc-2102	256	1	a	a	DET
dpc-2102	256	2	clinical	clinical	ADJ
dpc-2102	256	3	-	-	PUNCT
dpc-2102	256	4	pathologic	pathologic	ADJ
dpc-2102	256	5	study	study	NOUN
dpc-2102	256	6	.	.	PUNCT
dpc-2102	257	1	arch	arch	ADJ
dpc-2102	257	2	dermatol	dermatol	NOUN
dpc-2102	257	3	.	.	PUNCT
dpc-2102	258	1	1969;99(5):567–79	1969;99(5):567–79	NUM
dpc-2102	258	2	.	.	PUNCT
dpc-2102	259	1	doi:10.1001	doi:10.1001	PROPN
dpc-2102	259	2	/	/	SYM
dpc-2102	259	3	archderm	archderm	PROPN
dpc-2102	259	4	.1969.01610230059011	.1969.01610230059011	PROPN
dpc-2102	259	5	.	.	PUNCT
dpc-2102	260	1	pmid	pmid	NOUN
dpc-2102	260	2	:	:	PUNCT
dpc-2102	260	3	5780963	5780963	NUM
dpc-2102	260	4	.	.	PUNCT
dpc-2102	261	1	19	19	NUM
dpc-2102	261	2	.	.	PUNCT
dpc-2102	261	3	nestle	nestle	PROPN
dpc-2102	261	4	fo	fo	PROPN
dpc-2102	261	5	,	,	PUNCT
dpc-2102	261	6	kaplan	kaplan	PROPN
dpc-2102	261	7	dh	dh	PROPN
dpc-2102	261	8	,	,	PUNCT
dpc-2102	261	9	barker	barker	PROPN
dpc-2102	261	10	j.	j.	PROPN
dpc-2102	261	11	psoriasis	psoriasis	PROPN
dpc-2102	261	12	.	.	PUNCT
dpc-2102	262	1	n	n	PROPN
dpc-2102	262	2	engl	engl	PROPN
dpc-2102	262	3	j	j	PROPN
dpc-2102	262	4	med	med	PROPN
dpc-2102	262	5	.	.	PUNCT
dpc-2102	263	1	2009;361(5):496–509	2009;361(5):496–509	NUM
dpc-2102	263	2	.	.	PUNCT
dpc-2102	263	3	doi	doi	NOUN
dpc-2102	263	4	:	:	PUNCT
dpc-2102	263	5	10.1056	10.1056	NUM
dpc-2102	263	6	/	/	SYM
dpc-2102	263	7	nejmra0804595	nejmra0804595	PROPN
dpc-2102	263	8	.	.	PUNCT
dpc-2102	264	1	pmid	pmid	NOUN
dpc-2102	264	2	:	:	PUNCT
dpc-2102	264	3	19641206	19641206	NUM
dpc-2102	264	4	.	.	PUNCT
dpc-2102	265	1	20	20	NUM
dpc-2102	265	2	.	.	PUNCT
dpc-2102	266	1	dogan	dogan	PROPN
dpc-2102	266	2	s	s	PROPN
dpc-2102	266	3	,	,	PUNCT
dpc-2102	266	4	atakan	atakan	PROPN
dpc-2102	266	5	n.	n.	PROPN
dpc-2102	266	6	red	red	ADJ
dpc-2102	266	7	blood	blood	NOUN
dpc-2102	266	8	cell	cell	NOUN
dpc-2102	266	9	distribution	distribution	NOUN
dpc-2102	266	10	width	width	NOUN
dpc-2102	266	11	is	be	AUX
dpc-2102	266	12	a	a	DET
dpc-2102	266	13	reliable	reliable	ADJ
dpc-2102	266	14	marker	marker	NOUN
dpc-2102	266	15	of	of	ADP
dpc-2102	266	16	inflammation	inflammation	NOUN
dpc-2102	266	17	in	in	ADP
dpc-2102	266	18	plaque	plaque	NOUN
dpc-2102	266	19	psoriasis	psoriasis	NOUN
dpc-2102	266	20	.	.	PUNCT
dpc-2102	267	1	acta	acta	PROPN
dpc-2102	267	2	dermatovenerol	dermatovenerol	PROPN
dpc-2102	267	3	croat	croat	PROPN
dpc-2102	267	4	.	.	PUNCT
dpc-2102	268	1	2017;25(1):26–31	2017;25(1):26–31	X
dpc-2102	268	2	.	.	PUNCT
dpc-2102	268	3	doi	doi	PROPN
dpc-2102	268	4	:	:	PUNCT
dpc-2102	268	5	10.5937	10.5937	NUM
dpc-2102	268	6	/	/	SYM
dpc-2102	268	7	jomb0	jomb0	PROPN
dpc-2102	268	8	-	-	PUNCT
dpc-2102	268	9	27237	27237	NUM
dpc-2102	268	10	.	.	PUNCT
dpc-2102	269	1	pmid	pmid	NOUN
dpc-2102	269	2	:	:	PUNCT
dpc-2102	269	3	28511747	28511747	NUM
dpc-2102	269	4	.	.	PUNCT
dpc-2102	270	1	21	21	NUM
dpc-2102	270	2	.	.	PUNCT
dpc-2102	271	1	vadakayil	vadakayil	PROPN
dpc-2102	271	2	a	a	PRON
dpc-2102	271	3	,	,	PUNCT
dpc-2102	271	4	dandekeri	dandekeri	NOUN
dpc-2102	271	5	s	s	PART
dpc-2102	271	6	,	,	PUNCT
dpc-2102	271	7	srinath	srinath	PROPN
dpc-2102	271	8	m	m	PROPN
dpc-2102	271	9	,	,	PUNCT
dpc-2102	271	10	ali	ali	PROPN
dpc-2102	271	11	n.	n.	PROPN
dpc-2102	271	12	role	role	NOUN
dpc-2102	271	13	of	of	ADP
dpc-2102	271	14	c	c	NOUN
dpc-2102	271	15	-	-	PUNCT
dpc-2102	271	16	reactive	reactive	ADJ
dpc-2102	271	17	protein	protein	NOUN
dpc-2102	271	18	as	as	ADP
dpc-2102	271	19	a	a	DET
dpc-2102	271	20	marker	marker	NOUN
dpc-2102	271	21	of	of	ADP
dpc-2102	271	22	disease	disease	NOUN
dpc-2102	271	23	severity	severity	NOUN
dpc-2102	271	24	and	and	CCONJ
dpc-2102	271	25	cardiovascular	cardiovascular	ADJ
dpc-2102	271	26	risk	risk	NOUN
dpc-2102	271	27	in	in	ADP
dpc-2102	271	28	patients	patient	NOUN
dpc-2102	271	29	with	with	ADP
dpc-2102	271	30	psoriasis	psoriasis	NOUN
dpc-2102	271	31	.	.	PUNCT
dpc-2102	272	1	indian	indian	ADJ
dpc-2102	272	2	dermatol	dermatol	NOUN
dpc-2102	272	3	online	online	PROPN
dpc-2102	272	4	j.	j.	PROPN
dpc-2102	272	5	2015;6(5):322–325	2015;6(5):322–325	PROPN
dpc-2102	272	6	.	.	PUNCT
dpc-2102	272	7	doii	doii	ADJ
dpc-2102	272	8	:	:	PUNCT
dpc-2102	272	9	10.4103/2229	10.4103/2229	NUM
dpc-2102	272	10	-	-	SYM
dpc-2102	272	11	5178.164483	5178.164483	NUM
dpc-2102	272	12	.	.	PUNCT
dpc-2102	273	1	pmid	pmid	NOUN
dpc-2102	273	2	:	:	PUNCT
dpc-2102	273	3	26500861	26500861	NUM
dpc-2102	273	4	.	.	PUNCT
dpc-2102	274	1	pmcid	pmcid	ADJ
dpc-2102	274	2	:	:	PUNCT
dpc-2102	274	3	pmc4594390	pmc4594390	NOUN
dpc-2102	274	4	.	.	PUNCT
dpc-2102	275	1	22	22	NUM
dpc-2102	275	2	.	.	PUNCT
dpc-2102	276	1	elmets	elmet	NOUN
dpc-2102	276	2	ca	can	AUX
dpc-2102	276	3	,	,	PUNCT
dpc-2102	276	4	leonardi	leonardi	PROPN
dpc-2102	276	5	cl	cl	PROPN
dpc-2102	276	6	,	,	PUNCT
dpc-2102	276	7	davis	davis	PROPN
dpc-2102	276	8	dmr	dmr	PROPN
dpc-2102	276	9	,	,	PUNCT
dpc-2102	276	10	et	et	PROPN
dpc-2102	276	11	al	al	PROPN
dpc-2102	276	12	.	.	PUNCT
dpc-2102	277	1	joint	joint	ADJ
dpc-2102	277	2	aad	aad	ADJ
dpc-2102	277	3	-	-	PUNCT
dpc-2102	277	4	npf	npf	NOUN
dpc-2102	277	5	guidelines	guideline	NOUN
dpc-2102	277	6	of	of	ADP
dpc-2102	277	7	care	care	NOUN
dpc-2102	277	8	for	for	ADP
dpc-2102	277	9	the	the	DET
dpc-2102	277	10	management	management	NOUN
dpc-2102	277	11	and	and	CCONJ
dpc-2102	277	12	treatment	treatment	NOUN
dpc-2102	277	13	of	of	ADP
dpc-2102	277	14	psoriasis	psoriasis	NOUN
dpc-2102	277	15	with	with	ADP
dpc-2102	277	16	awareness	awareness	NOUN
dpc-2102	277	17	and	and	CCONJ
dpc-2102	277	18	attention	attention	NOUN
dpc-2102	277	19	to	to	ADP
dpc-2102	277	20	comorbidities	comorbiditie	NOUN
dpc-2102	277	21	.	.	PUNCT
dpc-2102	278	1	j	j	PROPN
dpc-2102	278	2	am	be	AUX
dpc-2102	278	3	acad	acad	ADJ
dpc-2102	278	4	dermatol	dermatol	NOUN
dpc-2102	278	5	.	.	PUNCT
dpc-2102	279	1	2019;80(4):1073–1113	2019;80(4):1073–1113	PROPN
dpc-2102	279	2	.	.	PUNCT
dpc-2102	280	1	doi	doi	NOUN
dpc-2102	280	2	:	:	PUNCT
dpc-2102	280	3	10.1016	10.1016	NUM
dpc-2102	280	4	/	/	SYM
dpc-2102	280	5	j.	j.	PROPN
dpc-2102	280	6	jaad.2018.11.058	jaad.2018.11.058	PROPN
dpc-2102	280	7	.	.	PUNCT
dpc-2102	281	1	pmid	pmid	NOUN
dpc-2102	281	2	:	:	PUNCT
dpc-2102	281	3	30772097	30772097	NUM
dpc-2102	281	4	.	.	PUNCT